Panc1	BXPC3	MIAPaCa2	HS766T	HPAFII	AVG	MULT	ID	name	Index
12.18607378	2.57345757	7.379765677	-0.630747834	-0.630747834	4.175560273	92.07355743	105815	Mitotic Prometaphase	276
11.75079763	2.690465598	2.690465598	2.690465598	2.690465598	4.502532005	615.7112941	760637	Gastric cancer network 2	1835
11.21492902	2.775671724	6.151374641	-0.600031194	-0.600031194	3.788382599	68.94209318	730315	Resolution of Sister Chromatid Cohesion	1801
9.825323311	2.157277023	9.825323311	-0.398738407	-0.398738407	4.202089366	33.11126378	138080	Aurora B signaling	986
9.093077932	1.956027596	4.335044375	-0.422989183	-0.422989183	2.907634307	13.79551639	137935	FOXM1 transcription factor network	856
8.870515066	-0.225116891	4.322699087	-0.225116891	-0.225116891	2.503572696	0.437449665	730316	Condensation of Prometaphase Chromosomes	1802
8.758814258	1.485018203	6.576675441	-1.424500219	-1.424500219	2.794301493	173.5835415	530733	Cell Cycle	1540
8.539777564	4.047994709	6.293886136	-0.443788146	-0.443788146	3.598816423	42.85058665	138007	PLK1 signaling events	921
8.457535073	-0.22977947	4.113877802	-0.22977947	-0.22977947	2.376414893	0.422113132	105806	Polo-like kinase mediated events	267
7.836108268	2.36749807	5.101803169	-0.366807029	2.36749807	3.46122011	82.19417555	760635	Gastric cancer network 1	1833
7.812972689	1.704375088	6.285823288	-1.349923712	-1.349923712	2.620664728	152.5324	105765	Cell Cycle, Mitotic	238
7.495686535	-0.25720208	3.619242228	-0.25720208	-0.25720208	2.068664505	0.461585859	187197	Kinesins	1229
7.162741779	1.87868156	4.520711669	-0.763348549	-0.763348549	2.407087582	35.44745381	730318	Separation of Sister Chromatids	1804
6.8887865	1.76962882	5.60899708	-0.789950019	-0.789950019	2.537502472	42.66869398	105818	Mitotic Anaphase	277
6.877088986	1.764439311	5.598926568	-0.791885527	-0.791885527	2.531336762	42.60307546	730317	Mitotic Metaphase and Anaphase	1803
6.811781112	-0.41378403	4.403259398	-0.41378403	-0.41378403	1.994737684	2.124986284	161049	Nucleosome assembly	1134
6.811781112	-0.41378403	4.403259398	-0.41378403	-0.41378403	1.994737684	2.124986284	161050	Deposition of New CENPA-containing Nucleosomes at the Centromere	1135
6.801767762	0.921234535	4.84159002	-1.038943208	-1.038943208	2.09734118	32.74640563	105812	M Phase	273
6.778523383	-0.146817221	-0.146817221	-0.146817221	-0.146817221	1.2382509	0.003149511	771571	Activation of NIMA Kinases NEK9, NEK6, NEK7	1839
6.244819555	-0.308325474	6.244819555	-0.308325474	-0.308325474	2.312932538	1.143057321	477139	G0 and Early G1	1535
6.138889283	6.138889283	6.138889283	-0.157084547	-0.157084547	3.620499751	5.708688301	105827	Phosphorylation of Emi1	286
6.118115055	2.75831327	1.078412378	-2.281389407	-0.601488514	1.414392556	24.97312277	920977	RB in Cancer	1991
5.796935346	-0.630000374	4.190201416	-0.630000374	-0.630000374	1.619427128	6.073734133	161048	Chromosome Maintenance	1133
5.27762478	-0.351991775	2.462816502	-0.351991775	-0.351991775	1.336893191	0.566849949	198852	Statin Pathway	1352
5.225841273	0.792779257	3.748153934	-0.684908081	-0.684908081	1.67939166	7.284344773	105801	G2/M Transition	265
5.161093787	0.771786527	3.697991367	-0.691315894	-0.691315894	1.649647979	7.039761078	160942	Mitotic G2-G2/M phases	1052
5.069845532	-0.190694579	-0.190694579	-0.190694579	-0.190694579	0.861413443	0.006704218	105781	E2F-enabled inhibition of pre-replication complex formation	248
5.055940689	-0.188539046	5.055940689	15.54490016	-0.188539046	5.055940689	14.12519627	161008	Neurofascin interactions	1101
5.052975039	1.322672148	3.187823593	-0.542479298	-0.542479298	1.695702437	6.269890849	105807	Centrosome maturation	268
5.052975039	1.322672148	3.187823593	-0.542479298	-0.542479298	1.695702437	6.269890849	105808	Recruitment of mitotic centrosome proteins and complexes	269
4.915081719	4.915081719	-0.197605355	-0.197605355	-0.197605355	1.847469474	0.186405026	105896	Regulation of the Fanconi anemia pathway	327
4.80592087	-0.203377514	-0.203377514	-0.203377514	-0.203377514	0.798482163	0.008222206	105809	Recruitment of NuMA to mitotic centrosomes	270
4.776110145	-0.200559799	-0.200559799	-0.200559799	-0.200559799	0.79477419	0.007727693	105751	G2/M DNA damage checkpoint	233
4.683367046	1.17877091	2.931068978	-0.573527158	-0.573527158	1.529230524	5.322572912	771569	Regulation of PLK1 Activity at G2/M Transition	1837
4.291781789	-0.222556897	-0.222556897	-0.222556897	-0.222556897	0.68031084	0.010529357	730314	MASTL Facilitates Mitotic Progression	1800
4.110164054	-0.226824501	4.110164054	12.78414117	-0.226824501	4.110164054	11.11142608	161007	CHL1 interactions	1100
4.038109485	-0.44593858	-2.687962613	-2.687962613	4.038109485	0.450871033	52.53850053	137993	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	908
3.932432536	-0.239688345	3.932432536	12.2766743	-0.239688345	3.932432536	10.90679442	161009	NrCAM interactions	1102
3.922205041	-0.239064962	-0.239064962	-0.239064962	-0.239064962	0.593189039	0.012811324	105830	Phosphorylation of the APC/C	289
3.728147837	-0.684557722	0.786344131	-0.684557722	0.786344131	0.786344131	1.080285565	187196	Factors involved in megakaryocyte development and platelet production	1228
3.593214677	-0.26257959	-0.26257959	-0.26257959	-0.26257959	0.508579264	0.01708154	198835	Hedgehog Signaling Pathway	1336
3.547402639	1.524361499	3.547402639	-0.498679641	-0.498679641	1.524361499	4.770371666	105810	Loss of proteins required for interphase microtubule organizationÂ from the centrosome	271
3.547402639	1.524361499	3.547402639	-0.498679641	-0.498679641	1.524361499	4.770371666	105811	Loss of Nlp from mitotic centrosomes	272
3.505269792	1.501456957	-0.502355878	1.501456957	1.501456957	1.501456957	5.96034774	169345	Notch signaling pathway	1161
3.4813967	-0.265465163	3.4813967	-0.265465163	-0.265465163	1.233279582	0.22674078	106158	HDL-mediated lipid transport	503
3.446291297	0.658988147	2.052639722	-0.734663428	-0.734663428	0.937718462	2.516049363	160941	Mitotic G1-G1/S phases	1051
3.433114728	3.433114728	3.433114728	-0.266561686	-0.266561686	1.953244163	2.87514931	105832	APC/C:Cdc20 mediated degradation of Cyclin B	291
3.353377385	-0.275818919	-0.275818919	-0.275818919	-0.275818919	0.450020342	0.019407904	105814	Golgi Cisternae Pericentriolar Stack Reorganization	275
3.350170166	-0.274182261	-0.274182261	-0.274182261	-0.274182261	0.450688224	0.018933211	106157	Chylomicron-mediated lipid transport	502
3.3051108	3.3051108	-0.280774846	-0.280774846	-0.280774846	1.153579412	0.241794624	105895	Fanconi Anemia pathway	326
3.074352757	-0.295354874	-0.295354874	-0.295354874	-0.295354874	0.378586652	0.023395389	105802	Cyclin A/B1 associated events during G2/M transition	266
2.883135562	-0.579882349	-0.579882349	-2.311391305	2.883135562	0.459023024	6.460756609	138073	C-MYB transcription factor network	982
2.721064604	-0.326210836	-0.326210836	-0.326210836	2.721064604	0.89269934	0.257023513	137929	IL27-mediated signaling events	850
2.63414443	-0.342626312	-0.342626312	-0.342626312	2.63414443	0.848081985	0.27908809	198846	Selenium Metabolism and Selenoproteins	1346
2.519075875	-0.351502297	2.519075875	-0.351502297	-0.351502297	0.796728972	0.27559225	137925	Aurora A signaling	846
2.499287471	-0.638845399	-2.207911834	-0.638845399	0.930221036	-0.011218825	2.094959534	672460	Neural Crest Differentiation	1746
2.481142578	-0.358830613	2.481142578	8.161088959	-0.358830613	2.481142578	6.468901349	161005	Interaction between L1 and Ankyrins	1098
2.450268213	-0.353884011	2.450268213	-0.353884011	2.450268213	1.328607324	1.842310211	106262	Striated Muscle Contraction	562
2.441570765	3.993301526	0.889840005	-2.213621517	0.889840005	1.200186157	17.08947184	198811	Cell cycle	1313
2.408450667	-0.367221417	-0.367221417	-0.367221417	2.408450667	0.743047417	0.287249654	169354	Noncanonical Wnt signaling pathway	1170
2.406550474	-0.358963746	2.406550474	-0.358963746	-0.358963746	0.747241942	0.267880879	106156	Lipoprotein metabolism	501
2.374613246	-0.36395583	-0.36395583	-5.841093982	-0.36395583	-0.911669645	0.66870277	198785	Vitamin A and carotenoid metabolism	1288
2.358055349	-0.367075067	-0.367075067	-0.367075067	-0.367075067	0.177951016	0.042812791	105778	E2F mediated regulation of DNA replication	246
2.352765247	-0.370500274	-0.370500274	-0.370500274	-0.370500274	0.17415283	0.044333573	833803	Nuclear Pore Complex (NPC) Disassembly	1898
2.254102925	-0.37904108	-3.012185085	-3.012185085	2.254102925	-0.37904108	17.47419078	83112	Thyroid cancer	151
2.237556857	2.237556857	-0.381613056	-0.381613056	-0.381613056	0.666054909	0.278238891	377262	Fanconi anemia pathway	1463
2.132674116	-0.391798086	-0.391798086	-0.391798086	-0.391798086	0.113096355	0.050254359	576261	Mitochondrial Protein Import	1636
2.052179856	-0.404637881	2.052179856	-0.404637881	-0.404637881	0.578089213	0.279016865	198903	Striated Muscle Contraction	1402
2.045874638	-0.413404888	2.045874638	-0.413404888	-0.413404888	0.570306922	0.295722834	771570	Nuclear Envelope Breakdown	1838
1.993811113	-0.418105796	1.993811113	4.405728022	1.993811113	1.993811113	14.60010262	198802	Heart Development	1304
1.987086015	-0.413356139	-0.413356139	-0.413356139	6.787970322	1.506997584	0.952642115	198887	Nuclear receptors in lipid metabolism and toxicity	1386
1.942911318	-0.421734599	-0.421734599	-0.421734599	-0.421734599	0.051194584	0.061462456	105750	G2/M Checkpoints	232
1.928691021	3.271276397	1.928691021	-0.75647973	-0.75647973	1.123139796	6.963653423	83054	Cell cycle	93
1.818181723	-0.446477582	-0.446477582	-0.446477582	-0.446477582	0.006454279	0.072249678	83062	Notch signaling pathway	101
1.810419138	-0.446820608	-0.446820608	-0.446820608	-0.446820608	0.004627341	0.072162557	198891	Notch Signaling Pathway	1390
1.794318086	-2.676666991	-0.441174452	-2.676666991	-2.676666991	-1.335371468	15.1807357	106111	Lipid digestion, mobilization, and transport	479
1.695334097	-0.468599909	-0.468599909	1.695334097	1.695334097	0.829760494	1.069966769	198907	Energy Metabolism	1405
1.66854664	-0.473636747	-0.473636747	-0.473636747	-0.473636747	-0.045200069	0.083969179	941401	Condensation of Prophase Chromosomes	2005
1.618791554	1.618791554	-0.477409875	-0.477409875	-0.477409875	0.361070696	0.285138627	138036	FoxO family signaling	947
1.609895835	-0.483188524	1.609895835	-0.483188524	-0.483188524	0.354045219	0.292378469	477134	Meiotic Synapsis	1530
1.603358362	-0.483532647	-0.483532647	-0.483532647	-0.483532647	-0.066154445	0.087646345	771568	Stimuli-sensing channels	1836
1.602907261	-0.487068958	-0.487068958	-0.487068958	1.602907261	0.34892153	0.296884926	198848	Nuclear Receptors	1348
1.524211133	-0.496886968	1.524211133	-0.496886968	-2.51798507	-0.092667348	1.444304031	106261	Muscle contraction	561
1.482688877	1.482688877	1.482688877	-0.504297021	-0.504297021	0.687894518	0.828939613	105831	APC/C:Cdc20 mediated degradation of mitotic proteins	290
1.472765723	1.472765723	1.472765723	-0.507290372	-0.507290372	0.680743285	0.822080303	105829	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	288
1.466734952	-2.045421217	-2.045421217	0.296016229	1.466734952	-0.17227126	2.66430732	198901	SIDS Susceptibility Pathways	1400
1.460709168	1.460709168	-0.50790157	1.460709168	1.460709168	1.06698702	2.312248868	137916	Regulation of retinoblastoma protein	837
1.458737145	-0.512396082	-0.512396082	-0.512396082	-0.512396082	-0.118169437	0.100554207	198868	AMPK signaling	1367
1.447409487	-0.511196043	-0.511196043	-2.469801574	-0.511196043	-0.511196043	0.477546789	137933	IL4-mediated signaling events	854
1.409947996	-0.515027082	-0.515027082	-0.515027082	1.409947996	0.254962949	0.271579128	842771	Inflammatory bowel disease (IBD)	1930
1.391859282	-2.429567808	-0.518854263	-0.518854263	3.302572826	0.245431155	3.006543807	83042	PPAR signaling pathway	81
1.38921704	-0.52800217	-0.52800217	-0.52800217	1.38921704	0.238885514	0.284084361	105979	Nuclear Receptor transcription pathway	386
1.351413929	-0.533140427	-0.533140427	-0.533140427	1.351413929	0.220681315	0.276758921	137997	Signaling events mediated by HDAC Class I	912
1.340181122	-0.538401892	-0.538401892	-0.538401892	-0.538401892	-0.162685289	0.112613331	198805	G1 to S cell cycle control	1307
1.320007266	-0.543225518	-0.543225518	-0.543225518	-0.543225518	-0.170578961	0.114946823	83086	Long-term depression	125
1.280746339	1.280746339	1.280746339	-0.548107493	-0.548107493	0.549204806	0.631132941	105826	Regulation of APC/C activators between G1/S and early anaphase	285
1.259857769	-2.359643112	-4.169393553	1.259857769	1.259857769	-0.549892671	19.6735969	83055	p53 signaling pathway	94
1.190943527	-0.570937569	-0.570937569	-0.570937569	-0.570937569	-0.21856135	0.126545194	198788	DNA damage response	1291
1.185213566	-2.324450533	-0.569618483	-0.569618483	1.185213566	-0.218652073	1.059452968	205243	Transcriptional Regulation of White Adipocyte Differentiation	1425
1.167796677	2.910906875	1.167796677	-0.575313521	-0.575313521	0.819174637	1.313929138	105825	APC/C-mediated degradation of cell cycle proteins	284
1.167796677	2.910906875	1.167796677	-0.575313521	-0.575313521	0.819174637	1.313929138	160944	Regulation of mitotic cell cycle	1053
1.12532527	-0.588672552	-0.588672552	-2.302670374	-2.302670374	-0.931472117	2.067707921	119304	Progesterone-mediated oocyte maturation	772
1.05250259	-0.605765237	1.05250259	-0.605765237	-0.605765237	0.057541894	0.246240445	169351	Validated targets of C-MYC transcriptional activation	1167
1.048963944	-0.610657833	1.048963944	-0.610657833	-0.610657833	0.053190878	0.250561833	477133	Meiosis	1529
1.033687396	-0.605915104	-0.605915104	-0.605915104	-0.605915104	-0.277994604	0.139327336	645290	MHC class II antigen presentation	1683
0.991724041	0.991724041	-0.62741725	2.610865332	0.991724041	0.991724041	1.597767014	138014	Glucocorticoid receptor regulatory network	928
0.988855186	0.988855186	-0.623496332	-0.623496332	-0.623496332	0.021444275	0.237010234	105837	DNA Repair	296
0.988190356	-0.632059449	-0.632059449	-0.632059449	0.988190356	0.016040473	0.246578386	198862	TCR Signaling Pathway	1362
0.987093485	-0.622516764	-0.622516764	-0.622516764	-0.622516764	-0.300594714	0.148239004	672448	Alzheimers Disease	1734
0.980852892	0.980852892	0.980852892	0.980852892	-0.628289741	0.659024366	0.581534489	83122	Systemic lupus erythematosus	161
0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.703217909	941402	Chromatin organization	2006
0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.703217909	941403	Chromatin modifying enzymes	2007
0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.932004447	0.703217909	941404	HATs acetylate histones	2008
0.923736725	-0.646442988	0.923736725	0.923736725	2.493916437	0.923736725	1.270740163	137963	Regulation of nuclear SMAD2/3 signaling	883
0.903122029	-0.649834775	-0.649834775	-0.649834775	-0.649834775	-0.339243414	0.161049072	698773	Circadian entrainment	1783
0.861627488	0.861627488	-0.666351742	-0.666351742	-0.666351742	-0.05516005	0.219659354	105769	G1/S Transition	241
0.859021244	-0.663526158	0.859021244	0.859021244	-0.663526158	0.250002283	0.279079419	198797	Apoptosis	1299
0.812398664	0.812398664	0.812398664	-0.675374734	-0.675374734	0.217289305	0.244566643	105739	Cell Cycle Checkpoints	224
0.805353842	0.805353842	0.805353842	-2.166705728	-2.166705728	-0.383469986	2.452223598	126909	Oocyte meiosis	827
0.79256856	-0.680333429	-0.680333429	-0.680333429	-0.680333429	-0.385753031	0.169794682	187193	Ion channel transport	1225
0.775282253	-0.69000267	0.775282253	3.705852099	-0.69000267	0.775282253	1.060496673	161003	L1CAM interactions	1096
0.753637642	-0.698178274	0.753637642	-0.698178274	-0.698178274	-0.117451908	0.193296573	105813	Mitotic Prophase	274
0.724361417	-0.707041443	-2.138444303	0.724361417	3.587167137	0.438080845	2.845804393	530749	PPARA Activates Gene Expression	1555
0.696053517	-0.716966209	-2.129985934	0.696053517	3.522092968	0.413449572	2.605922539	119544	Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	796
0.608973368	-0.749432539	0.608973368	0.608973368	1.967379276	0.608973368	0.332977999	585563	Alcoholism	1656
0.545001188	-0.769046282	-2.083093752	-2.083093752	-2.083093752	-1.29466527	3.788579241	921162	FoxO signaling pathway	1997
0.528332708	-0.774583958	-0.774583958	-0.774583958	1.831249374	0.007166042	0.449635385	193147	Osteoclast differentiation	1256
0.519910802	-2.076397822	-2.076397822	0.519910802	1.818065114	-0.258981785	2.118791609	198832	Adipogenesis	1333
0.480359604	-2.063917959	-0.791779178	-0.791779178	-0.791779178	-0.791779178	0.492120138	83097	Alzheimer"s disease	136
0.448201987	-2.046313036	-0.799055525	-0.799055525	0.448201987	-0.549604022	0.262466296	83100	Huntington"s disease	139
0.411281	0.411281	4.103763413	0.411281	-2.050373943	0.657446494	0.585371169	198906	Calcium Regulation in the Cardiac Cell	1404
0.329021354	-3.206941614	3.864984322	0.329021354	-4.385595937	-0.613902104	5.884581425	198759	Myometrial Relaxation and Contraction Pathways	1263
0.326359464	-0.85889372	-2.044146905	0.326359464	2.696865834	0.089308827	0.504316637	160977	Fatty acid, triacylglycerol, and ketone body metabolism	1080
0.275118374	1.424077966	0.275118374	-0.873841217	-0.873841217	0.045326456	0.082307235	366162	Antigen processing: Ubiquitination & Proteasome degradation	1439
0.219121738	-0.899988261	-0.899988261	0.219121738	-0.899988261	-0.452344261	0.035001081	83050	Calcium signaling pathway	89
0.2007987	-3.131959807	0.2007987	1.311718202	2.422637704	0.2007987	0.401297996	523016	Transcriptional misregulation in cancer	1536
0.07308763	-2.010665189	-2.010665189	-2.010665189	-3.052541598	-1.802289907	1.813530015	711360	Integrated Pancreatic Cancer Pathway	1787
0.033993816	1.060997311	0.033993816	-0.993009679	-0.993009679	-0.171406883	0.001208985	366161	Class I MHC mediated antigen processing & presentation	1438
0	0	0	0	0	0	0	106070	Fusion and Uncoating of the Influenza Virion	453
0	0	0	0	0	0	0	106071	Fusion of the Influenza Virion to the Host Cell Endosome	454
0	0	0	0	0	0	0	106072	Uncoating of the Influenza Virion	455
0	0	0	0	0	0	0	106086	Packaging of Eight RNA Segments	466
0	0	0	0	0	0	0	106087	Budding	467
0	0	0	0	0	0	0	106088	Release	468
-0.007071245	-0.007071245	-0.007071245	-0.007071245	-0.007071245	-0.007071245	1.76799E-11	106081	Viral RNP Complexes in the Host Cell Nucleus	462
-0.049558221	-0.049558221	-0.049558221	-0.049558221	-0.049558221	-0.049558221	2.98936E-07	645269	Response of Mtb to phagocytosis	1670
-0.049558221	-0.049558221	-0.049558221	-0.049558221	-0.049558221	-0.049558221	2.98936E-07	645273	Mtb iron assimilation by chelation	1671
-0.076928629	-0.076928629	0.895006043	-1.048863301	-0.076928629	-0.076928629	0.000427375	373901	HTLV-I infection	1461
-0.077039059	-0.077039059	-0.077039059	-0.077039059	-0.077039059	-0.077039059	2.71366E-06	833798	Sperm Motility And Taxes	1896
-0.081820038	-0.081820038	-0.081820038	-0.081820038	-0.081820038	-0.081820038	3.66689E-06	105731	Conjugation of benzoate with glycine	220
-0.086929138	-0.086929138	-0.086929138	-0.086929138	-0.086929138	-0.086929138	4.96394E-06	161023	Free fatty acid receptors	1112
-0.095570662	-0.095570662	-0.095570662	-0.095570662	-0.095570662	-0.095570662	7.97302E-06	576257	IRF3 mediated activation of type 1 IFN	1632
-0.097156135	-0.097156135	-0.097156135	-0.097156135	-0.097156135	-0.097156135	8.65668E-06	106151	Pregnenolone biosynthesis	497
-0.099232169	-0.099232169	-0.099232169	-0.099232169	-0.099232169	-0.099232169	9.62193E-06	161068	Zinc efflux and compartmentalization by the SLC30 family	1150
-0.101010153	-0.101010153	-0.101010153	-0.101010153	-0.101010153	-0.101010153	1.05154E-05	730342	Phosphate bond hydrolysis by NUDT proteins	1818
-0.102015656	-0.102015656	-0.102015656	-0.102015656	-0.102015656	-0.102015656	1.10493E-05	771586	The retinoid cycle in cones (daylight vision)	1853
-0.104261614	-0.104261614	-0.104261614	-0.104261614	-0.104261614	-0.104261614	1.23203E-05	106364	Muscarinic acetylcholine receptors	606
-0.104737475	-0.104737475	-0.104737475	-0.104737475	-0.104737475	-0.104737475	1.26041E-05	545331	inositol pyrophosphates biosynthesis	1605
-0.10570462	-0.10570462	-0.10570462	-0.10570462	-0.10570462	-0.10570462	1.31968E-05	920973	Influenza A virus infection	1988
-0.105950451	-0.105950451	-0.105950451	-0.105950451	-0.105950451	-0.105950451	1.3351E-05	366169	The IPAF inflammasome	1445
-0.10716242	-0.10716242	-0.10716242	-0.10716242	-0.10716242	-0.10716242	1.41323E-05	105733	Conjugation of salicylate with glycine	221
-0.108808873	-0.108808873	-0.108808873	-0.108808873	-0.108808873	-0.108808873	1.52518E-05	106069	Entry of Influenza Virion into Host Cell via Endocytosis	452
-0.109055375	-0.109055375	-0.109055375	-0.109055375	-0.109055375	-0.109055375	1.54254E-05	545311	palmitate biosynthesis I (animals)	1595
-0.109278342	-0.109278342	-0.109278342	-0.109278342	-0.109278342	-0.109278342	1.55837E-05	576278	Post-transcriptional Silencing By Small RNAs	1653
-0.109523744	-0.109523744	-0.109523744	-0.109523744	8.979583638	1.708297732	0.00129208	106197	Digestion of dietary carbohydrate	522
-0.11252292	-0.11252292	-0.11252292	-0.11252292	-0.11252292	-0.11252292	1.80387E-05	106412	Activation of C3 and C5	644
-0.112967196	-0.112967196	-0.112967196	-0.112967196	-0.112967196	-0.112967196	1.83976E-05	645322	Hydrolysis of LPC	1711
-0.11342028	-0.11342028	-0.11342028	-0.11342028	-0.11342028	-0.11342028	1.87695E-05	119565	Sodium-coupled phosphate cotransporters	817
-0.113447375	-0.113447375	-0.113447375	-0.113447375	8.613273748	1.63189685	0.001426744	105708	Vitamins	209
-0.116324511	-0.116324511	-0.116324511	-0.116324511	-0.116324511	-0.116324511	2.12989E-05	106083	Virus Assembly and Release	464
-0.116324511	-0.116324511	-0.116324511	-0.116324511	-0.116324511	-0.116324511	2.12989E-05	106084	Assembly of Viral Components at the Budding Site	465
-0.116349737	-0.116349737	-0.116349737	-0.116349737	-0.116349737	-0.116349737	2.1322E-05	545307	sphingomyelin metabolism/ceramide salvage	1591
-0.116545074	-0.116545074	-0.116545074	-0.116545074	-0.116545074	-0.116545074	2.15015E-05	105994	Autointegration results in viral DNA circles	400
-0.116545074	-0.116545074	-0.116545074	-0.116545074	-0.116545074	-0.116545074	2.15015E-05	205240	Integration of viral DNA into host genomic DNA	1423
-0.116981811	-0.116981811	-0.116981811	-0.116981811	-0.116981811	-0.116981811	2.19074E-05	142205	UDP-N-acetyl-D-galactosamine biosynthesis II	995
-0.117432733	-0.117432733	-0.117432733	-0.117432733	-0.117432733	-0.117432733	2.23329E-05	105729	Amino Acid conjugation	218
-0.117432733	-0.117432733	-0.117432733	-0.117432733	-0.117432733	-0.117432733	2.23329E-05	105730	Conjugation of carboxylic acids	219
-0.119170635	-0.119170635	-0.119170635	-0.119170635	-0.119170635	-0.119170635	2.40351E-05	106362	Orexin and neuropeptides FF and QRFP bind to their respective receptors	604
-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	2.55877E-05	105987	Uncoating of the HIV Virion	394
-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	2.55877E-05	105988	Reverse Transcription of HIV RNA	395
-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	2.55877E-05	105989	Minus-strand DNA synthesis	396
-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	2.55877E-05	105990	Plus-strand DNA synthesis	397
-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	-0.120671918	2.55877E-05	119575	Inositol transporters	821
-0.121097635	-0.121097635	-0.121097635	-0.121097635	-0.121097635	-0.121097635	2.60422E-05	413397	Coenzyme A biosynthesis, pantothenate => CoA	1500
-0.121309965	-0.121309965	-0.121309965	-0.121309965	-0.121309965	-0.121309965	2.62714E-05	782393	CMP phosphorylation	1878
-0.121521946	-0.121521946	-0.121521946	-0.121521946	-0.121521946	-0.121521946	2.65017E-05	782401	pyrimidine deoxyribonucleosides degradation	1883
-0.121818651	-0.121818651	-0.121818651	-0.121818651	-0.121818651	-0.121818651	2.68268E-05	413395	C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone	1499
-0.122590177	-0.122590177	-0.122590177	-0.122590177	-0.122590177	-0.122590177	2.76872E-05	119569	Organic anion transporters	818
-0.123823179	-0.123823179	-0.123823179	-0.123823179	-0.123823179	-0.123823179	2.91078E-05	142133	arginine biosynthesis IV	990
-0.124039128	-0.124039128	-0.124039128	-0.124039128	-0.124039128	-0.124039128	2.93625E-05	142279	adenosine nucleotides degradation	1012
-0.124039128	-0.124039128	-0.124039128	-0.124039128	-0.124039128	-0.124039128	2.93625E-05	730336	Synthesis of 15-eicosatetraenoic acid derivatives	1813
-0.124259726	-0.124259726	-0.124259726	-0.124259726	-0.124259726	-0.124259726	2.96246E-05	161073	Organic cation transport	1154
-0.124443417	-0.124443417	-0.124443417	-0.124443417	-0.124443417	-0.124443417	2.98442E-05	730337	Synthesis of 12-eicosatetraenoic acid derivatives	1814
-0.125358503	-0.125358503	-0.125358503	-0.125358503	-0.125358503	-0.125358503	3.09577E-05	106411	Terminal pathway of complement	643
-0.125829352	-1.073339533	-2.020849713	-1.073339533	-0.125829352	-0.883837497	0.036861431	105938	Generic Transcription Pathway	353
-0.125947442	-0.125947442	-0.125947442	-0.125947442	-0.125947442	-0.125947442	3.16918E-05	106377	Opsins	615
-0.126966875	-0.126966875	-0.126966875	-0.126966875	-0.126966875	-0.126966875	3.29953E-05	413359	Creatine pathway	1478
-0.127119741	-0.127119741	-0.127119741	-0.127119741	-0.127119741	-0.127119741	3.31944E-05	83013	Vitamin B6 metabolism	60
-0.127322631	-0.127322631	-0.127322631	-0.127322631	-0.127322631	-0.127322631	3.34602E-05	106436	Activation of PKB	664
-0.127941466	-0.127941466	-0.127941466	-0.127941466	-0.127941466	-0.127941466	3.42812E-05	161010	Transport and synthesis of PAPS	1103
-0.128131186	-0.128131186	-0.128131186	-0.128131186	-0.128131186	-0.128131186	3.45362E-05	142262	phosphatidylethanolamine biosynthesis II	1005
-0.128526467	-0.128526467	-0.128526467	-0.128526467	-0.128526467	-0.128526467	3.50722E-05	106100	PKA-mediated phosphorylation of key metabolic factors	473
-0.129128103	-0.129128103	-0.129128103	-0.129128103	-0.129128103	-0.129128103	3.59008E-05	106447	p75NTR negatively regulates cell cycle via SC1	673
-0.129362733	-0.129362733	-0.129362733	-0.129362733	-0.129362733	-0.129362733	3.62281E-05	142227	glutathione redox reactions I	999
-0.130753459	-0.130753459	-0.130753459	-0.130753459	-0.130753459	-0.130753459	3.82178E-05	187207	Molybdenum cofactor biosynthesis	1238
-0.13111493	-0.13111493	-0.13111493	-0.13111493	-0.13111493	-0.13111493	3.8749E-05	545273	glycoaminoglycan-protein linkage region biosynthesis	1577
-0.131121746	-0.131121746	-0.131121746	-0.131121746	-0.131121746	-0.131121746	3.87591E-05	366231	Tandem pore domain potassium channels	1453
-0.131148286	-0.131148286	-0.131148286	-0.131148286	-0.131148286	-0.131148286	3.87983E-05	413386	Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE	1494
-0.131712252	-0.131712252	-0.131712252	-0.131712252	-0.131712252	-0.131712252	3.96397E-05	119562	Sodium/Proton exchangers	814
-0.132814251	-0.132814251	7.204989683	-0.132814251	7.204989683	2.802307323	0.121618813	160956	Vitamin D (calciferol) metabolism	1063
-0.132885933	-0.132885933	-0.132885933	-7.704733969	-0.132885933	-1.64725554	0.002402557	771582	Retinoid cycle disease events	1850
-0.134436007	-0.134436007	-0.134436007	-0.134436007	-0.134436007	-0.134436007	4.39115E-05	413346	Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P	1470
-0.134446419	-0.134446419	-0.134446419	-0.134446419	-0.134446419	-0.134446419	4.39285E-05	413364	Glycosaminoglycan biosynthesis, chondroitin sulfate backbone	1482
-0.134446419	-0.134446419	-0.134446419	-0.134446419	-0.134446419	-0.134446419	4.39285E-05	545275	chondroitin and dermatan biosynthesis	1579
-0.136564362	-0.136564362	-0.136564362	-14.74237852	-0.136564362	-3.057727195	0.005127635	545295	retinoate biosynthesis I	1588
-0.136929991	-0.136929991	-0.136929991	-0.136929991	-0.136929991	-0.136929991	4.81385E-05	105882	Processing of DNA ends prior to end rejoining	314
-0.137150072	-0.137150072	-0.137150072	-0.137150072	-0.137150072	-0.137150072	4.85266E-05	161022	Relaxin receptors	1111
-0.137339031	-0.137339031	-0.137339031	-0.137339031	-0.137339031	-0.137339031	4.88618E-05	771575	Ubiquinol biosynthesis	1843
-0.138075612	-0.138075612	-0.138075612	-0.138075612	-0.138075612	-0.138075612	5.01863E-05	782379	pyrimidine deoxyribonucleotide phosphorylation	1870
-0.138263445	-0.138263445	-0.138263445	-0.138263445	-0.138263445	-0.138263445	5.05286E-05	105785	DNA replication initiation	252
-0.138263445	-0.138263445	-0.138263445	-0.138263445	-0.138263445	-0.138263445	5.05286E-05	106544	Telomere C-strand synthesis initiation	741
-0.13898988	-0.13898988	-0.13898988	-0.13898988	-0.13898988	-0.13898988	5.187E-05	198830	Arylamine metabolism	1331
-0.139186075	-0.139186075	-0.139186075	-0.139186075	-0.139186075	-0.139186075	5.22371E-05	545270	uracil degradation I (reductive)	1576
-0.139186075	-0.139186075	-0.139186075	-0.139186075	-0.139186075	-0.139186075	5.22371E-05	545364	thymine degradation	1619
-0.139372557	-0.139372557	-0.139372557	-0.139372557	-0.139372557	-0.139372557	5.2588E-05	106075	vRNP Assembly	458
-0.139558811	-0.139558811	-0.139558811	-0.139558811	-0.139558811	-0.139558811	5.29403E-05	545351	sphingosine and sphingosine-1-phosphate metabolism	1611
-0.139793671	-0.139793671	-0.139793671	-0.139793671	-0.139793671	-0.139793671	5.33873E-05	545317	zymosterol biosynthesis	1600
-0.140292308	-0.140292308	-0.140292308	-0.140292308	-0.140292308	-0.140292308	5.43462E-05	413366	GPI-anchor biosynthesis, core oligosaccharide	1484
-0.141237398	-0.141237398	-0.141237398	-0.141237398	-0.141237398	-0.141237398	5.62016E-05	920992	Thyroxine (Thyroid Hormone) Production	1994
-0.141788613	-0.141788613	-0.141788613	-0.141788613	-0.141788613	-0.141788613	5.73069E-05	545362	purine nucleotides degradation	1618
-0.141987535	-0.141987535	-0.141987535	-0.141987535	-0.141987535	-0.141987535	5.771E-05	664436	Nucleotide sugar biosynthesis, glucose => UDP-glucose	1731
-0.142372063	-0.142372063	-0.142372063	-0.142372063	-0.142372063	-0.142372063	5.84957E-05	106153	Mineralocorticoid biosynthesis	499
-0.142783139	-0.142783139	6.738332013	-0.142783139	-0.142783139	1.233439891	0.002800658	413405	C1-unit interconversion, eukaryotes	1504
-0.14326422	-0.14326422	-0.14326422	-0.14326422	-0.14326422	-0.14326422	6.03516E-05	142308	ethanol degradation IV	1015
-0.143690758	-0.143690758	-0.143690758	-0.143690758	-0.143690758	-0.143690758	6.12554E-05	198902	Glucocorticoid &amp; Mineralcorticoid Metabolism	1401
-0.144134428	-0.144134428	-0.144134428	-0.144134428	-0.144134428	-0.144134428	6.22069E-05	545289	heme biosynthesis	1585
-0.144368261	-0.144368261	-0.144368261	-0.144368261	-0.144368261	-0.144368261	6.27132E-05	413385	Phosphatidylcholine (PC) biosynthesis, choline => PC	1493
-0.144503942	-0.144503942	-0.144503942	-0.144503942	-0.144503942	-0.144503942	6.30084E-05	413351	Urea cycle	1473
-0.144548481	-0.144548481	-0.144548481	-0.144548481	-0.144548481	-0.144548481	6.31056E-05	106264	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	564
-0.144855629	-0.144855629	-0.144855629	-0.144855629	-0.144855629	-0.144855629	6.37789E-05	106255	Coenzyme A biosynthesis	557
-0.145043826	-0.145043826	-0.145043826	-0.145043826	-0.145043826	-0.145043826	6.41943E-05	106361	Vasopressin-like receptors	603
-0.145223378	-0.145223378	-0.145223378	-0.145223378	-0.145223378	-0.145223378	6.45926E-05	172845	Sulfur relay system	1175
-0.146359718	-0.146359718	-0.146359718	-0.146359718	-0.146359718	-0.146359718	6.71596E-05	106288	Pyrimidine catabolism	571
-0.146517505	-0.146517505	-0.146517505	-0.146517505	-0.146517505	-0.146517505	6.75224E-05	119564	Multifunctional anion exchangers	816
-0.147019031	-0.147019031	-0.147019031	-0.147019031	-0.147019031	-0.147019031	6.86859E-05	782392	pyrimidine deoxyribonucleosides salvage	1877
-0.147070279	-0.147070279	-0.147070279	-0.147070279	-0.147070279	-0.147070279	6.88057E-05	366245	Methionine salvage pathway	1459
-0.147362364	-0.147362364	-0.147362364	-0.147362364	-0.147362364	-0.147362364	6.94917E-05	782388	UTP and CTP de novo biosynthesis	1874
-0.147373475	-0.147373475	-0.147373475	-0.147373475	-0.147373475	-0.147373475	6.95179E-05	106234	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	540
-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	7.29821E-05	106152	Glucocorticoid biosynthesis	498
-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	7.29821E-05	106220	Pentose phosphate pathway (hexose monophosphate shunt)	530
-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	7.29821E-05	187219	ER Quality Control Compartment (ERQC)	1249
-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	-0.148813827	7.29821E-05	198829	Pentose Phosphate Pathway	1330
-0.149380103	-0.149380103	-0.149380103	-0.149380103	-0.149380103	-0.149380103	7.43813E-05	105822	Assembly of the ORC complex at the origin of replication	281
-0.149513916	-0.149513916	-0.149513916	-0.149513916	-0.149513916	-0.149513916	7.4715E-05	530755	Degradation of cysteine and homocysteine	1559
-0.14964802	-0.14964802	-0.14964802	-0.14964802	-0.14964802	-0.14964802	7.50507E-05	142307	oxidative ethanol degradation III	1014
-0.149984528	-0.149984528	-0.149984528	-0.149984528	-0.149984528	-0.149984528	7.58983E-05	106131	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	485
-0.150511099	-0.150511099	-0.150511099	-0.150511099	-0.150511099	-0.150511099	7.72401E-05	730335	Synthesis of 5-eicosatetraenoic acids	1812
-0.15178722	-0.15178722	-0.15178722	-0.15178722	-0.15178722	-0.15178722	8.05705E-05	142202	glycogen biosynthesis II (from UDP-D-Glucose)	993
-0.152152076	-0.152152076	-0.152152076	-0.152152076	-0.152152076	-0.152152076	8.15435E-05	730312	TRIF-mediated programmed cell death	1798
-0.152269427	-0.152269427	-0.152269427	-0.152269427	-0.152269427	-0.152269427	8.18585E-05	413376	Chondroitin sulfate degradation	1487
-0.152543925	-0.152543925	-0.152543925	-0.152543925	-0.152543925	-0.152543925	8.2599E-05	645330	Acyl chain remodeling of CL	1716
-0.15278406	-0.15278406	-0.15278406	-0.15278406	-0.15278406	-0.15278406	8.32511E-05	106171	Urea cycle	512
-0.152817451	-0.152817451	-0.152817451	-0.152817451	-0.152817451	-0.152817451	8.33422E-05	106456	Activation of TRKA receptors	680
-0.152970616	-0.152970616	-0.152970616	-0.152970616	-0.152970616	-0.152970616	8.37607E-05	142200	dolichyl-diphosphooligosaccharide biosynthesis	992
-0.153445263	-0.153445263	-0.153445263	-0.153445263	-0.153445263	-0.153445263	8.50682E-05	835387	guanosine deoxyribonucleotides de novo biosynthesis	1921
-0.153445263	-0.153445263	-0.153445263	-0.153445263	-0.153445263	-0.153445263	8.50682E-05	835388	adenosine deoxyribonucleotides de novo biosynthesis	1922
-0.153625736	-0.153625736	-0.153625736	-0.153625736	-0.153625736	-0.153625736	8.55697E-05	198889	Nifedipine Activity	1388
-0.154011493	-0.154011493	-0.154011493	-0.154011493	-0.154011493	-0.154011493	8.66494E-05	160985	Thyroxine biosynthesis	1083
-0.154126529	-0.154126529	-0.154126529	-0.154126529	-0.154126529	-0.154126529	8.69735E-05	545310	oleate biosynthesis II (animals)	1594
-0.154503219	-0.154503219	-0.154503219	-0.154503219	-0.154503219	-0.154503219	8.80415E-05	106542	Telomere Extension By Telomerase	739
-0.154814767	-0.154814767	-0.154814767	-0.154814767	-0.154814767	-0.154814767	8.89328E-05	833808	Conjugation of SUMO to E1 (UBA2:SAE1)	1903
-0.155028334	-0.155028334	-0.155028334	-0.155028334	-0.155028334	-0.155028334	8.95479E-05	106284	Pyrimidine salvage reactions	570
-0.155048053	-0.155048053	-0.155048053	-6.548782193	-0.155048053	-1.433794881	0.003784651	105715	Ethanol oxidation	211
-0.155312224	-0.155312224	-0.155312224	-0.155312224	-0.155312224	-0.155312224	9.03708E-05	413360	Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP	1479
-0.155839481	-0.155839481	-0.155839481	-0.155839481	-0.155839481	-0.155839481	9.19152E-05	106239	Attachment of GPI anchor to uPAR	544
-0.156022193	-0.156022193	-0.156022193	-0.156022193	-0.156022193	-0.156022193	9.24553E-05	82936	Synthesis and degradation of ketone bodies	11
-0.156022193	-0.156022193	-0.156022193	-0.156022193	-0.156022193	-0.156022193	9.24553E-05	142257	phosphatidylcholine biosynthesis I	1004
-0.156331483	-0.156331483	-0.156331483	-0.156331483	-0.156331483	-0.156331483	9.33753E-05	106276	Purine catabolism	568
-0.156343463	-0.156343463	-0.156343463	-0.156343463	-0.156343463	-0.156343463	9.34111E-05	106235	Removal of aminoterminal propeptides from gamma-carboxylated proteins	541
-0.156374827	-0.156374827	-0.156374827	-0.156374827	-0.156374827	-0.156374827	9.35049E-05	106329	Regulation of gene expression in early pancreatic precursor cells	576
-0.156941205	-0.156941205	-0.156941205	-0.156941205	-0.156941205	-0.156941205	9.52105E-05	413361	N-glycan precursor biosynthesis	1480
-0.157044167	-0.157044167	-0.157044167	-0.157044167	-0.157044167	-0.157044167	9.55232E-05	142460	pentose phosphate pathway	1030
-0.157168382	-0.157168382	-0.157168382	-0.157168382	-0.157168382	-0.157168382	9.59016E-05	106089	Host Interactions with Influenza Factors	469
-0.157230091	-0.157230091	-0.157230091	-0.157230091	-0.157230091	-0.157230091	9.609E-05	106330	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	577
-0.157492779	-6.585769462	-0.157492779	-0.157492779	-0.157492779	-1.443148115	0.00405181	545341	phenylalanine degradation IV	1608
-0.157877245	-0.157877245	6.157212544	-0.157877245	-0.157877245	1.105140713	0.003825272	142236	folate transformations	1000
-0.158043385	-0.158043385	-0.158043385	-0.158043385	-0.158043385	-0.158043385	9.86011E-05	142203	colanic acid building blocks biosynthesis	994
-0.158559435	-0.158559435	-0.158559435	-0.158559435	-0.158559435	-0.158559435	0.000100221	477116	Klotho-mediated ligand binding	1514
-0.158649161	-0.158649161	-0.158649161	-0.158649161	-0.158649161	-0.158649161	0.000100505	142226	gamma-glutamyl cycle	998
-0.158706385	-0.158706385	-0.158706385	-0.158706385	-0.158706385	-0.158706385	0.000100687	833800	Interaction With The Zona Pellucida	1897
-0.159185909	-0.159185909	-0.159185909	-0.159185909	-0.159185909	-0.159185909	0.000102217	106408	Lectin pathway of complement activation	641
-0.159220364	-0.159220364	-0.159220364	-0.159220364	-0.159220364	-0.159220364	0.000102328	576267	Pre-NOTCH Processing in the Endoplasmic Reticulum	1642
-0.159475233	-0.159475233	6.219534091	-0.159475233	-0.159475233	1.116326632	0.004022822	137942	EphrinA-EPHA pathway	863
-0.159531648	-0.159531648	-0.159531648	-0.159531648	-0.159531648	-0.159531648	0.000103332	413380	Fatty acid biosynthesis, elongation, mitochondria	1489
-0.160207166	-0.160207166	-0.160207166	-0.160207166	-0.160207166	-0.160207166	0.000105538	106376	Lysosphingolipid and LPA receptors	614
-0.160844157	-0.160844157	-0.160844157	-0.160844157	-0.160844157	-0.160844157	0.000107653	413478	Malonate semialdehyde pathway, propanoyl-CoA => Acetyl-CoA	1507
-0.161170785	-0.161170785	-0.161170785	-0.161170785	-0.161170785	-0.161170785	0.000108751	645327	Synthesis of PG	1714
-0.161305066	-0.161305066	-0.161305066	-0.161305066	-0.161305066	-0.161305066	0.000109204	82933	Fatty acid biosynthesis	8
-0.161351592	-0.161351592	-0.161351592	-0.161351592	-0.161351592	-0.161351592	0.000109362	739008	Trans-sulfuration pathway	1826
-0.161468089	-0.161468089	-0.161468089	-0.161468089	-0.161468089	-0.161468089	0.000109757	545264	fatty acid activation	1575
-0.16182227	-0.16182227	-0.16182227	-0.16182227	-0.16182227	-0.16182227	0.000110966	730343	Mitochondrial Iron-Sulfur Cluster Biogenesis	1819
-0.161969417	-0.161969417	-0.161969417	-0.161969417	-0.161969417	-0.161969417	0.000111472	198798	Ganglio Sphingolipid Metabolism	1300
-0.162118713	-0.162118713	-0.162118713	-0.162118713	-0.162118713	-0.162118713	0.000111987	161069	Zinc influx into cells by the SLC39 gene family	1151
-0.162579824	-0.162579824	-0.162579824	-0.162579824	-0.162579824	-0.162579824	0.000113588	138004	Alternative NF-kappaB pathway	918
-0.163038073	-0.163038073	-0.163038073	-0.163038073	-0.163038073	-0.163038073	0.000115198	106258	Nicotinate metabolism	559
-0.16360187	-0.16360187	-0.16360187	-0.16360187	-0.16360187	-0.16360187	0.000117204	782398	superpathway of pyrimidine ribonucleosides degradation	1882
-0.163871209	-0.163871209	-0.163871209	-0.163871209	12.27417125	2.323737282	0.008851213	198914	Nicotine metabolism	1412
-0.163908706	-0.163908706	-0.163908706	-0.163908706	-0.163908706	-0.163908706	0.000118307	545308	ceramide de novo biosynthesis	1592
-0.164069388	-0.164069388	-0.164069388	5.957922704	5.957922704	2.284727449	0.15677341	645349	Abacavir transport and metabolism	1728
-0.164141112	-0.164141112	-0.164141112	-0.164141112	-0.164141112	-0.164141112	0.000119148	106446	NADE modulates death signalling	672
-0.16526068	-0.16526068	-0.16526068	-0.16526068	-0.16526068	-0.16526068	0.000123267	105669	Apoptotic factor-mediated response	186
-0.165399509	-0.165399509	-0.165399509	-0.165399509	-0.165399509	-0.165399509	0.000123786	105871	Presynaptic phase of homologous DNA pairing and strand exchange	312
-0.165509251	-0.165509251	-0.165509251	-0.165509251	-0.165509251	-0.165509251	0.000124197	835390	guanosine ribonucleotides de novo biosynthesis	1924
-0.165709903	-0.165709903	-0.165709903	-0.165709903	-0.165709903	-0.165709903	0.000124952	119563	Cation-coupled Chloride cotransporters	815
-0.16580519	-0.16580519	-0.16580519	-0.16580519	-0.16580519	-0.16580519	0.000125311	161038	RSK activation	1125
-0.165827706	-0.165827706	-0.165827706	-0.165827706	-0.165827706	-0.165827706	0.000125397	545299	C20 prostanoid biosynthesis	1589
-0.165986729	-0.165986729	-0.165986729	-0.165986729	-0.165986729	-0.165986729	0.000125999	198820	Acetylcholine Synthesis	1321
-0.166477246	-0.166477246	-0.166477246	5.854399639	5.854399639	2.241873508	0.158135501	138084	Glypican 3 network	988
-0.167268141	-0.167268141	-0.167268141	-0.167268141	-0.167268141	-0.167268141	0.000130938	142359	leucine degradation I	1019
-0.167425921	-0.167425921	-0.167425921	-0.167425921	-0.167425921	-0.167425921	0.000131557	106187	Lysine catabolism	516
-0.167459942	-0.167459942	-0.167459942	-0.167459942	-0.167459942	-0.167459942	0.000131691	142413	2-oxobutanoate degradation I	1023
-0.167794732	-0.167794732	-0.167794732	-0.167794732	5.750890687	1.015942352	0.004558777	730338	Synthesis of Lipoxins (LX)	1815
-0.167884535	-0.167884535	-0.167884535	-0.167884535	-0.167884535	-0.167884535	0.000133369	105986	Binding and entry of HIV virion	393
-0.168526707	-0.168526707	-0.168526707	-0.168526707	-0.168526707	-0.168526707	0.000135939	198854	Phase I, non P450	1354
-0.168699157	-0.168699157	-0.168699157	-0.168699157	-0.168699157	-0.168699157	0.000136636	576277	Small Interfering RNA (siRNA) Biogenesis	1652
-0.16918597	-0.16918597	-0.16918597	-0.16918597	-0.16918597	-0.16918597	0.000138619	142166	citrulline biosynthesis	991
-0.169430139	-0.169430139	-0.169430139	-0.169430139	-0.169430139	-0.169430139	0.000139622	698758	Glial Cell Differentiation	1781
-0.169586422	-0.169586422	-0.169586422	-0.169586422	-0.169586422	-0.169586422	0.000140267	833816	Scavenging by Class F Receptors	1910
-0.170053817	-0.170053817	-0.170053817	-0.170053817	-0.170053817	-0.170053817	0.000142211	645291	The activation of arylsulfatases	1684
-0.170074828	-0.170074828	-0.170074828	-0.170074828	-0.170074828	-0.170074828	0.000142298	119561	Sodium/Calcium exchangers	813
-0.170295312	-0.170295312	-0.170295312	-0.170295312	-0.170295312	-0.170295312	0.000143223	142215	NAD de novo biosynthesis	997
-0.170357347	-0.170357347	-0.170357347	-0.170357347	-0.170357347	-0.170357347	0.000143484	477131	Regulation of Signaling by NODAL	1527
-0.17038855	-0.17038855	-0.17038855	-0.17038855	5.50922978	0.965535116	0.004643576	198764	Vitamin D synthesis	1268
-0.170414372	-0.170414372	-0.170414372	-0.170414372	-0.170414372	-0.170414372	0.000143725	105974	Recycling of eIF2:GDP	382
-0.170586661	-0.170586661	-0.170586661	-0.170586661	-0.170586661	-0.170586661	0.000144453	782395	purine deoxyribonucleosides salvage	1879
-0.170851038	-0.170851038	-0.170851038	-0.170851038	-0.170851038	-0.170851038	0.000145575	83026	Sulfur metabolism	68
-0.170896547	-0.170896547	-0.170896547	-0.170896547	-0.170896547	-0.170896547	0.000145769	106139	Beta-oxidation of very long chain fatty acids	488
-0.171458515	-0.171458515	-0.171458515	-0.171458515	-0.171458515	-0.171458515	0.000148182	833807	Proteolytic Processing of SUMO	1902
-0.171603641	-0.171603641	-0.171603641	11.66313024	-0.171603641	2.195343135	0.010113957	366222	Ca2+ activated K+ channels	1448
-0.171806452	-0.171806452	-0.171806452	-0.171806452	-0.171806452	-0.171806452	0.000149692	106233	Gamma-carboxylation of protein precursors	539
-0.171841827	-0.171841827	5.623835297	-0.171841827	-0.171841827	0.987293598	0.004903974	142322	glycine betaine degradation	1016
-0.172075384	-0.172075384	-0.172075384	-0.172075384	-0.172075384	-0.172075384	0.000150867	755437	Type III interferon signaling	1829
-0.172149658	-0.172149658	-0.172149658	-0.172149658	-0.172149658	-0.172149658	0.000151193	142243	choline biosynthesis III	1002
-0.172215502	-0.172215502	-0.172215502	-0.172215502	-0.172215502	-0.172215502	0.000151482	119529	Inactivation of Cdc42 and Rac	782
-0.172267695	-0.172267695	5.522532139	-0.172267695	-0.172267695	0.966692272	0.004863553	82970	Cyanoamino acid metabolism	30
-0.172366727	-0.172366727	-0.172366727	-0.172366727	-0.172366727	-0.172366727	0.000152148	161076	Transport of nucleotide sugars	1156
-0.172714247	-0.172714247	-0.172714247	-0.172714247	-0.172714247	-0.172714247	0.000153688	105651	FasL/ CD95L signaling	177
-0.172745551	-0.172745551	-0.172745551	-0.172745551	-0.172745551	-0.172745551	0.000153828	106435	Release of eIF4E	663
-0.17307026	-0.17307026	-0.17307026	-0.17307026	-0.17307026	-0.17307026	0.000155279	106025	Nef Mediated CD8 Down-regulation	426
-0.173161182	-0.173161182	-0.173161182	-0.173161182	-0.173161182	-0.173161182	0.000155687	106190	Tryptophan catabolism	518
-0.173173999	-0.173173999	-0.173173999	-0.173173999	-0.173173999	-0.173173999	0.000155745	198818	Heme Biosynthesis	1319
-0.173303297	-0.173303297	5.671664576	-0.173303297	-0.173303297	0.995690277	0.005116086	771572	Clearance of Nuclear Envelope Membranes from Chromatin	1840
-0.173722839	-0.173722839	-0.173722839	-0.173722839	-0.173722839	-0.173722839	0.000158228	106189	Phenylalanine and tyrosine catabolism	517
-0.174219217	-5.991221457	-0.174219217	-0.174219217	-0.174219217	-1.337619665	0.005519498	142324	dopamine degradation	1017
-0.174310663	-0.174310663	-0.174310663	-0.174310663	-0.174310663	-0.174310663	0.000160924	105870	Homologous DNA pairing and strand exchange	311
-0.174506742	-0.174506742	-0.174506742	-0.174506742	-0.174506742	-0.174506742	0.000161831	106353	FGFR3b ligand binding and activation	596
-0.174546849	-0.174546849	-0.174546849	-0.174546849	-0.174546849	-0.174546849	0.000162017	137982	S1P5 pathway	899
-0.174850638	-0.174850638	-0.174850638	-0.174850638	-0.174850638	-0.174850638	0.000163432	137951	EphrinB-EPHB pathway	871
-0.175002358	-0.175002358	-0.175002358	-0.175002358	-0.175002358	-0.175002358	0.000164142	198895	Non-homologous end joining	1394
-0.175153962	-0.175153962	-0.175153962	-0.175153962	-0.175153962	-0.175153962	0.000164854	413382	beta-Oxidation, acyl-CoA synthesis	1491
-0.175163293	-0.175163293	-0.175163293	-0.175163293	-0.175163293	-0.175163293	0.000164898	106192	Creatine metabolism	519
-0.175335532	-0.175335532	-0.175335532	-0.175335532	-0.175335532	-0.175335532	0.00016571	106123	mitochondrial fatty acid beta-oxidation of saturated fatty acids	484
-0.175456826	-0.175456826	-0.175456826	-0.175456826	-0.175456826	-0.175456826	0.000166284	160953	SLBP independent Processing of Histone Pre-mRNAs	1060
-0.17607519	-0.17607519	-0.17607519	-0.17607519	-0.17607519	-0.17607519	0.000169235	142283	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1013
-0.17617037	-0.17617037	-0.17617037	-0.17617037	-0.17617037	-0.17617037	0.000169693	106374	P2Y receptors	613
-0.176225961	-0.176225961	-0.176225961	-0.176225961	-0.176225961	-0.176225961	0.000169961	106547	Removal of the Flap Intermediate from the C-strand	744
-0.176241653	-0.176241653	-0.176241653	-0.176241653	-0.176241653	-0.176241653	0.000170037	142438	nicotine degradation III	1029
-0.17692204	-0.17692204	-0.17692204	-0.17692204	-0.17692204	-0.17692204	0.000173344	119572	Facilitative Na+-independent glucose transporters	820
-0.177010824	-0.177010824	-0.177010824	-0.177010824	-0.177010824	-0.177010824	0.00017378	105881	Nonhomologous End-joining (NHEJ)	313
-0.177564163	-0.177564163	-0.177564163	-0.177564163	-0.177564163	-0.177564163	0.000176513	833809	Transfer of SUMO from E1 to E2 (UBE2I, UBC9)	1904
-0.177990828	-0.177990828	-0.177990828	-0.177990828	-0.177990828	-0.177990828	0.000178644	161030	Highly sodium permeable acetylcholine nicotinic receptors	1117
-0.178150372	-0.178150372	-0.178150372	-0.178150372	-0.178150372	-0.178150372	0.000179446	106254	Vitamin B5 (pantothenate) metabolism	556
-0.17819105	-0.17819105	-0.17819105	-0.17819105	-0.17819105	-0.17819105	0.000179651	106454	Axonal growth inhibition (RHOA activation)	678
-0.178325027	-0.178325027	-0.178325027	-0.178325027	-0.178325027	-0.178325027	0.000180327	106484	CREB phosphorylation	703
-0.178638267	-5.796193848	-5.796193848	-5.796193848	-5.796193848	-4.672682732	201.6258003	413388	Acylglycerol degradation	1496
-0.178952558	-0.178952558	-0.178952558	-0.178952558	-0.178952558	-0.178952558	0.000183523	413365	Glycosaminoglycan biosynthesis, heparan sulfate backbone	1483
-0.179084508	-0.179084508	-0.179084508	-0.179084508	-0.179084508	-0.179084508	0.0001842	105692	MEK activation	198
-0.179084508	-0.179084508	-0.179084508	-0.179084508	-0.179084508	-0.179084508	0.0001842	105693	RAF phosphorylates MEK	199
-0.179312215	-0.179312215	-0.179312215	-0.179312215	-0.179312215	-0.179312215	0.000185374	413432	Bile acid biosynthesis, cholesterol => cholate	1505
-0.179353164	-0.179353164	-0.179353164	-0.179353164	-0.179353164	-0.179353164	0.000185586	106251	Vitamin C (ascorbate) metabolism	555
-0.179652134	-0.179652134	-0.179652134	-0.179652134	-0.179652134	-0.179652134	0.000187138	771589	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1856
-0.179990526	-0.179990526	-0.179990526	-0.179990526	-0.179990526	-0.179990526	0.000188907	198869	Nucleotide GPCRs	1368
-0.180107176	-0.180107176	-0.180107176	-0.180107176	-0.180107176	-0.180107176	0.00018952	106525	Acetylcholine Neurotransmitter Release Cycle	730
-0.180254994	-0.180254994	-0.180254994	-0.180254994	-0.180254994	-0.180254994	0.000190299	105652	TNF signaling	178
-0.180442864	-0.180442864	-0.180442864	-0.180442864	-0.180442864	-0.180442864	0.000191293	105839	Base-Excision Repair, AP Site Formation	298
-0.18072875	-0.18072875	-0.18072875	-0.18072875	-0.18072875	-0.18072875	0.000192813	161011	Role of DCC in regulating apoptosis	1104
-0.180765894	-0.180765894	-0.180765894	-0.180765894	-0.180765894	-0.180765894	0.000193011	119560	Bicarbonate transporters	812
-0.180811031	-0.180811031	-0.180811031	-0.180811031	-0.180811031	-0.180811031	0.000193252	106103	PP2A-mediated dephosphorylation of key metabolic factors	474
-0.180832172	-0.180832172	-0.180832172	-0.180832172	-0.180832172	-0.180832172	0.000193365	907939	tryptophan degradation via kynurenine	1977
-0.18087608	-0.18087608	-0.18087608	-0.18087608	-0.18087608	-0.18087608	0.0001936	413401	Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol	1503
-0.181273789	-0.181273789	-0.181273789	-0.181273789	-0.181273789	-0.181273789	0.000195738	413374	N-glycan precursor trimming	1485
-0.181273822	-0.181273822	-0.181273822	-0.181273822	-0.181273822	-0.181273822	0.000195738	105864	ATM mediated response to DNA double-strand break	308
-0.181273822	-0.181273822	-0.181273822	-0.181273822	-0.181273822	-0.181273822	0.000195738	105865	ATM mediated phosphorylation of repair proteins	309
-0.181317445	-0.181317445	-0.181317445	-0.181317445	-0.181317445	-0.181317445	0.000195974	645316	Synthesis of PE	1707
-0.181391904	-0.181391904	-0.181391904	-0.181391904	-0.181391904	-0.181391904	0.000196376	545316	bile acid biosynthesis, neutral pathway	1599
-0.181464359	-0.181464359	-0.181464359	-0.181464359	-0.181464359	-0.181464359	0.000196769	161072	Organic cation/anion/zwitterion transport	1153
-0.181888502	-0.181888502	-0.181888502	-0.181888502	-0.181888502	-0.181888502	0.000199079	106546	Processive synthesis on the C-strand of the telomere	743
-0.182087424	-0.182087424	-0.182087424	-0.182087424	-0.182087424	-0.182087424	0.00020017	413387	C5 isoprenoid biosynthesis, mevalonate pathway	1495
-0.182233747	-0.182233747	-0.182233747	-0.182233747	-0.182233747	-0.182233747	0.000200976	106154	Androgen biosynthesis	500
-0.18231347	-0.18231347	-0.18231347	-0.18231347	-0.18231347	-0.18231347	0.000201416	730325	Synthesis of pyrophosphates in the cytosol	1808
-0.182474034	-0.182474034	-0.182474034	-0.182474034	-0.182474034	-0.182474034	0.000202304	413384	Triacylglycerol biosynthesis	1492
-0.183020094	-0.183020094	-0.183020094	-0.183020094	-0.183020094	-0.183020094	0.00020535	530766	Membrane binding and targetting of GAG proteins	1568
-0.183236519	-0.183236519	-0.183236519	-0.183236519	-0.183236519	-0.183236519	0.000206567	119531	Role of Abl in Robo-Slit signaling	784
-0.183382074	-0.183382074	-0.183382074	-0.183382074	-0.183382074	-0.183382074	0.000207388	106369	Hormone ligand-binding receptors	609
-0.183732791	-0.183732791	-0.183732791	-0.183732791	-0.183732791	-0.183732791	0.000209379	161056	Pyrimidine biosynthesis	1141
-0.183759031	-0.183759031	-0.183759031	-0.183759031	-0.183759031	-0.183759031	0.000209529	160952	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1059
-0.184236378	-0.184236378	-0.184236378	-0.184236378	-0.184236378	-0.184236378	0.000212264	198831	Codeine and morphine metabolism	1332
-0.184398167	-0.184398167	-0.184398167	-0.184398167	-0.184398167	-0.184398167	0.000213198	413482	Fatty acid biosynthesis, elongation, endoplasmic reticulum	1508
-0.184510681	10.73328109	-11.10230245	-5.643406568	-0.184510681	-1.276289858	22.89443448	105680	Apoptotic cleavage of cell adhesion proteins	190
-0.184542929	-0.184542929	-0.184542929	-0.184542929	-0.184542929	-0.184542929	0.000214036	106452	p75NTR regulates axonogenesis	677
-0.184815365	-0.184815365	-0.184815365	-0.184815365	-0.184815365	-0.184815365	0.000215621	187084	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	1183
-0.184815365	-0.184815365	-0.184815365	-0.184815365	-0.184815365	-0.184815365	0.000215621	187086	IRAK2 mediated activation of TAK1 complex	1185
-0.185351673	-0.185351673	-0.185351673	-0.185351673	-0.185351673	-0.185351673	0.000218767	160995	mRNA Decay by 3" to 5" Exoribonuclease	1088
-0.185420932	-0.185420932	-0.185420932	-0.185420932	-0.185420932	-0.185420932	0.000219176	187085	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1184
-0.185476136	-0.185476136	-0.185476136	-0.185476136	-0.185476136	-0.185476136	0.000219503	105728	Glutathione synthesis and recycling	217
-0.185734931	-0.185734931	-0.185734931	-0.185734931	-0.185734931	-0.185734931	0.000221039	530745	Downregulation of ERBB4 signaling	1551
-0.185969785	-0.185969785	-0.185969785	-0.185969785	-0.185969785	-0.185969785	0.00022244	105993	2-LTR circle formation	399
-0.186003119	-0.186003119	-0.186003119	-0.186003119	-0.186003119	-0.186003119	0.000222639	672815	eicosapentaenoate biosynthesis II (metazoa)	1750
-0.186022457	5.174855266	-0.186022457	5.174855266	5.174855266	3.030504177	4.795405925	545361	thyroid hormone metabolism II (via conjugation and/or degradation)	1617
-0.186166076	-0.186166076	-0.186166076	-0.186166076	-0.186166076	-0.186166076	0.000223616	413392	Inosine monophosphate biosynthesis, PRPP + glutamine => IMP	1498
-0.186272471	-5.569869913	-0.186272471	-0.186272471	-0.186272471	-1.26299196	0.006705633	106526	Neurotransmitter Clearance In The Synaptic Cleft	731
-0.186348515	-0.186348515	-0.186348515	-0.186348515	-0.186348515	-0.186348515	0.000224714	413347	Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate	1471
-0.186543353	-0.186543353	-0.186543353	-0.186543353	-0.186543353	-0.186543353	0.000225891	105849	Displacement of DNA glycosylase by APE1	302
-0.186559383	-0.186559383	-0.186559383	-0.186559383	-0.186559383	-0.186559383	0.000225988	105707	Eicosanoids	208
-0.18659627	-0.18659627	-0.18659627	-5.450242825	-0.18659627	-1.239325581	0.006607356	545294	the visual cycle I (vertebrates)	1587
-0.186882745	-0.186882745	-0.186882745	-0.186882745	-0.186882745	-0.186882745	0.000227953	413343	Pentose phosphate pathway (Pentose phosphate cycle)	1469
-0.186957892	-0.186957892	-0.186957892	-0.186957892	-0.186957892	-0.186957892	0.000228412	106350	FGFR2b ligand binding and activation	593
-0.187115814	-0.187115814	-0.187115814	-0.187115814	-0.187115814	-0.187115814	0.000229378	413353	Methionine degradation	1475
-0.187311614	-0.187311614	-0.187311614	-0.187311614	-0.187311614	-0.187311614	0.000230581	106379	Calcitonin-like ligand receptors	617
-0.187863286	-0.187863286	-0.187863286	-0.187863286	-0.187863286	-0.187863286	0.000233997	106232	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	538
-0.187902314	-0.187902314	-0.187902314	-0.187902314	-0.187902314	-0.187902314	0.00023424	187179	GABA A receptor activation	1214
-0.187946621	5.084048358	-0.187946621	5.084048358	5.084048358	2.975250367	4.641924396	160971	Heme degradation	1074
-0.188415123	-0.188415123	-0.188415123	-0.188415123	-0.188415123	-0.188415123	0.000237454	545276	chondroitin sulfate biosynthesis (late stages)	1580
-0.188492525	-0.188492525	-0.188492525	-0.188492525	-0.188492525	-0.188492525	0.000237942	106161	ER to Golgi Transport	505
-0.188492525	-0.188492525	-0.188492525	-0.188492525	-0.188492525	-0.188492525	0.000237942	106162	COPII (Coat Protein 2) Mediated Vesicle Transport	506
-0.188657055	-0.188657055	-0.188657055	-0.188657055	-0.188657055	-0.188657055	0.000238982	198838	Arachidonate Epoxygenase / Epoxide Hydrolase	1339
-0.188699227	-0.188699227	-0.188699227	-0.188699227	-0.188699227	-0.188699227	0.000239249	545352	acetone degradation I (to methylglyoxal)	1612
-0.188735122	-0.188735122	-0.188735122	-0.188735122	-0.188735122	-0.188735122	0.000239477	106473	Cam-PDE 1 activation	694
-0.188775962	-0.188775962	-0.188775962	-0.188775962	-0.188775962	-0.188775962	0.000239736	138043	Signaling mediated by p38-gamma and p38-delta	953
-0.18885838	-0.18885838	-0.18885838	-0.18885838	-0.18885838	-0.18885838	0.00024026	161039	CREB phosphorylation through the activation of Adenylate Cyclase	1126
-0.189059764	-0.189059764	-0.189059764	-0.189059764	-0.189059764	-0.189059764	0.000241544	477123	Cross-presentation of particulate exogenous antigens (phagosomes)	1520
-0.18909447	-0.18909447	-0.18909447	-0.18909447	-0.18909447	-0.18909447	0.000241765	187093	Interleukin-1 processing	1192
-0.189124696	-0.189124696	-0.189124696	-0.189124696	-0.189124696	-0.189124696	0.000241959	142385	tryptophan degradation	1021
-0.189584821	-0.189584821	-0.189584821	-0.189584821	-0.189584821	-0.189584821	0.000244916	142207	mevalonate pathway I	996
-0.189647833	-0.189647833	-0.189647833	-0.189647833	-0.189647833	-0.189647833	0.000245324	645345	Linoleic acid (LA) metabolism	1724
-0.189816338	-5.499364256	-0.189816338	-0.189816338	5.11973158	-0.189816338	0.192557505	835391	phenylalanine utilization	1925
-0.189907902	-0.189907902	-0.189907902	-0.189907902	-0.189907902	-0.189907902	0.00024701	198808	Aflatoxin B1 metabolism	1310
-0.189957556	-0.189957556	-0.189957556	-0.189957556	-0.189957556	-0.189957556	0.000247333	106365	Adrenoceptors	607
-0.190098685	-0.190098685	-0.190098685	-0.190098685	-0.190098685	-0.190098685	0.000248254	907941	guanosine nucleotides de novo biosynthesis	1978
-0.190312687	-0.190312687	-0.190312687	-0.190312687	-0.190312687	-0.190312687	0.000249654	198775	TFs Regulate miRNAs related to cardiac hypertrophy	1278
-0.190802983	-0.190802983	-0.190802983	-0.190802983	-0.190802983	-0.190802983	0.000252887	833823	Regulation of innate immune responses to cytosolic DNA	1913
-0.190887302	-0.190887302	-0.190887302	-0.190887302	-0.190887302	-0.190887302	0.000253446	83012	Riboflavin metabolism	59
-0.190916842	-0.190916842	-0.190916842	-0.190916842	-0.190916842	-0.190916842	0.000253642	161067	Zinc transporters	1149
-0.190993782	-0.190993782	-0.190993782	-0.190993782	-0.190993782	-0.190993782	0.000254154	198875	Mismatch repair	1374
-0.191084079	-0.191084079	-0.191084079	-0.191084079	-0.191084079	-0.191084079	0.000254755	106455	Regulated proteolysis of p75NTR	679
-0.191476213	-0.191476213	-0.191476213	-0.191476213	-0.191476213	-0.191476213	0.00025738	187186	Transport of organic anions	1219
-0.191828399	-0.191828399	-0.191828399	-0.191828399	-0.191828399	-0.191828399	0.000259755	106023	Nef mediated downregulation of MHC class I complex cell surface expression	424
-0.191834909	-0.191834909	-0.191834909	5.028162617	5.028162617	1.896164102	0.178484929	545337	putrescine degradation III	1607
-0.191874417	-0.191874417	-0.191874417	-0.191874417	-0.191874417	-0.191874417	0.000260067	106508	VEGF binds to VEGFR leading to receptor dimerization	718
-0.191896035	-0.191896035	-0.191896035	-0.191896035	-0.191896035	-0.191896035	0.000260214	161041	CREB phosphorylation through the activation of CaMKK	1128
-0.191918871	-0.191918871	-0.191918871	-0.191918871	-0.191918871	-0.191918871	0.000260368	105848	Base-free sugar-phosphate removal via the single-nucleotide replacement pathway	301
-0.19265525	-0.19265525	-0.19265525	-0.19265525	-0.19265525	-0.19265525	0.000265402	138028	Effects of Botulinum toxin	941
-0.192865658	-0.192865658	-0.192865658	-0.192865658	-0.192865658	-0.192865658	0.000266854	119521	Sema4D mediated inhibition of cell attachment and migration	775
-0.192933956	-0.192933956	-0.192933956	-0.192933956	-0.192933956	-0.192933956	0.000267327	782381	pyrimidine deoxyribonucleotides biosynthesis from CTP	1872
-0.193407558	-0.193407558	-0.193407558	-0.193407558	-0.193407558	-0.193407558	0.000270625	105790	Unwinding of DNA	257
-0.193728602	-0.193728602	-0.193728602	-0.193728602	-0.193728602	-0.193728602	0.000272878	187172	Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1210
-0.193785407	-0.193785407	-0.193785407	-0.193785407	-0.193785407	-0.193785407	0.000273278	106520	Serotonin Neurotransmitter Release Cycle	727
-0.193785407	-0.193785407	-0.193785407	-0.193785407	-0.193785407	-0.193785407	0.000273278	106523	Dopamine Neurotransmitter Release Cycle	729
-0.194029305	-0.194029305	-0.194029305	-0.194029305	-0.194029305	-0.194029305	0.000275003	106477	Negative regulation of the PI3K/AKT network	698
-0.194139682	-0.194139682	-0.194139682	-0.194139682	-0.194139682	-0.194139682	0.000275786	106020	Nef and signal transduction	422
-0.194305859	-0.194305859	-0.194305859	-0.194305859	-0.194305859	-0.194305859	0.000276968	160996	mRNA Decay by 5" to 3" Exoribonuclease	1089
-0.194439219	-0.194439219	-0.194439219	-0.194439219	-0.194439219	-0.194439219	0.00027792	105823	CDC6 association with the ORC:origin complex	282
-0.194654301	-0.194654301	-0.194654301	-0.194654301	-0.194654301	-0.194654301	0.00027946	698759	RalA downstream regulated genes	1782
-0.195364662	-0.195364662	-0.195364662	-0.195364662	-0.195364662	-0.195364662	0.000284597	106149	Recycling of bile acids and salts	495
-0.195581737	-0.195581737	-0.195581737	-0.195581737	-0.195581737	-0.195581737	0.000286181	782380	pyrimidine deoxyribonucleotides de novo biosynthesis	1871
-0.196096515	-0.196096515	-0.196096515	-0.196096515	-0.196096515	-0.196096515	0.000289968	137923	Rapid glucocorticoid signaling	844
-0.196406103	-0.196406103	-0.196406103	-0.196406103	-0.196406103	-0.196406103	0.000292264	106163	Golgi to ER Retrograde Transport	507
-0.196406103	-0.196406103	-0.196406103	-0.196406103	-0.196406103	-0.196406103	0.000292264	106164	COPI Mediated Transport	508
-0.19644328	-0.19644328	-0.19644328	-0.19644328	-5.285647436	-1.214284112	0.007871308	730308	Crosslinking of collagen fibrils	1794
-0.19651092	-5.334051301	-0.19651092	-0.19651092	-0.19651092	-1.224018996	0.007954336	106519	Norepinephrine Neurotransmitter Release Cycle	726
-0.19669817	-0.19669817	4.899109355	-0.19669817	-0.19669817	0.822463335	0.00733362	106260	Metabolism of folate and pterines	560
-0.197264326	-0.197264326	-0.197264326	-0.197264326	-0.197264326	-0.197264326	0.000298705	645326	Acyl chain remodelling of PI	1713
-0.197351658	-0.197351658	4.824319035	-0.197351658	-0.197351658	0.80698248	0.007318113	698757	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1780
-0.197537366	-0.197537366	-0.197537366	-0.197537366	-0.197537366	-0.197537366	0.000300778	545309	gamma-linolenate biosynthesis II (animals)	1593
-0.197591271	-0.197591271	-0.197591271	-0.197591271	-0.197591271	-0.197591271	0.000301189	119536	Regulation of Insulin Secretion by Free Fatty Acids	789
-0.197591271	-0.197591271	-0.197591271	-0.197591271	-0.197591271	-0.197591271	0.000301189	119537	Regulation of Insulin Secretion by Fatty Acids Bound to GPR40 (FFAR1)	790
-0.197864129	-0.197864129	-0.197864129	-0.197864129	-0.197864129	-0.197864129	0.000303274	106016	APOBEC3G mediated resistance to HIV-1 infection	419
-0.197909877	-0.197909877	-0.197909877	-0.197909877	-0.197909877	-0.197909877	0.000303625	545313	stearate biosynthesis I (animals)	1596
-0.198218577	-0.198218577	-0.198218577	-0.198218577	-0.198218577	-0.198218577	0.000306	618581	Guanine ribonucleotide biosynthesis IMP => GDP,GTP	1658
-0.198667051	-0.198667051	-0.198667051	-0.198667051	-0.198667051	-0.198667051	0.000309478	106024	Nef Mediated CD4 Down-regulation	425
-0.198762127	-0.198762127	-0.198762127	-0.198762127	-5.237092332	-1.206428168	0.008173814	198823	Complement Activation, Classical Pathway	1324
-0.19880275	-0.19880275	-0.19880275	-0.19880275	-0.19880275	-0.19880275	0.000310536	82939	Ubiquinone and other terpenoid-quinone biosynthesis	14
-0.198824728	-0.198824728	-0.198824728	-0.198824728	-0.198824728	-0.198824728	0.000310708	106047	Elevation of cytosolic Ca2+ levels	435
-0.198981264	-0.198981264	-0.198981264	-0.198981264	-0.198981264	-0.198981264	0.000311933	576274	Signaling by NOTCH4	1649
-0.199691949	-0.199691949	-0.199691949	-0.199691949	-0.199691949	-0.199691949	0.000317543	524496	Ceramide biosynthesis	1537
-0.199885548	-0.199885548	-0.199885548	-0.199885548	-0.199885548	-0.199885548	0.000319085	161029	Highly calcium permeable nicotinic acetylcholine receptors	1116
-0.200428226	-0.200428226	-0.200428226	-0.200428226	-0.200428226	-0.200428226	0.000323441	106138	Beta-oxidation of pristanoyl-CoA	487
-0.200715876	-0.200715876	-0.200715876	-0.200715876	-0.200715876	-0.200715876	0.000325768	119534	Nectin/Necl trans heterodimerization	787
-0.201097832	-0.201097832	-0.201097832	-0.201097832	-0.201097832	-0.201097832	0.00032888	106326	Heme biosynthesis	573
-0.201748582	-0.201748582	-0.201748582	-0.201748582	-0.201748582	-0.201748582	0.000334235	782391	superpathway of pyrimidine deoxyribonucleoside salvage	1876
-0.202131379	-5.168504316	-0.202131379	-0.202131379	-0.202131379	-1.195405966	0.008627795	413399	GABA biosynthesis, eukaryotes, putrescine => GABA	1501
-0.202170295	-0.202170295	-0.202170295	-0.202170295	4.740868694	0.786437503	0.007920039	142437	nicotine degradation IV	1028
-0.20249816	-0.20249816	-0.20249816	-0.20249816	-0.20249816	-0.20249816	0.000340491	138037	EGFR-dependent Endothelin signaling events	948
-0.202735562	-0.202735562	-0.202735562	-0.202735562	-0.202735562	-0.202735562	0.000342491	106499	Adenylate cyclase activating pathway	710
-0.203111925	-5.062248897	-5.062248897	-9.921385869	-5.062248897	-5.062248897	261.4196611	545293	retinol biosynthesis	1586
-0.20337115	-0.20337115	-0.20337115	-0.20337115	-0.20337115	-0.20337115	0.000347894	82997	Glycosphingolipid biosynthesis - ganglio series	53
-0.203934675	-0.203934675	-0.203934675	-0.203934675	-0.203934675	-0.203934675	0.000352741	833805	SUMOylation	1900
-0.203934675	-0.203934675	-0.203934675	-0.203934675	-0.203934675	-0.203934675	0.000352741	833806	Processing and Activation of SUMO	1901
-0.203980317	-0.203980317	-0.203980317	-0.203980317	-0.203980317	-0.203980317	0.000353135	82967	Taurine and hypotaurine metabolism	28
-0.204100532	-0.204100532	-0.204100532	-0.204100532	-0.204100532	-0.204100532	0.000354177	413446	Methionine salvage pathway	1506
-0.20411311	-0.20411311	-0.20411311	-0.20411311	-0.20411311	-0.20411311	0.000354286	105664	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	185
-0.204301068	-0.204301068	-0.204301068	-0.204301068	-0.204301068	-0.204301068	0.000355921	187188	Passive Transport by Aquaporins	1221
-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	0.000357754	106257	Biotin transport and metabolism	558
-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	0.000357754	187083	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	1182
-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	-0.204511056	0.000357754	187087	IRAK1 recruits IKK complex	1186
-0.205291316	-0.205291316	-0.205291316	-0.205291316	-0.205291316	-0.205291316	0.00036463	161015	Synthesis of substrates in N-glycan biosythesis	1108
-0.20534031	-0.20534031	-0.20534031	-0.20534031	-0.20534031	-0.20534031	0.000365066	106246	Folding of actin by CCT/TriC	550
-0.205511722	4.658671053	-5.069694497	4.658671053	-5.069694497	-0.205511722	114.6368568	105928	Gap junction assembly	349
-0.205686969	-0.205686969	-0.205686969	-0.205686969	-0.205686969	-0.205686969	0.000368158	82983	Glycosaminoglycan biosynthesis - keratan sulfate	40
-0.205701033	-0.205701033	-0.205701033	-0.205701033	-0.205701033	-0.205701033	0.000368284	576273	Signaling by NOTCH3	1648
-0.20601876	-0.20601876	-0.20601876	-0.20601876	-0.20601876	-0.20601876	0.000371137	105709	Miscellaneous substrates	210
-0.20632905	-5.118925485	-5.118925485	-5.118925485	-5.118925485	-4.136406198	141.669255	142418	triacylglycerol degradation	1024
-0.206394493	-0.206394493	-0.206394493	-0.206394493	-0.206394493	-0.206394493	0.000374533	106273	Purine salvage	567
-0.206607713	-0.206607713	-0.206607713	-0.206607713	-0.206607713	-0.206607713	0.000376472	160974	Regulation of Rheb GTPase activity by AMPK	1077
-0.206807533	-5.055753202	-0.206807533	-0.206807533	-0.206807533	-1.176596667	0.009248074	545354	noradrenaline and adrenaline degradation	1614
-0.207180426	-0.207180426	-0.207180426	-0.207180426	-0.207180426	-0.207180426	0.000381719	187229	DSCAM interactions	1254
-0.2073424	-0.2073424	-0.2073424	-0.2073424	-0.2073424	-0.2073424	0.000383213	730332	Synthesis of IP2, IP, and Ins in the cytosol	1809
-0.207440542	-0.207440542	-0.207440542	-0.207440542	-0.207440542	-0.207440542	0.000384121	106373	Nucleotide-like (purinergic) receptors	612
-0.207724621	-0.207724621	-0.207724621	-0.207724621	-0.207724621	-0.207724621	0.000386759	413352	Lysine degradation, lysine => saccharopine => acetoacetyl-CoA	1474
-0.207759741	-0.207759741	-0.207759741	-0.207759741	-0.207759741	-0.207759741	0.000387086	160969	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	1072
-0.207889837	-0.207889837	-0.207889837	-0.207889837	-0.207889837	-0.207889837	0.000388299	161001	Netrin mediated repulsion signals	1094
-0.2081362	-0.2081362	-0.2081362	-0.2081362	-0.2081362	-0.2081362	0.000390605	106368	Serotonin receptors	608
-0.208417624	-0.208417624	-0.208417624	-0.208417624	-0.208417624	-0.208417624	0.000393253	106109	Regulation of pyruvate dehydrogenase (PDH) complex	477
-0.208472065	-0.208472065	-0.208472065	-0.208472065	-0.208472065	-0.208472065	0.000393767	160973	Regulation of AMPK activity via LKB1	1076
-0.208993216	-0.208993216	-0.208993216	-0.208993216	-0.208993216	-0.208993216	0.000398713	161002	Role of second messengers in netrin-1 signaling	1095
-0.20921988	-0.20921988	-0.20921988	-0.20921988	-0.20921988	-0.20921988	0.00040088	105847	Resolution of AP sites via the single-nucleotide replacement pathway	300
-0.209584394	-0.209584394	-0.209584394	-0.209584394	-0.209584394	-0.209584394	0.000404385	82938	Primary bile acid biosynthesis	13
-0.209761139	-0.209761139	-0.209761139	-0.209761139	-0.209761139	-0.209761139	0.000406093	105866	Recruitment of repair and signaling proteins to double-strand breaks	310
-0.210777839	-0.210777839	-0.210777839	-0.210777839	-0.210777839	-0.210777839	0.00041603	920989	miRNA Regulation of DNA Damage Response	1993
-0.210907079	-0.210907079	-0.210907079	-0.210907079	-0.210907079	-0.210907079	0.000417307	771576	Cytosolic Iron-sulfur Cluster Assembly	1844
-0.211011686	-0.211011686	-0.211011686	-0.211011686	-0.211011686	-0.211011686	0.000418343	833819	IRF3-mediated induction of type I IFN	1911
-0.211269647	-0.211269647	-0.211269647	-0.211269647	-0.211269647	-0.211269647	0.000420906	106266	Purine ribonucleoside monophosphate biosynthesis	566
-0.211642767	-0.211642767	-0.211642767	-0.211642767	-0.211642767	-0.211642767	0.000424636	545280	dermatan sulfate biosynthesis	1583
-0.211728616	-0.211728616	4.551569841	-0.211728616	-0.211728616	0.740931075	0.009147016	771573	Nuclear Envelope Reassembly	1841
-0.211728616	-0.211728616	4.551569841	-0.211728616	-0.211728616	0.740931075	0.009147016	771574	Initiation of Nuclear Envelope Reformation	1842
-0.211977873	-0.211977873	-0.211977873	-0.211977873	-0.211977873	-0.211977873	0.000428009	187099	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1198
-0.212083975	-0.212083975	-0.212083975	-0.212083975	-0.212083975	-0.212083975	0.000429081	106517	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	724
-0.212279356	-0.212279356	-0.212279356	-0.212279356	-0.212279356	-0.212279356	0.000431061	198757	Mitochondrial Gene Expression	1261
-0.212427277	-0.212427277	-0.212427277	-0.212427277	-0.212427277	-0.212427277	0.000432565	106433	S6K1-mediated signalling	662
-0.212517532	-0.212517532	-0.212517532	-0.212517532	-0.212517532	-0.212517532	0.000433485	137921	Ras signaling in the CD4+ TCR pathway	842
-0.212739913	-0.212739913	-0.212739913	-0.212739913	-0.212739913	-0.212739913	0.000435758	105795	Removal of the Flap Intermediate	262
-0.213178583	-0.213178583	-0.213178583	-0.213178583	-0.213178583	-0.213178583	0.000440269	106060	Common Pathway	444
-0.21381596	-0.21381596	-0.21381596	-0.21381596	-0.21381596	-0.21381596	0.00044689	161032	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1119
-0.214096496	-0.214096496	-0.214096496	-0.214096496	-0.214096496	-0.214096496	0.000449829	106355	FGFR4 ligand binding and activation	598
-0.214153153	4.44641601	-0.214153153	4.44641601	4.44641601	2.582188345	4.031616609	105722	Glucuronidation	213
-0.214153153	-0.214153153	-0.214153153	-0.214153153	4.44641601	0.71796068	0.009352075	160983	Amine-derived hormones	1082
-0.214237832	-0.214237832	-0.214237832	-0.214237832	-0.214237832	-0.214237832	0.000451316	645324	Acyl chain remodelling of PS	1712
-0.214690058	-0.214690058	4.483123022	4.483123022	-0.214690058	1.664435174	0.198882748	672464	SRF and miRs in Smooth Muscle Differentiation and Proliferation	1749
-0.215149008	-0.215149008	-0.215149008	-0.215149008	-0.215149008	-0.215149008	0.000460996	105691	RAF/MAP kinase cascade	197
-0.21543217	-0.21543217	-0.21543217	-0.21543217	-0.21543217	-0.21543217	0.000464037	672461	Iron metabolism in placenta	1747
-0.21555111	-0.21555111	-0.21555111	-0.21555111	-0.21555111	-0.21555111	0.00046532	645328	Acyl chain remodelling of PG	1715
-0.215783071	-0.215783071	-0.215783071	-0.215783071	-0.215783071	-0.215783071	0.000467829	730341	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1817
-0.215909701	-0.215909701	-0.215909701	-0.215909701	-0.215909701	-0.215909701	0.000469203	106122	Mitochondrial Fatty Acid Beta-Oxidation	483
-0.21662841	-0.21662841	-0.21662841	-0.21662841	-0.21662841	-0.21662841	0.000477064	545288	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1584
-0.216711468	-0.216711468	-0.216711468	-0.216711468	-0.216711468	-0.216711468	0.00047798	576253	Trafficking and processing of endosomal TLR	1628
-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	0.000483088	645346	O2/CO2 exchange in erythrocytes	1725
-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	0.000483088	645347	Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes	1726
-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	-0.217172692	0.000483088	645348	Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes	1727
-0.217252277	-4.934999888	-0.217252277	-0.217252277	-0.217252277	-1.1608018	0.010993716	920962	Serotonin Transporter Activity	1985
-0.217349163	-0.217349163	-0.217349163	-0.217349163	-0.217349163	-0.217349163	0.000485054	105794	Processive synthesis on the lagging strand	261
-0.217643296	-0.217643296	-0.217643296	-0.217643296	-0.217643296	-0.217643296	0.000488345	645263	Regulation of Gene Expression by Hypoxia-inducible Factor	1664
-0.217663698	-0.217663698	-0.217663698	-0.217663698	-0.217663698	-0.217663698	0.000488574	106108	Import of palmitoyl-CoA into the mitochondrial matrix	476
-0.217741607	-0.217741607	-0.217741607	-0.217741607	-0.217741607	-0.217741607	0.000489449	105939	Notch-HLH transcription pathway	354
-0.21797026	-0.21797026	-0.21797026	-0.21797026	-0.21797026	-0.21797026	0.000492024	833796	Reproduction	1894
-0.21797026	-0.21797026	-0.21797026	-0.21797026	-0.21797026	-0.21797026	0.000492024	833797	Fertilization	1895
-0.21816587	-0.21816587	-0.21816587	-0.21816587	-0.21816587	-0.21816587	0.000494236	83015	Pantothenate and CoA biosynthesis	62
-0.218416607	-0.218416607	-0.218416607	-0.218416607	-0.218416607	-0.218416607	0.000497082	106121	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	482
-0.218731487	-0.218731487	-0.218731487	-0.218731487	-0.218731487	-0.218731487	0.000500676	187218	Calnexin/calreticulin cycle	1248
-0.218951571	-0.218951571	-0.218951571	-0.218951571	-0.218951571	-0.218951571	0.0005032	142373	superpathway of methionine degradation	1020
-0.219090957	-0.219090957	-0.219090957	-0.219090957	-0.219090957	-0.219090957	0.000504803	833794	Activation of the phototransduction cascade	1892
-0.21951757	-0.21951757	-0.21951757	-0.21951757	-0.21951757	-0.21951757	0.000509737	106104	ChREBP activates metabolic gene expression	475
-0.219816034	-0.219816034	-0.219816034	-0.219816034	-0.219816034	-0.219816034	0.000513212	82996	Glycosphingolipid biosynthesis - globo series	52
-0.220935519	-0.220935519	-4.720640581	-0.220935519	-4.720640581	-2.020817543	0.240324746	105934	Formation of annular gap junctions	351
-0.220946592	-0.220946592	-0.220946592	4.320607193	-0.220946592	0.687364165	0.010296604	703093	superpathway of citrulline metabolism	1785
-0.221195861	-0.221195861	4.377470691	-0.221195861	-0.221195861	0.698537449	0.010479275	119523	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	777
-0.22145645	-0.22145645	-0.22145645	-0.22145645	-0.22145645	-0.22145645	0.00053265	187098	TRAF3-dependent IRF activation pathway	1197
-0.221508402	-0.221508402	-0.221508402	-0.221508402	-0.221508402	-0.221508402	0.000533275	105991	Integration of provirus	398
-0.22163218	-0.22163218	-0.22163218	-0.22163218	-0.22163218	-0.22163218	0.000534766	106347	FGFR1c ligand binding and activation	591
-0.22163218	-0.22163218	-0.22163218	-0.22163218	-0.22163218	-0.22163218	0.000534766	645279	Signaling by activated point mutants of FGFR1	1676
-0.2221471	-0.2221471	-0.2221471	-0.2221471	-0.2221471	-0.2221471	0.000541007	545327	D-myo-inositol (1,4,5)-trisphosphate degradation	1603
-0.222174063	-0.222174063	-0.222174063	-0.222174063	-0.222174063	-0.222174063	0.000541336	105982	Mitochondrial tRNA aminoacylation	389
-0.22221855	-0.22221855	-0.22221855	-0.22221855	-0.22221855	-0.22221855	0.000541878	187091	TRAF6 mediated induction of TAK1 complex	1190
-0.222520758	-0.222520758	-0.222520758	-0.222520758	-0.222520758	-0.222520758	0.000545573	106238	Synthesis of glycosylphosphatidylinositol (GPI)	543
-0.222947729	-0.222947729	-0.222947729	-0.222947729	-0.222947729	-0.222947729	0.000550827	161028	Presynaptic nicotinic acetylcholine receptors	1115
-0.223099829	-0.223099829	-0.223099829	-0.223099829	-0.223099829	-0.223099829	0.000552709	413390	Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol	1497
-0.223173753	-0.223173753	-0.223173753	-0.223173753	-0.223173753	-0.223173753	0.000553625	645341	Synthesis of PIPs at the late endosome membrane	1721
-0.223381621	-0.223381621	-0.223381621	4.293941357	-0.223381621	0.680082974	0.010691678	106224	eNOS activation	533
-0.223440553	-0.223440553	-0.223440553	-0.223440553	-0.223440553	-0.223440553	0.000556942	905990	Glycogen synthesis	1937
-0.22350877	-0.22350877	-0.22350877	-0.22350877	4.202407471	0.661674478	0.010487608	105706	Fatty acids	207
-0.223912173	-0.223912173	-0.223912173	-0.223912173	-0.223912173	-0.223912173	0.000562845	83018	Folate biosynthesis	63
-0.223953618	-0.223953618	-0.223953618	-0.223953618	-0.223953618	-0.223953618	0.000563366	524497	Sphingosine biosynthesis	1538
-0.2243653	-0.2243653	-0.2243653	-0.2243653	4.276443128	0.675796386	0.01083691	137983	ALK2 signaling events	900
-0.224874378	-0.224874378	-0.224874378	-0.224874378	-0.224874378	-0.224874378	0.000575042	106450	NF-kB is activated and signals survival	676
-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	0.000577947	106352	FGFR3 ligand binding and activation	595
-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	0.000577947	106354	FGFR3c ligand binding and activation	597
-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	0.000577947	645283	Signaling by FGFR3 mutants	1679
-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	-0.225101104	0.000577947	645284	Signaling by activated point mutants of FGFR3	1680
-0.225265521	-0.225265521	-0.225265521	-0.225265521	-0.225265521	-0.225265521	0.000580061	198767	NLR proteins	1271
-0.225345528	-0.225345528	-0.225345528	-0.225345528	-0.225345528	-0.225345528	0.000581092	106008	Assembly Of The HIV Virion	412
-0.22564422	-0.22564422	-0.22564422	-0.22564422	-0.22564422	-0.22564422	0.000584953	685555	Metabolism of Angiotensinogen to Angiotensins	1773
-0.225754791	-0.225754791	-0.225754791	-0.225754791	-0.225754791	-0.225754791	0.000586388	105701	Endogenous sterols	204
-0.22607789	-0.22607789	-0.22607789	-0.22607789	-0.22607789	-0.22607789	0.000590596	198899	Sulfation Biotransformation Reaction	1398
-0.226124392	-0.226124392	-0.226124392	-0.226124392	-0.226124392	-0.226124392	0.000591204	730340	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1816
-0.226131484	-0.226131484	-0.226131484	-0.226131484	-0.226131484	-0.226131484	0.000591296	82976	Other glycan degradation	34
-0.226200431	-0.226200431	-0.226200431	-4.696564683	-0.226200431	-1.120273282	0.012295722	198783	Alanine and aspartate metabolism	1286
-0.226374804	-0.226374804	-0.226374804	-0.226374804	-0.226374804	-0.226374804	0.000594484	477112	ABCA transporters in lipid homeostasis	1511
-0.226501186	-0.226501186	-0.226501186	-0.226501186	-0.226501186	-0.226501186	0.000596146	685548	STING mediated induction of host immune responses	1766
-0.226808277	-0.226808277	-0.226808277	-0.226808277	-0.226808277	-0.226808277	0.000600198	142255	CDP-diacylglycerol biosynthesis I	1003
-0.227129742	-0.227129742	-0.227129742	-0.227129742	-0.227129742	-0.227129742	0.000604463	198908	IL-1 Signaling Pathway	1406
-0.227280581	-0.227280581	-0.227280581	-0.227280581	-0.227280581	-0.227280581	0.000606473	771591	Constitutive Signaling by NOTCH1 HD Domain Mutants	1858
-0.227581123	-0.227581123	-0.227581123	-0.227581123	-0.227581123	-0.227581123	0.000610494	106173	Amino acid synthesis and interconversion (transamination)	513
-0.227643882	-0.227643882	-0.227643882	-0.227643882	-0.227643882	-0.227643882	0.000611336	83075	Renin-angiotensin system	114
-0.227757481	-0.227757481	-0.227757481	-0.227757481	-0.227757481	-0.227757481	0.000612863	833830	NOTCH2 intracellular domain regulates transcription	1919
-0.227969832	-0.227969832	4.143455509	-0.227969832	-0.227969832	0.646315237	0.011191085	645300	Hyaluronan uptake and degradation	1692
-0.228285817	-0.228285817	-0.228285817	-0.228285817	-0.228285817	-0.228285817	0.000620004	645319	Synthesis of PC	1709
-0.228563676	-0.228563676	-0.228563676	-0.228563676	-0.228563676	-0.228563676	0.000623787	730313	Establishment of Sister Chromatid Cohesion	1799
-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	0.00063207	105791	Leading Strand Synthesis	258
-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	0.00063207	105792	Polymerase switching	259
-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	-0.229167478	0.00063207	106545	Polymerase switching on the C-strand of the telomere	742
-0.2292081	-0.2292081	-0.2292081	-0.2292081	-0.2292081	-0.2292081	0.00063263	714485	2-Oxocarboxylic acid metabolism	1791
-0.229428537	-0.229428537	-0.229428537	-0.229428537	-0.229428537	-0.229428537	0.000635678	413375	Dermatan sulfate degradation	1486
-0.229612156	-0.229612156	-0.229612156	-0.229612156	-0.229612156	-0.229612156	0.000638226	106476	AKT phosphorylates targets in the nucleus	697
-0.22964961	-0.22964961	-0.22964961	-0.22964961	-0.22964961	-0.22964961	0.000638747	645296	EGFR Transactivation by Gastrin	1689
-0.230312464	-0.230312464	-0.230312464	-0.230312464	-0.230312464	-0.230312464	0.000648018	105922	Formation of ATP by chemiosmotic coupling	343
-0.23035691	4.111903418	-4.572617239	-0.23035691	4.111903418	0.638095155	4.102543079	198821	Glucuronidation	1322
-0.230386831	-0.230386831	-0.230386831	-0.230386831	-0.230386831	-0.230386831	0.000649065	106506	Signaling by VEGF	716
-0.230386831	-0.230386831	-0.230386831	-0.230386831	-0.230386831	-0.230386831	0.000649065	106507	VEGF ligand-receptor interactions	717
-0.231318137	-0.231318137	-0.231318137	-0.231318137	-0.231318137	-0.231318137	0.00066229	106193	Metabolism of polyamines	520
-0.231809358	-0.231809358	-0.231809358	-0.231809358	-0.231809358	-0.231809358	0.000669352	105780	Inhibition of replication initiation of damaged DNA by RB1/E2F1	247
-0.23187516	-0.23187516	-0.23187516	-0.23187516	-0.23187516	-0.23187516	0.000670303	413354	Leucine degradation, leucine => acetoacetate + acetyl-CoA	1476
-0.231889696	-0.231889696	-0.231889696	-0.231889696	-0.231889696	-0.231889696	0.000670513	160139	Activation of the AP-1 family of transcription factors	1047
-0.231933738	-0.231933738	-0.231933738	-0.231933738	-0.231933738	-0.231933738	0.00067115	106345	FGFR1 ligand binding and activation	590
-0.23202973	-0.23202973	-0.23202973	-0.23202973	-0.23202973	-0.23202973	0.00067254	545274	heparan sulfate biosynthesis (late stages)	1578
-0.232032778	-0.232032778	-0.232032778	-0.232032778	-0.232032778	-0.232032778	0.000672584	105889	Repair synthesis of patch ~27-30 bases long by DNA polymerase	320
-0.232032778	-0.232032778	-0.232032778	-0.232032778	-0.232032778	-0.232032778	0.000672584	105894	Repair synthesis for gap-filling by DNA polymerase in TC-NER	325
-0.232783346	-0.232783346	-0.232783346	-0.232783346	-0.232783346	-0.232783346	0.000683533	119541	G beta:gamma signalling through PLC beta	794
-0.232801982	-0.232801982	-0.232801982	-0.232801982	-0.232801982	-0.232801982	0.000683807	545315	D-myo-inositol-5-phosphate metabolism	1598
-0.23298615	-0.23298615	-0.23298615	-0.23298615	-0.23298615	-0.23298615	0.000686516	645310	Dermatan sulfate biosynthesis	1702
-0.233080718	-0.233080718	-0.233080718	-0.233080718	-0.233080718	-0.233080718	0.00068791	530770	Activation of Chaperone Genes by ATF6-alpha	1571
-0.233185701	-0.233185701	-0.233185701	-0.233185701	-0.233185701	-0.233185701	0.000689461	366167	The NLRP3 inflammasome	1444
-0.233250712	-0.233250712	-0.233250712	-0.233250712	-0.233250712	-0.233250712	0.000690422	137926	Visual signal transduction: Cones	847
-0.233439835	-0.233439835	-0.233439835	-0.233439835	-0.233439835	-0.233439835	0.000693226	782390	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1875
-0.233507416	-0.233507416	-0.233507416	-0.233507416	-0.233507416	-0.233507416	0.00069423	106449	p75NTR recruits signalling complexes	675
-0.233602955	-0.233602955	-0.233602955	-0.233602955	-0.233602955	-0.233602955	0.000695651	142264	phosphatidylglycerol biosynthesis II (non-plastidic)	1006
-0.233778794	-0.233778794	-0.233778794	-0.233778794	-0.233778794	-0.233778794	0.000698274	413356	N-glycan biosynthesis, complex type	1477
-0.234314392	-0.234314392	-0.234314392	-0.234314392	-0.234314392	-0.234314392	0.000706309	160978	Synthesis of very long-chain fatty acyl-CoAs	1081
-0.234486332	-0.234486332	-0.234486332	-0.234486332	-0.234486332	-0.234486332	0.000708904	545356	melatonin degradation I	1615
-0.234503681	-0.234503681	-0.234503681	-0.234503681	-0.234503681	-0.234503681	0.000709167	105682	Apoptosis induced DNA fragmentation	191
-0.234503681	-0.234503681	-0.234503681	-0.234503681	-0.234503681	-0.234503681	0.000709167	105683	Activation of DNA fragmentation factor	192
-0.234691259	-0.234691259	-0.234691259	-0.234691259	-0.234691259	-0.234691259	0.000712008	105900	Association of licensing factors with the pre-replicative complex	331
-0.235315376	-0.235315376	-0.235315376	-0.235315376	-0.235315376	-0.235315376	0.000721525	106432	mTORC1-mediated signalling	661
-0.235432176	-0.235432176	-0.235432176	-0.235432176	-0.235432176	-0.235432176	0.000723318	105724	Cytosolic sulfonation of small molecules	214
-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	0.000724824	106535	Acetylcholine Binding And Downstream Events	733
-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	0.000724824	161027	Activation of Nicotinic Acetylcholine Receptors	1114
-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	-0.23553017	0.000724824	161031	Postsynaptic nicotinic acetylcholine receptors	1118
-0.235542474	-0.235542474	-0.235542474	-0.235542474	-0.235542474	-0.235542474	0.000725014	187217	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1247
-0.235542775	-0.235542775	-0.235542775	-0.235542775	-0.235542775	-0.235542775	0.000725018	142358	isoleucine degradation I	1018
-0.235570903	-0.235570903	-0.235570903	-0.235570903	-0.235570903	-0.235570903	0.000725451	106445	NRIF signals cell death from the nucleus	671
-0.23560602	-0.23560602	3.96040503	-0.23560602	-0.23560602	0.60359619	0.012203521	905995	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1942
-0.235924615	-0.235924615	-0.235924615	-0.235924615	-0.235924615	-0.235924615	0.000730914	413381	beta-Oxidation	1490
-0.2360637	-0.2360637	-0.2360637	-0.2360637	-0.2360637	-0.2360637	0.000733071	106500	Adenylate cyclase inhibitory pathway	711
-0.2360637	-0.2360637	-0.2360637	-0.2360637	-0.2360637	-0.2360637	0.000733071	187182	Inhibition of adenylate cyclase pathway	1217
-0.236179837	-0.236179837	-0.236179837	-0.236179837	-0.236179837	-0.236179837	0.000734876	106480	Retrograde neurotrophin signalling	699
-0.236343547	-0.236343547	-0.236343547	-0.236343547	-0.236343547	-0.236343547	0.000737427	105888	Gap-filling DNA repair synthesis and ligation in GG-NER	319
-0.236343547	-0.236343547	-0.236343547	-0.236343547	-0.236343547	-0.236343547	0.000737427	105893	Gap-filling DNA repair synthesis and ligation in TC-NER	324
-0.236355198	-0.236355198	-0.236355198	-0.236355198	-0.236355198	-0.236355198	0.000737608	161060	ADP signalling through P2Y purinoceptor 12	1144
-0.236395586	-0.236395586	-0.236395586	-0.236395586	-0.236395586	-0.236395586	0.000738239	105679	Caspase-mediated cleavage of cytoskeletal proteins	189
-0.237375395	-0.237375395	-0.237375395	-0.237375395	-0.237375395	-0.237375395	0.000753665	82982	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	39
-0.237657301	-0.237657301	-0.237657301	-0.237657301	-0.237657301	-0.237657301	0.000758151	105850	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	303
-0.237657301	-0.237657301	-0.237657301	-0.237657301	-0.237657301	-0.237657301	0.000758151	105851	Removal of DNA patch containing abasic residue	304
-0.237692815	-0.237692815	-0.237692815	-0.237692815	-0.237692815	-0.237692815	0.000758718	198758	Urea cycle and metabolism of amino groups	1262
-0.237736549	-4.556293298	-0.237736549	-0.237736549	4.0808202	-0.237736549	0.249831385	920995	Dopamine metabolism	1996
-0.237751697	-0.237751697	-0.237751697	-0.237751697	-0.237751697	-0.237751697	0.000759658	413341	Glycolysis, core module involving three-carbon compounds	1467
-0.237788149	-0.237788149	-0.237788149	-0.237788149	-0.237788149	-0.237788149	0.000760241	106371	Prostanoid ligand receptors	611
-0.238056031	-0.238056031	-0.238056031	-0.238056031	-0.238056031	-0.238056031	0.000764532	160954	Processing of Intronless Pre-mRNAs	1061
-0.23840654	-0.23840654	3.951515082	-0.23840654	-0.23840654	0.599577784	0.012765455	119525	CRMPs in Sema3A signaling	779
-0.238548102	-0.238548102	-0.238548102	-0.238548102	-0.238548102	-0.238548102	0.000772467	161047	Presynaptic function of Kainate receptors	1132
-0.238639991	-0.238639991	-0.238639991	-0.238639991	-0.238639991	-0.238639991	0.000773956	198910	BMP signalling and regulation	1408
-0.238756651	-0.238756651	-4.423798739	-0.238756651	-4.423798739	-1.912773486	0.266352733	105933	Gap junction degradation	350
-0.238781146	-4.416928927	-0.238781146	-0.238781146	-0.238781146	-1.074410702	0.014358879	545353	serotonin degradation	1613
-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	0.000787971	142266	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1007
-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	0.000787971	142267	cholesterol biosynthesis I	1008
-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	-0.239498062	0.000787971	142268	cholesterol biosynthesis III (via desmosterol)	1009
-0.240085979	-0.240085979	-0.240085979	-0.240085979	-0.240085979	-0.240085979	0.00079769	530762	Interleukin-7 signaling	1565
-0.240230575	-0.240230575	-0.240230575	-0.240230575	-0.240230575	-0.240230575	0.000800095	187205	GP1b-IX-V activation signalling	1237
-0.240361785	-0.240361785	-0.240361785	-0.240361785	-0.240361785	-0.240361785	0.000802282	187088	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1187
-0.240411094	-0.240411094	-0.240411094	-0.240411094	-0.240411094	-0.240411094	0.000803105	106463	Signalling to p38 via RIT and RIN	685
-0.240717958	-0.240717958	-0.240717958	-0.240717958	-0.240717958	-0.240717958	0.000808244	138069	S1P4 pathway	978
-0.240913655	-0.240913655	-0.240913655	-0.240913655	-0.240913655	-0.240913655	0.000811535	187226	N-Glycan antennae elongation	1252
-0.24140452	-0.24140452	-0.24140452	-0.24140452	-0.24140452	-0.24140452	0.000819836	137978	Circadian rhythm pathway	895
-0.241501114	-0.241501114	-0.241501114	-0.241501114	-0.241501114	-0.241501114	0.000821478	106475	AKT phosphorylates targets in the cytosol	696
-0.241722025	-0.241722025	-0.241722025	-0.241722025	-0.241722025	-0.241722025	0.000825242	187216	Stabilization of mRNA by HuR	1246
-0.242213143	-0.242213143	-0.242213143	-0.242213143	-0.242213143	-0.242213143	0.000833659	82969	Selenocompound metabolism	29
-0.242475563	-0.242475563	3.860325837	-0.242475563	-0.242475563	0.578084717	0.013344302	645298	Hyaluronan metabolism	1691
-0.242651915	-0.242651915	-0.242651915	-0.242651915	-0.242651915	-0.242651915	0.000841237	413377	Heparan sulfate degradation	1488
-0.243134749	-0.243134749	-0.243134749	-0.243134749	-0.243134749	-0.243134749	0.00084964	105653	TRAIL signaling	179
-0.243229721	-0.243229721	-0.243229721	3.861913253	-0.243229721	0.577798874	0.01351665	198763	ACE Inhibitor Pathway	1267
-0.243476058	-0.243476058	-0.243476058	3.828029929	7.899535915	2.199427534	0.436461246	82960	Phenylalanine metabolism	25
-0.24347966	-0.24347966	-0.24347966	-0.24347966	-0.24347966	-0.24347966	0.000855684	83047	Non-homologous end-joining	86
-0.243567203	-0.243567203	-0.243567203	-0.243567203	-0.243567203	-0.243567203	0.000857223	545279	chondroitin sulfate biosynthesis	1582
-0.243800325	-0.243800325	-0.243800325	-4.230723059	-0.243800325	-1.041184872	0.01494692	771585	The canonical retinoid cycle in rods (twilight vision)	1852
-0.244178937	-0.244178937	-0.244178937	-0.244178937	-0.244178937	-0.244178937	0.000868043	782404	fatty acid beta-oxidation VI (peroxisome)	1884
-0.245677041	-0.245677041	-0.245677041	-0.245677041	-0.245677041	-0.245677041	0.000895	161070	Na+/Cl- dependent neurotransmitter transporters	1152
-0.246000653	-0.246000653	-0.246000653	-0.246000653	-0.246000653	-0.246000653	0.00090091	160136	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	1044
-0.246234632	-0.246234632	-0.246234632	-0.246234632	-0.246234632	-0.246234632	0.000905202	198839	GPCRs, Class C Metabotropic glutamate, pheromone	1340
-0.246446895	-0.246446895	-0.246446895	-0.246446895	-0.246446895	-0.246446895	0.000909111	545332	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1606
-0.246680989	-0.246680989	-0.246680989	-0.246680989	-0.246680989	-0.246680989	0.000913437	645343	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1722
-0.246680989	-0.246680989	-0.246680989	-0.246680989	-0.246680989	-0.246680989	0.000913437	645344	alpha-linolenic acid (ALA) metabolism	1723
-0.246683446	-0.246683446	-0.246683446	-0.246683446	-0.246683446	-0.246683446	0.000913482	618580	Adenine ribonucleotide biosynthesis, IMP => ADP,ATP	1657
-0.246873504	-0.246873504	-0.246873504	-0.246873504	-0.246873504	-0.246873504	0.000917006	413348	Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate	1472
-0.247316928	-0.247316928	-0.247316928	-0.247316928	-0.247316928	-0.247316928	0.000925272	187203	Reduction of cytosolic Ca++ levels	1235
-0.247384811	-0.247384811	-0.247384811	-0.247384811	-0.247384811	-0.247384811	0.000926542	106030	Platelet Adhesion to exposed collagen	429
-0.247408164	-0.247408164	-0.247408164	-0.247408164	-0.247408164	-0.247408164	0.00092698	105905	Activation of Chaperones by ATF6-alpha	335
-0.247520783	-0.247520783	-0.247520783	-0.247520783	-0.247520783	-0.247520783	0.000929091	106437	SOS-mediated signalling	665
-0.247681973	-0.247681973	-0.247681973	-0.247681973	-0.247681973	-0.247681973	0.00093212	106076	Viral Messenger RNA Synthesis	459
-0.247809864	-0.247809864	-0.247809864	-0.247809864	3.723502062	0.546452521	0.014041903	187171	Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1)	1209
-0.247888084	-4.328350378	-0.247888084	-0.247888084	-0.247888084	-1.063980543	0.016343498	545359	superpathway of melatonin degradation	1616
-0.247974224	-0.247974224	-0.247974224	-0.247974224	-0.247974224	-0.247974224	0.000937633	106423	SHC-mediated signalling	654
-0.248415098	-0.248415098	-0.248415098	-0.248415098	-0.248415098	-0.248415098	0.000945997	105924	Regulation of Insulin Secretion by Acetylcholine	345
-0.248512173	-0.248512173	-0.248512173	-0.248512173	-0.248512173	-0.248512173	0.000947847	106522	Glutamate Neurotransmitter Release Cycle	728
-0.248610289	-0.248610289	-0.248610289	-0.248610289	-0.248610289	-0.248610289	0.00094972	119555	CD28 dependent Vav1 pathway	807
-0.249049939	-0.249049939	-0.249049939	-0.249049939	-0.249049939	-0.249049939	0.000958147	198890	Homologous recombination	1389
-0.24978743	-0.24978743	-0.24978743	-0.24978743	-0.24978743	-0.24978743	0.000972418	106566	RNA Polymerase III Chain Elongation	762
-0.249804304	-0.249804304	-0.249804304	-0.249804304	-0.249804304	-0.249804304	0.000972746	106059	Intrinsic Pathway	443
-0.250751092	-0.250751092	-0.250751092	3.78061695	-0.250751092	0.555522516	0.014946311	477136	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1532
-0.250799048	-0.250799048	-0.250799048	-0.250799048	-0.250799048	-0.250799048	0.000992269	160972	Energy dependent regulation of mTOR by LKB1-AMPK	1075
-0.2509551	-0.2509551	-0.2509551	-0.2509551	-0.2509551	-0.2509551	0.00099536	545328	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	1604
-0.251184232	-0.251184232	-0.251184232	-0.251184232	-0.251184232	-0.251184232	0.000999912	106471	PKA activation	693
-0.251237624	-0.251237624	-0.251237624	-0.251237624	-0.251237624	-0.251237624	0.001000975	138029	Sumoylation by RanBP2 regulates transcriptional repression	942
-0.251557788	3.763730131	3.763730131	-0.251557788	-0.251557788	1.35455738	0.225501925	105763	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	236
-0.251557788	3.763730131	3.763730131	-0.251557788	-0.251557788	1.35455738	0.225501925	105764	Inactivation of APC/C via direct inhibition of the APC/C complex	237
-0.251768457	-0.251768457	-0.251768457	-0.251768457	-0.251768457	-0.251768457	0.001011595	105838	Base Excision Repair	297
-0.251768457	-0.251768457	-0.251768457	-0.251768457	-0.251768457	-0.251768457	0.001011595	105846	Resolution of Abasic Sites (AP sites)	299
-0.25214312	-0.25214312	-0.25214312	-0.25214312	-0.25214312	-0.25214312	0.001019144	187199	Prostacyclin signalling through prostacyclin receptor	1231
-0.252354211	-0.252354211	-0.252354211	-0.252354211	-0.252354211	-0.252354211	0.001023417	477119	Spry regulation of FGF signaling	1516
-0.252630868	-0.252630868	-0.252630868	-0.252630868	-0.252630868	-0.252630868	0.00102904	106462	p38MAPK events	684
-0.252689656	-0.252689656	-0.252689656	-0.252689656	-0.252689656	-0.252689656	0.001030237	187195	Ligand-gated ion channel transport	1227
-0.253248064	-0.253248064	-0.253248064	-0.253248064	-0.253248064	-0.253248064	0.001041671	198777	Keap1-Nrf2 Pathway	1280
-0.253266579	-0.253266579	-0.253266579	-0.253266579	-0.253266579	-0.253266579	0.001042052	645317	Acyl chain remodelling of PE	1708
-0.253434527	-0.253434527	-0.253434527	-0.253434527	-0.253434527	-0.253434527	0.001045512	106448	p75NTR signals via NF-kB	674
-0.254038084	-0.254038084	-0.254038084	-0.254038084	-0.254038084	-0.254038084	0.001058021	142242	triacylglycerol biosynthesis	1001
-0.254173504	-0.254173504	-0.254173504	3.689558137	3.689558137	1.323319152	0.223531919	198905	Irinotecan Pathway	1403
-0.254523945	-0.254523945	-0.254523945	-0.254523945	-0.254523945	-0.254523945	0.001068177	137949	LPA4-mediated signaling events	869
-0.25454954	-0.25454954	-0.25454954	-0.25454954	-0.25454954	-0.25454954	0.001068714	187213	Destabilization of mRNA by Butyrate Response Factor 1 (BRF1)	1243
-0.254886447	-4.13739135	-0.254886447	-0.254886447	3.627618456	-0.254886447	0.248535502	198793	Biogenic Amine Synthesis	1296
-0.255117694	3.604454072	-0.255117694	-0.255117694	-0.255117694	0.516796659	0.015268691	530740	Downregulation of ERBB2:ERBB3 signaling	1546
-0.255354154	-0.255354154	-0.255354154	-0.255354154	-0.255354154	-0.255354154	0.001085712	106538	Trafficking of GluR2-containing AMPA receptors	736
-0.255468772	-0.255468772	3.615270192	-0.255468772	-0.255468772	0.518679021	0.015398983	138016	ErbB receptor signaling network	930
-0.255664141	-0.255664141	-0.255664141	-0.255664141	-0.255664141	-0.255664141	0.001092318	137961	EPHA2 forward signaling	881
-0.255701026	-0.255701026	-0.255701026	-0.255701026	-0.255701026	-0.255701026	0.001093106	106212	Glycogen breakdown (glycogenolysis)	529
-0.255721418	-0.255721418	-0.255721418	-0.255721418	-0.255721418	-0.255721418	0.001093542	138066	JNK signaling in the CD4+ TCR pathway	975
-0.255725329	-0.255725329	-0.255725329	-0.255725329	-0.255725329	-0.255725329	0.001093626	105886	Formation of incision complex in GG-NER	317
-0.255725329	-0.255725329	-0.255725329	-0.255725329	-0.255725329	-0.255725329	0.001093626	105887	Dual incision reaction in GG-NER	318
-0.256458295	-0.256458295	-0.256458295	-0.256458295	-0.256458295	-0.256458295	0.001109389	187201	cGMP effects	1233
-0.256474848	3.66515891	3.66515891	-0.256474848	-0.256474848	1.312178655	0.226631337	105755	Mitotic Spindle Checkpoint	235
-0.256903561	-0.256903561	-0.256903561	-0.256903561	-0.256903561	-0.256903561	0.001119053	698755	Drug Induction of Bile Acid Pathway	1779
-0.257697655	-0.257697655	-0.257697655	-4.259214038	-4.259214038	-1.858304208	0.310449046	161066	Metal ion SLC transporters	1148
-0.25804004	-0.25804004	-0.25804004	-4.155925847	-0.25804004	-1.037617202	0.018425369	142387	valine degradation I	1022
-0.258135242	-0.258135242	-0.258135242	-0.258135242	3.597506909	0.512993188	0.01597316	105705	CYP2E1 reactions	206
-0.258216384	-0.258216384	-0.258216384	-0.258216384	-0.258216384	-0.258216384	0.001147939	645338	Synthesis of PIPs at the early endosome membrane	1720
-0.258608327	-0.258608327	-0.258608327	-0.258608327	-0.258608327	-0.258608327	0.001156678	142421	fatty acid beta-oxidation I	1026
-0.258657996	-0.258657996	-0.258657996	-0.258657996	-0.258657996	-0.258657996	0.001157789	161014	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	1107
-0.258808201	-0.258808201	-0.258808201	-0.258808201	-0.258808201	-0.258808201	0.001161155	187214	Destabilization of mRNA by Tristetraprolin (TTP)	1244
-0.258855504	-0.258855504	-0.258855504	-0.258855504	-0.258855504	-0.258855504	0.001162216	645321	Acyl chain remodelling of PC	1710
-0.25914859	3.580089784	3.580089784	-0.25914859	-0.25914859	1.276546759	0.223066518	105834	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	293
-0.259160597	3.620489055	-4.138810249	-0.259160597	3.620489055	0.516769334	3.643744666	82932	Ascorbate and aldarate metabolism	7
-0.259395611	-0.259395611	-0.259395611	-0.259395611	-0.259395611	-0.259395611	0.001174392	105736	Proteolytic cleavage of SNARE complex proteins	223
-0.259684043	-0.259684043	-0.259684043	-4.138459886	-0.259684043	-1.035439211	0.018820008	187174	GABA synthesis, release, reuptake and degradation	1212
-0.259776792	-0.259776792	-0.259776792	-0.259776792	-0.259776792	-0.259776792	0.001183046	941398	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	2002
-0.26009814	-0.26009814	-0.26009814	-0.26009814	-0.26009814	-0.26009814	0.001190382	477125	Endosomal/Vacuolar pathway	1522
-0.26093193	-0.26093193	-0.26093193	-0.26093193	3.593306329	0.509915722	0.016657244	645294	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1687
-0.261358206	-0.261358206	-0.261358206	-0.261358206	-0.261358206	-0.261358206	0.001219497	119530	Activation of Rac	783
-0.261696679	-0.261696679	-0.261696679	-0.261696679	-0.261696679	-0.261696679	0.001227414	161057	Synthesis and interconversion of nucleotide di- and triphosphates	1142
-0.261790887	-0.261790887	-0.261790887	-4.066890996	-0.261790887	-1.022810909	0.019102079	198842	Osteoblast Signaling	1342
-0.262076636	-0.262076636	-0.262076636	-0.262076636	3.479202969	0.486179285	0.01641319	187170	Incretin Synthesis, Secretion, and Inactivation	1208
-0.26233547	-0.26233547	-0.26233547	-0.26233547	-0.26233547	-0.26233547	0.001242468	760636	Sphingolipid Metabolism	1834
-0.262981878	-0.262981878	-0.262981878	-0.262981878	-0.262981878	-0.262981878	0.001257851	198817	Mitochondrial LC-Fatty Acid Beta-Oxidation	1318
-0.263390675	-0.263390675	-0.263390675	-0.263390675	-0.263390675	-0.263390675	0.001267658	205244	Endosomal Sorting Complex Required For Transport (ESCRT)	1426
-0.263507944	-0.263507944	-0.263507944	-0.263507944	-0.263507944	-0.263507944	0.001270482	105985	Early Phase of HIV Life Cycle	392
-0.263598791	-0.263598791	-0.263598791	-0.263598791	-0.263598791	-0.263598791	0.001272674	833832	WNT ligand biogenesis and trafficking	1920
-0.264010699	-0.264010699	-0.264010699	-0.264010699	-0.264010699	-0.264010699	0.001282648	83041	Protein export	80
-0.264386351	-0.264386351	-0.264386351	-0.264386351	-0.264386351	-0.264386351	0.0012918	106465	Frs2-mediated activation	687
-0.264753383	-0.264753383	-0.264753383	-0.264753383	-0.264753383	-0.264753383	0.001300791	82993	alpha-Linolenic acid metabolism	49
-0.264817133	-0.264817133	-0.264817133	-0.264817133	-0.264817133	-0.264817133	0.001302358	645334	Synthesis of PIPs at the Golgi membrane	1718
-0.265084875	-0.265084875	-0.265084875	-0.265084875	-0.265084875	-0.265084875	0.001308955	198898	Estrogen metabolism	1397
-0.265094802	-0.265094802	-0.265094802	-0.265094802	-0.265094802	-0.265094802	0.0013092	106339	GRB2 events in EGFR signaling	584
-0.26555223	-0.26555223	-0.26555223	-0.26555223	-0.26555223	-0.26555223	0.001320535	105776	G1/S-Specific Transcription	244
-0.265716367	-0.265716367	-0.265716367	-0.265716367	-0.265716367	-0.265716367	0.001324621	205111	Interleukin-6 signaling	1422
-0.266254195	-0.266254195	-0.266254195	-0.266254195	-0.266254195	-0.266254195	0.001338081	106248	Post-chaperonin tubulin folding pathway	552
-0.266302539	-3.990813568	-0.266302539	-3.990813568	-3.990813568	-2.501009156	4.507491674	199556	Vitamin digestion and absorption	1418
-0.266696037	-0.266696037	-0.266696037	-0.266696037	-0.266696037	-0.266696037	0.00134922	82934	Fatty acid elongation	9
-0.266721714	-0.266721714	-0.266721714	-0.266721714	-0.266721714	-0.266721714	0.00134987	545278	heparan sulfate biosynthesis	1581
-0.267610438	-0.267610438	-0.267610438	-0.267610438	-0.267610438	-0.267610438	0.001372509	106351	FGFR2c ligand binding and activation	594
-0.267685511	-0.267685511	-0.267685511	-0.267685511	-0.267685511	-0.267685511	0.001374435	106466	ARMS-mediated activation	688
-0.267989825	-0.267989825	-0.267989825	-0.267989825	-0.267989825	-0.267989825	0.001382266	730319	Cohesin Loading onto Chromatin	1805
-0.268374811	-0.268374811	-0.268374811	-0.268374811	-0.268374811	-0.268374811	0.001392223	413400	Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4	1502
-0.268653701	-0.268653701	-0.268653701	-0.268653701	-0.268653701	-0.268653701	0.001399472	106179	Branched-chain amino acid catabolism	515
-0.268926724	-0.268926724	-0.268926724	-0.268926724	-0.268926724	-0.268926724	0.001406597	906028	TRP channels	1975
-0.269259398	-0.269259398	-0.269259398	-0.269259398	-0.269259398	-0.269259398	0.001415319	105793	Lagging Strand Synthesis	260
-0.269283347	-0.269283347	-0.269283347	-0.269283347	-0.269283347	-0.269283347	0.001415949	138048	Nongenotropic Androgen signaling	958
-0.269530039	-0.269530039	-0.269530039	-0.269530039	-0.269530039	-0.269530039	0.001422446	142419	phospholipases	1025
-0.269584452	-0.269584452	-0.269584452	-0.269584452	-0.269584452	-0.269584452	0.001423883	161044	Ionotropic activity of Kainate Receptors	1130
-0.269584452	-0.269584452	-0.269584452	-0.269584452	-0.269584452	-0.269584452	0.001423883	161046	Activation of Ca-permeable Kainate Receptor	1131
-0.269709809	-0.269709809	-0.269709809	-0.269709809	-0.269709809	-0.269709809	0.001427196	82984	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	41
-0.269817386	-0.269817386	-0.269817386	-0.269817386	-0.269817386	-0.269817386	0.001430045	106470	PKA-mediated phosphorylation of CREB	692
-0.270013611	-0.270013611	-0.270013611	-0.270013611	-0.270013611	-0.270013611	0.001435252	119540	G beta:gamma signalling through PI3Kgamma	793
-0.270109495	-0.270109495	-0.270109495	-0.270109495	-0.270109495	-0.270109495	0.001437803	106281	Pyrimidine metabolism	569
-0.270119055	-0.270119055	3.402471765	-0.270119055	-0.270119055	0.464399109	0.018114044	83008	One carbon pool by folate	58
-0.270226008	-0.270226008	-0.270226008	-0.270226008	-0.270226008	-0.270226008	0.001440906	771602	NOTCH2 Activation and Transmission of Signal to the Nucleus	1866
-0.270633164	-0.270633164	-0.270633164	-0.270633164	-0.270633164	-0.270633164	0.001451794	530748	Termination of O-glycan biosynthesis	1554
-0.270795607	-0.270795607	-0.270795607	-0.270795607	-0.270795607	-0.270795607	0.001456157	187215	Destabilization of mRNA by KSRP	1245
-0.270929894	-0.270929894	-0.270929894	-0.270929894	-0.270929894	-0.270929894	0.001459771	187209	Signal regulatory protein (SIRP) family interactions	1240
-0.270982538	-0.270982538	-0.270982538	-0.270982538	-0.270982538	-0.270982538	0.001461189	137946	Atypical NF-kappaB pathway	867
-0.271059585	-0.271059585	-0.271059585	-3.969007543	-0.271059585	-1.010649177	0.021425995	198915	Fatty Acid Omega Oxidation	1413
-0.271347239	-0.271347239	-0.271347239	-0.271347239	-0.271347239	-0.271347239	0.001471049	198913	miRNAs involved in DDR	1411
-0.271861566	-0.271861566	-0.271861566	-0.271861566	-0.271861566	-0.271861566	0.001485043	138056	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	966
-0.272251018	-0.272251018	-0.272251018	-0.272251018	-0.272251018	-0.272251018	0.001495711	106115	Fatty Acyl-CoA Biosynthesis	481
-0.272307803	-0.272307803	-0.272307803	-0.272307803	-0.272307803	-0.272307803	0.001497271	198876	Nucleotide Metabolism	1375
-0.272488066	-0.272488066	-0.272488066	-0.272488066	-0.272488066	-0.272488066	0.001502233	782397	TCA cycle	1881
-0.272712293	-0.272712293	-0.272712293	-0.272712293	-0.272712293	-0.272712293	0.001508424	138021	Paxillin-dependent events mediated by a4b1	935
-0.27275052	-0.27275052	-0.27275052	-0.27275052	-0.27275052	-0.27275052	0.001509482	576254	Regulation of Complement cascade	1629
-0.273564736	-0.273564736	-0.273564736	-0.273564736	-0.273564736	-0.273564736	0.001532147	105734	Botulinum neurotoxicity	222
-0.273572255	-0.273572255	-0.273572255	-0.273572255	-0.273572255	-0.273572255	0.001532358	161000	DCC mediated attractive signaling	1093
-0.27359937	-0.27359937	-0.27359937	-0.27359937	-0.27359937	-0.27359937	0.001533118	138038	Arf6 downstream pathway	949
-0.273608281	-0.273608281	-0.273608281	-0.273608281	-0.273608281	-0.273608281	0.001533367	545325	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1601
-0.273620479	-0.273620479	-0.273620479	-0.273620479	-0.273620479	-0.273620479	0.001533709	138074	Visual signal transduction: Rods	983
-0.273809293	-0.273809293	-0.273809293	-0.273809293	-0.273809293	-0.273809293	0.001539008	835389	adenosine ribonucleotides de novo biosynthesis	1923
-0.273897511	-0.273897511	-0.273897511	-0.273897511	-0.273897511	-0.273897511	0.001541489	105923	Inhibition of Insulin Secretion by Adrenaline/Noradrenaline	344
-0.273992818	-0.273992818	3.41614614	-0.273992818	-0.273992818	0.464034974	0.019252767	119524	Sema3A PAK dependent Axon repulsion	778
-0.274351696	-0.274351696	-0.274351696	-0.274351696	-0.274351696	-0.274351696	0.001554312	137950	Signaling events mediated by the Hedgehog family	870
-0.274404469	-0.274404469	-0.274404469	-0.274404469	-0.274404469	-0.274404469	0.001555808	530753	Sulfur amino acid metabolism	1558
-0.274930944	-0.274930944	-0.274930944	-0.274930944	-0.274930944	-0.274930944	0.00157079	106009	Budding and maturation of HIV virion	413
-0.274993489	-0.274993489	-0.274993489	-0.274993489	-0.274993489	-0.274993489	0.001572578	106381	Class C/3 (Metabotropic glutamate/pheromone receptors)	619
-0.275243833	-0.275243833	-0.275243833	-0.275243833	-0.275243833	-0.275243833	0.001579749	730334	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1811
-0.275299332	-0.275299332	-0.275299332	-0.275299332	-0.275299332	-0.275299332	0.001581342	106554	RNA Polymerase I Promoter Escape	750
-0.275348506	-0.275348506	-0.275348506	-0.275348506	-0.275348506	-0.275348506	0.001582755	106340	SHC1 events in EGFR signaling	585
-0.275408803	3.341253087	-0.275408803	3.341253087	3.341253087	1.894588331	2.829330977	106325	Metabolism of porphyrins	572
-0.275451595	-0.275451595	-0.275451595	-0.275451595	-0.275451595	-0.275451595	0.00158572	138046	Syndecan-1-mediated signaling events	956
-0.275601422	-0.275601422	-0.275601422	-0.275601422	-0.275601422	-0.275601422	0.001590037	106370	Eicosanoid ligand-binding receptors	610
-0.275723976	-0.275723976	-0.275723976	-0.275723976	-0.275723976	-0.275723976	0.001593576	160137	activated TAK1 mediates p38 MAPK activation	1045
-0.275765187	-0.275765187	-0.275765187	-0.275765187	-0.275765187	-0.275765187	0.001594767	83022	Terpenoid backbone biosynthesis	66
-0.275956985	-0.275956985	-3.972634619	-0.275956985	-0.275956985	-1.015292512	0.023037969	576275	Signaling by Hippo	1650
-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	0.001603975	105654	Caspase-8 activation	180
-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	0.001603975	105655	Dimerization of procaspase-8	181
-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	-0.276082904	0.001603975	833813	Regulation by c-FLIP	1908
-0.276240517	-0.276240517	-0.276240517	-0.276240517	-0.276240517	-0.276240517	0.001608559	106063	Tie2 Signaling	447
-0.276423875	-3.887447709	-0.276423875	-3.887447709	-0.276423875	-1.720833408	0.319194773	187108	Rap1 signalling	1207
-0.276509461	-0.276509461	-0.276509461	-0.276509461	-0.276509461	-0.276509461	0.001616404	160967	Cell-extracellular matrix interactions	1071
-0.276757794	-0.276757794	-0.276757794	-0.276757794	3.343357239	0.447265212	0.019614725	198858	Nicotine Activity on Dopaminergic Neurons	1358
-0.277313751	-0.277313751	-0.277313751	-0.277313751	-0.277313751	-0.277313751	0.00164005	161062	Thromboxane signalling through TP receptor	1146
-0.277550565	-0.277550565	3.310692037	-0.277550565	3.310692037	1.157746476	0.234349438	106150	Metabolism of steroid hormones and vitamin D	496
-0.277828058	-0.277828058	-0.277828058	-0.277828058	-0.277828058	-0.277828058	0.001655314	198791	Type II diabetes mellitus	1294
-0.277852762	-0.277852762	-0.277852762	-0.277852762	3.323608835	0.442439557	0.019809284	82937	Steroid biosynthesis	12
-0.278277606	-0.278277606	-0.278277606	-0.278277606	-0.278277606	-0.278277606	0.00166875	137962	Wnt signaling network	882
-0.278555509	-0.278555509	-0.278555509	-0.278555509	-0.278555509	-0.278555509	0.001677099	105862	Homologous Recombination Repair	306
-0.278555509	-0.278555509	-0.278555509	-0.278555509	-0.278555509	-0.278555509	0.001677099	105863	Homologous recombination repair of replication-independent double-strand breaks	307
-0.278703066	-0.278703066	-0.278703066	-0.278703066	-0.278703066	-0.278703066	0.001681546	106245	Formation of tubulin folding intermediates by CCT/TriC	549
-0.278732589	-0.278732589	-0.278732589	-0.278732589	-0.278732589	-0.278732589	0.001682437	106543	Telomere C-strand (Lagging Strand) Synthesis	740
-0.279267579	-0.279267579	-0.279267579	-0.279267579	-0.279267579	-0.279267579	0.001698645	106236	Post-translational modification: synthesis of GPI-anchored proteins	542
-0.279726104	-0.279726104	-0.279726104	-0.279726104	-0.279726104	-0.279726104	0.001712636	119526	Other semaphorin interactions	780
-0.280024315	-0.280024315	-0.280024315	-0.280024315	-0.280024315	-0.280024315	0.001721784	755438	SREBF and miR33 in cholesterol and lipid homeostasis	1830
-0.280396629	-0.280396629	-0.280396629	-0.280396629	-0.280396629	-0.280396629	0.001733261	106556	RNA Polymerase I Transcription Termination	752
-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	0.001733813	106349	FGFR2 ligand binding and activation	592
-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	0.001733813	645280	Signaling by FGFR2 mutants	1677
-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	-0.280414505	0.001733813	645281	Activated point mutants of FGFR2	1678
-0.280462616	-0.280462616	-0.280462616	-0.280462616	-0.280462616	-0.280462616	0.001735301	82988	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	44
-0.280957052	-0.280957052	-0.280957052	-0.280957052	-0.280957052	-0.280957052	0.001750651	187096	Regulation of signaling by CBL	1195
-0.281582122	-0.281582122	-0.281582122	-0.281582122	-0.281582122	-0.281582122	0.001770212	106416	Translocation of ZAP-70 to Immunological synapse	648
-0.281862626	-0.281862626	-0.281862626	-0.281862626	-0.281862626	-0.281862626	0.001779047	477130	Signaling by NODAL	1526
-0.282186052	-0.282186052	-0.282186052	-0.282186052	-0.282186052	-0.282186052	0.001789278	645262	Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha	1663
-0.282301517	-0.282301517	-0.282301517	-0.282301517	-0.282301517	-0.282301517	0.001792941	198809	Cholesterol biosynthesis	1311
-0.282834962	-0.282834962	-3.833807497	-0.282834962	-3.833807497	-1.703223976	0.332552246	187183	Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits	1218
-0.282834962	-0.282834962	-3.833807497	-0.282834962	-3.833807497	-1.703223976	0.332552246	366225	G protein gated Potassium channels	1450
-0.282834962	-0.282834962	-3.833807497	-0.282834962	-3.833807497	-1.703223976	0.332552246	366226	Activation of G protein gated Potassium channels	1451
-0.283040096	-0.283040096	-0.283040096	-0.283040096	-0.283040096	-0.283040096	0.001816518	106247	Association of TriC/CCT with target proteins during biosynthesis	551
-0.283378633	-0.283378633	-0.283378633	-0.283378633	-0.283378633	-0.283378633	0.001827408	187223	N-glycan antennae elongation in the medial/trans-Golgi	1251
-0.284190121	-0.284190121	-3.756274677	-0.284190121	-0.284190121	-0.978607032	0.024501533	106205	Pyruvate metabolism	528
-0.284197876	-0.284197876	-0.284197876	-0.284197876	-0.284197876	-0.284197876	0.001853976	645314	Synthesis of PA	1706
-0.284350034	3.241378845	-3.810078914	-0.284350034	3.241378845	0.420795742	3.236682704	82929	Pentose and glucuronate interconversions	4
-0.284887583	-0.284887583	-0.284887583	-0.284887583	-0.284887583	-0.284887583	0.001876582	137975	RXR and RAR heterodimerization with other nuclear receptor	892
-0.284959462	-0.284959462	-0.284959462	-0.284959462	-0.284959462	-0.284959462	0.001878951	941397	WNT5A-dependent internalization of FZD4	2001
-0.285274055	-0.285274055	-0.285274055	-0.285274055	3.170498868	0.40588053	0.020997941	477121	Regulation of KIT signaling	1518
-0.285773404	-0.285773404	-0.285773404	-0.285773404	-0.285773404	-0.285773404	0.001905939	160951	Processing of Capped Intronless Pre-mRNA	1058
-0.285833309	-0.285833309	-0.285833309	-0.285833309	-0.285833309	-0.285833309	0.001907938	645309	Chondroitin sulfate biosynthesis	1701
-0.285935077	-0.285935077	-0.285935077	-0.285935077	-0.285935077	-0.285935077	0.001911337	144182	Proximal tubule bicarbonate reclamation	1033
-0.286361541	-3.82824826	-0.286361541	-3.82824826	-0.286361541	-1.703116229	0.344147216	198878	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1377
-0.286849894	-0.286849894	3.209187811	-0.286849894	-0.286849894	0.412357647	0.021727708	83002	Glyoxylate and dicarboxylate metabolism	55
-0.287060536	-0.287060536	-0.287060536	-0.287060536	-0.287060536	-0.287060536	0.00194925	106064	PECAM1 interactions	448
-0.287436623	-0.287436623	-0.287436623	-0.287436623	-0.287436623	-0.287436623	0.001962052	545326	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	1602
-0.287603291	-0.287603291	-3.799242986	-0.287603291	-0.287603291	-0.98993123	0.025993962	198877	Apoptosis Modulation by HSP70	1376
-0.287953684	-0.287953684	-0.287953684	-0.287953684	-0.287953684	-0.287953684	0.001979763	137952	Syndecan-3-mediated signaling events	872
-0.288075889	-0.288075889	-0.288075889	-0.288075889	-0.288075889	-0.288075889	0.001983968	119535	Tight junction interactions	788
-0.288113477	-0.288113477	-0.288113477	-0.288113477	-0.288113477	-0.288113477	0.001985262	198859	Triacylglyceride Synthesis	1359
-0.288465216	-0.288465216	-0.288465216	-0.288465216	-0.288465216	-0.288465216	0.00199741	106512	Beta-catenin phosphorylation cascade	721
-0.28871719	-0.28871719	-0.28871719	-0.28871719	-0.28871719	-0.28871719	0.002006149	366166	Inflammasomes	1443
-0.289135047	-0.289135047	-0.289135047	-0.289135047	-0.289135047	-0.289135047	0.002020709	198787	TCA Cycle	1290
-0.289692835	-0.289692835	-0.289692835	-0.289692835	-0.289692835	-0.289692835	0.002040275	106099	PKA activation in glucagon signalling	472
-0.28989557	-0.28989557	-0.28989557	3.165355562	-0.28989557	0.401154656	0.022355728	106222	Metabolism of nitric oxide	531
-0.28989557	-0.28989557	-0.28989557	3.165355562	-0.28989557	0.401154656	0.022355728	106223	eNOS activation and regulation	532
-0.290485555	-0.290485555	-0.290485555	-0.290485555	-0.290485555	-0.290485555	0.002068344	545349	3-phosphoinositide degradation	1610
-0.290959101	-0.290959101	-0.290959101	-0.290959101	-0.290959101	-0.290959101	0.002085258	119554	CD28 dependent PI3K/Akt signaling	806
-0.292151468	-0.292151468	-0.292151468	-0.292151468	-0.292151468	-0.292151468	0.002128337	106464	Prolonged ERK activation events	686
-0.292452154	-0.292452154	-0.292452154	-0.292452154	-0.292452154	-0.292452154	0.002139312	730347	SHC-related events triggered by IGF1R	1822
-0.292780022	-0.292780022	-0.292780022	-0.292780022	-0.292780022	-0.292780022	0.002151331	106494	G-protein activation	706
-0.293092284	-0.293092284	-0.293092284	-0.293092284	-0.293092284	-0.293092284	0.002162828	137927	Arf1 pathway	848
-0.293101673	-0.293101673	-0.293101673	-0.293101673	-0.293101673	-0.293101673	0.002163174	106415	Phosphorylation of CD3 and TCR zeta chains	647
-0.29344719	-0.29344719	-0.29344719	-0.29344719	-0.29344719	-0.29344719	0.002175954	83045	Mismatch repair	84
-0.293484277	-0.293484277	-0.293484277	-0.293484277	3.192077213	0.403628021	0.023681693	106136	Peroxisomal lipid metabolism	486
-0.29370933	-0.29370933	-0.29370933	-0.29370933	3.105704217	0.386173379	0.023111656	82931	Galactose metabolism	6
-0.293879806	-0.293879806	-0.293879806	-0.293879806	-0.293879806	-0.293879806	0.002192041	187204	Platelet sensitization by LDL	1236
-0.294198733	-0.294198733	-0.294198733	-0.294198733	-0.294198733	-0.294198733	0.002203961	137931	Sphingosine 1-phosphate (S1P) pathway	852
-0.294470784	-0.294470784	-0.294470784	-0.294470784	-0.294470784	-0.294470784	0.002214171	119539	G-protein beta:gamma signalling	792
-0.294522877	-0.294522877	-0.294522877	-0.294522877	-0.294522877	-0.294522877	0.00221613	106336	Signaling by BMP	581
-0.294821525	-0.294821525	-0.294821525	-0.294821525	-0.294821525	-0.294821525	0.002227388	83034	Biosynthesis of unsaturated fatty acids	73
-0.294860434	-0.294860434	-0.294860434	-0.294860434	-0.294860434	-0.294860434	0.002228859	105819	Mitotic Telophase/Cytokinesis	278
-0.294917162	-0.294917162	-0.294917162	3.052610212	9.74766496	2.383104737	0.763259261	82958	Histidine metabolism	23
-0.294975158	-0.294975158	-0.294975158	3.097493598	-0.294975158	0.383518593	0.023450504	187200	Nitric oxide stimulates guanylate cyclase	1232
-0.295580356	-0.295580356	-0.295580356	-0.295580356	-0.295580356	-0.295580356	0.002256201	198888	Eicosanoid Synthesis	1387
-0.295816	-0.295816	-0.295816	-0.295816	-0.295816	-0.295816	0.002265209	198794	Cytokines and Inflammatory Response	1297
-0.296182995	-0.296182995	-0.296182995	-0.296182995	-0.296182995	-0.296182995	0.002279295	106021	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	423
-0.296209518	-0.296209518	-0.296209518	-0.296209518	-0.296209518	-0.296209518	0.002280316	161061	ADP signalling through P2Y purinoceptor 1	1145
-0.297470131	-0.297470131	-0.297470131	-0.297470131	-0.297470131	-0.297470131	0.002329254	530769	Signaling by constitutively active EGFR	1570
-0.297496267	-0.297496267	-0.297496267	-0.297496267	-0.297496267	-0.297496267	0.002330277	198873	Fatty Acid Biosynthesis	1372
-0.298388737	-0.298388737	-0.298388737	-0.298388737	-0.298388737	-0.298388737	0.002365441	198892	Small Ligand GPCRs	1391
-0.29863036	-3.652143673	-0.29863036	-3.652143673	-0.29863036	-1.640035685	0.355220142	106044	Effects of PIP2 hydrolysis	434
-0.298985553	-0.298985553	-0.298985553	-0.298985553	-0.298985553	-0.298985553	0.002389192	114227	Dorso-ventral axis formation	766
-0.299213623	-0.299213623	-0.299213623	-0.299213623	-0.299213623	-0.299213623	0.002398318	106231	PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	537
-0.29997014	-0.29997014	-0.29997014	-0.29997014	-0.29997014	-0.29997014	0.002428791	82981	Glycosaminoglycan degradation	38
-0.301004269	-0.301004269	-0.301004269	-0.301004269	-0.301004269	-0.301004269	0.002470946	106564	RNA Polymerase III Transcription Initiation From Type 2 Promoter	760
-0.301397673	-0.301397673	-0.301397673	-0.301397673	-0.301397673	-0.301397673	0.002487136	187107	Regulation of IFNG signaling	1206
-0.301405422	-0.301405422	-0.301405422	-3.665305224	-0.301405422	-0.974185382	0.030249235	83007	Butanoate metabolism	57
-0.301454207	-0.301454207	-0.301454207	-0.301454207	-0.301454207	-0.301454207	0.002489469	147586	Collecting duct acid secretion	1034
-0.301621081	-0.301621081	-0.301621081	-0.301621081	-0.301621081	-0.301621081	0.002496367	105919	Citric acid cycle (TCA cycle)	341
-0.30189361	-0.30189361	-0.30189361	-0.30189361	-0.30189361	-0.30189361	0.002507665	105659	Activation of BAD and translocation to mitochondria	184
-0.302579278	-0.302579278	-0.302579278	-0.302579278	-0.302579278	-0.302579278	0.002536272	105981	Cytosolic tRNA aminoacylation	388
-0.302643895	-0.302643895	-0.302643895	-0.302643895	-0.302643895	-0.302643895	0.002538982	83037	RNA polymerase	76
-0.303024356	-0.303024356	-0.303024356	-0.303024356	-0.303024356	-0.303024356	0.002554981	106567	RNA Polymerase III Transcription Termination	763
-0.303195532	-0.303195532	-0.303195532	-0.303195532	-0.303195532	-0.303195532	0.002562206	187090	IKK complex recruitment mediated by RIP1	1189
-0.303345615	-0.303345615	-0.303345615	-0.303345615	-0.303345615	-0.303345615	0.002568553	198819	Signal Transduction of S1P Receptor	1320
-0.304484893	-0.304484893	-0.304484893	-0.304484893	-0.304484893	-0.304484893	0.002617151	106005	Abortive elongation of HIV-1 transcript in the absence of Tat	410
-0.304570022	-0.304570022	-0.304570022	-0.304570022	-0.304570022	-0.304570022	0.002620811	106335	MicroRNA (miRNA) Biogenesis	580
-0.304825121	-0.304825121	-0.304825121	-0.304825121	-0.304825121	-0.304825121	0.002631805	198781	GPCRs, Class B Secretin-like	1284
-0.305853727	-3.585786454	-3.585786454	-0.305853727	-3.585786454	-2.273813363	4.313013524	530772	Activation of Genes by ATF4	1573
-0.306034158	-0.306034158	-0.306034158	-0.306034158	-0.306034158	-0.306034158	0.002684414	645311	CS/DS degradation	1703
-0.306676655	-0.96492232	-0.96492232	-2.939659313	-0.96492232	-1.228220585	0.809943596	366160	Adaptive Immune System	1437
-0.306726645	-6.853720141	-0.306726645	-0.306726645	-0.306726645	-1.616125344	0.060664188	105908	Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	338
-0.306914953	-0.306914953	-0.306914953	-0.306914953	-0.306914953	-0.306914953	0.002723267	106142	Cholesterol biosynthesis	489
-0.307004926	-0.307004926	-0.307004926	-0.307004926	-0.307004926	-0.307004926	0.002727261	576270	Activated NOTCH1 Transmits Signal to the Nucleus	1645
-0.30768998	-0.30768998	-0.30768998	-0.30768998	-0.30768998	-0.30768998	0.002757825	137937	S1P1 pathway	858
-0.307888089	-0.307888089	-0.307888089	-0.307888089	-0.307888089	-0.307888089	0.002766715	106334	Regulatory RNA pathways	579
-0.308773782	-0.308773782	-0.308773782	-0.308773782	-0.308773782	-0.308773782	0.002806739	161075	Transport of vitamins, nucleosides, and related molecules	1155
-0.309225486	-0.309225486	-0.309225486	-0.309225486	-0.309225486	-0.309225486	0.002827329	106565	RNA Polymerase III Transcription Initiation From Type 3 Promoter	761
-0.309514385	-0.309514385	-0.309514385	-0.309514385	-0.309514385	-0.309514385	0.002840561	161034	Unblocking of NMDA receptor, glutamate binding and activation	1121
-0.309799387	-0.309799387	-0.309799387	-0.309799387	-0.309799387	-0.309799387	0.002853664	855811	Citrate cycle (TCA cycle, Krebs cycle)	1932
-0.310380068	-0.310380068	-0.310380068	-0.310380068	-0.310380068	-0.310380068	0.002880508	530750	Sphingolipid de novo biosynthesis	1556
-0.310654993	-0.310654993	-0.310654993	-0.310654993	-0.310654993	-0.310654993	0.002893288	187100	TRAF6 mediated IRF7 activation	1199
-0.310847236	2.935599095	2.935599095	-0.310847236	-0.310847236	0.987731296	0.258841866	530742	SHC1 events in ERBB4 signaling	1548
-0.310918661	-0.310918661	-0.310918661	-0.310918661	-0.310918661	-0.310918661	0.002905587	645278	Signaling by FGFR1 fusion mutants	1675
-0.311079074	-0.311079074	-0.311079074	-0.311079074	-0.311079074	-0.311079074	0.002913091	106563	RNA Polymerase III Transcription Initiation From Type 1 Promoter	759
-0.311238182	-0.311238182	-0.311238182	-0.311238182	-0.311238182	-0.311238182	0.002920548	119557	PD-1 signaling	809
-0.311525547	2.885247636	-3.508298729	2.885247636	-3.508298729	-0.311525547	31.91927266	105927	Gap junction trafficking	348
-0.311757676	-0.311757676	-0.311757676	-3.488096704	-3.488096704	-1.582293287	0.368662105	645306	HS-GAG biosynthesis	1698
-0.312765594	-0.312765594	-0.312765594	-0.312765594	-0.312765594	-0.312765594	0.002992918	941400	Detoxification of Reactive Oxygen Species	2004
-0.313123062	-0.313123062	-0.313123062	-0.313123062	-0.313123062	-0.313123062	0.003010061	545314	3-phosphoinositide biosynthesis	1597
-0.313463329	2.911468042	-0.313463329	-0.313463329	-0.313463329	0.331522945	0.02810988	169344	C-MYC pathway	1160
-0.313469143	-0.313469143	-0.313469143	-3.502371925	-3.502371925	-1.589030256	0.377840857	645307	HS-GAG degradation	1699
-0.314760853	-0.314760853	-0.314760853	-0.314760853	-0.314760853	-0.314760853	0.003089609	105891	Formation of transcription-coupled NER (TC-NER) repair complex	322
-0.314760853	-0.314760853	-0.314760853	-0.314760853	-0.314760853	-0.314760853	0.003089609	105892	Dual incision reaction in TC-NER	323
-0.314856933	-0.314856933	-0.314856933	-0.314856933	-0.314856933	-0.314856933	0.003094328	106244	Prefoldin mediated transfer of substrate to CCT/TriC	548
-0.315974878	-0.315974878	-0.315974878	-0.315974878	-0.315974878	-0.315974878	0.003149653	187192	Transferrin endocytosis and recycling	1224
-0.316008184	-0.316008184	-3.490374672	-3.490374672	-0.316008184	-1.585754779	0.384449311	138002	E-cadherin signaling in keratinocytes	917
-0.316297056	-0.316297056	-0.316297056	-0.316297056	-0.316297056	-0.316297056	0.003165744	105649	Extrinsic Pathway for Apoptosis	175
-0.316297056	-0.316297056	-0.316297056	-0.316297056	-0.316297056	-0.316297056	0.003165744	105650	Death Receptor Signalling	176
-0.316418639	-0.316418639	-0.316418639	-0.316418639	-0.316418639	-0.316418639	0.003171833	198828	Hypertrophy Model	1329
-0.317595698	-0.317595698	-0.317595698	-0.317595698	-0.317595698	-0.317595698	0.003231269	106170	Amino acid transport across the plasma membrane	511
-0.317984928	-0.317984928	-0.317984928	-0.317984928	-0.317984928	-0.317984928	0.003251118	82992	Linoleic acid metabolism	48
-0.318187691	-0.318187691	-0.318187691	-0.318187691	-0.318187691	-0.318187691	0.003261496	187202	Platelet calcium homeostasis	1234
-0.31922754	-0.31922754	-0.31922754	-0.31922754	-0.31922754	-0.31922754	0.003315139	82978	Other types of O-glycan biosynthesis	36
-0.319638988	-0.319638988	-0.319638988	-0.319638988	-0.319638988	-0.319638988	0.003336558	106541	Extension of Telomeres	738
-0.319827607	-0.319827607	-0.319827607	-0.319827607	-0.319827607	-0.319827607	0.003346415	161063	Thrombin signalling through proteinase activated receptors (PARs)	1147
-0.319892531	-0.319892531	-0.319892531	-0.319892531	-0.319892531	-0.319892531	0.003349812	530763	Prolactin receptor signaling	1566
-0.320290646	-0.320290646	-0.320290646	-0.320290646	-0.320290646	-0.320290646	0.003370709	771578	FCGR activation	1846
-0.321175429	-0.321175429	-0.321175429	-0.321175429	-0.321175429	-0.321175429	0.003417524	920968	IL17 signaling pathway	1987
-0.321461298	-0.321461298	-0.321461298	-0.321461298	-0.321461298	-0.321461298	0.00343276	138049	PDGFR-alpha signaling pathway	959
-0.322294993	-0.322294993	-0.322294993	-0.322294993	-0.322294993	-0.322294993	0.003477505	160994	Deadenylation of mRNA	1087
-0.322700489	-0.322700489	-0.322700489	-0.322700489	-0.322700489	-0.322700489	0.003499437	576266	Pre-NOTCH Transcription and Translation	1641
-0.322788721	-0.322788721	-0.322788721	-0.322788721	-0.322788721	-0.322788721	0.003504223	83043	Base excision repair	82
-0.323295923	-0.323295923	-0.323295923	-0.323295923	-0.323295923	-0.323295923	0.003531841	119547	Lysosome Vesicle Biogenesis	799
-0.323511678	-3.387069236	-0.323511678	-0.323511678	-0.323511678	-0.93622319	0.037100855	198916	Oxidative Stress	1414
-0.323515229	-0.323515229	-3.413441008	-0.323515229	-3.413441008	-1.559485541	0.39451997	366224	Inwardly rectifying K+ channels	1449
-0.323792707	-0.323792707	-0.323792707	-3.419325278	-3.419325278	-1.562005735	0.396900843	645305	A tetrasaccharide linker sequence is required for GAG synthesis	1697
-0.324166651	-0.324166651	-0.324166651	-0.324166651	-0.324166651	-0.324166651	0.003579659	142269	superpathway of cholesterol biosynthesis	1010
-0.324760928	-0.324760928	-0.324760928	-0.324760928	-0.324760928	-0.324760928	0.003612592	576268	Pre-NOTCH Processing in Golgi	1643
-0.324886723	-3.401465535	-3.401465535	-0.324886723	-3.401465535	-2.17083401	4.153958475	105907	PERK regulated gene expression	337
-0.324920821	-0.324920821	-0.324920821	-0.324920821	-0.324920821	-0.324920821	0.003621494	187105	Regulation of IFNA signaling	1204
-0.324944426	-3.410836416	-3.410836416	-0.324944426	-0.324944426	-1.559301222	0.39916188	198790	EBV LMP1 signaling	1293
-0.32494451	-0.32494451	-0.32494451	-0.32494451	-0.32494451	-0.32494451	0.003622814	905992	Oncogene Induced Senescence	1939
-0.325889597	-3.384449869	-0.325889597	-0.325889597	2.732670675	-0.325889597	0.320100884	835394	tryptophan utilization II	1928
-0.326371568	-0.326371568	-0.326371568	-0.326371568	-0.326371568	-0.326371568	0.003703067	106380	Glucagon-type ligand receptors	618
-0.327239014	-0.327239014	-0.327239014	-0.327239014	-0.327239014	-0.327239014	0.00375254	198896	TP53 network	1395
-0.327302197	-0.327302197	-0.327302197	-0.327302197	-0.327302197	-0.327302197	0.003756164	82995	Glycosphingolipid biosynthesis - lacto and neolacto series	51
-0.327336536	-0.327336536	-0.327336536	-0.327336536	-0.327336536	-0.327336536	0.003758135	106344	FGFR ligand binding and activation	589
-0.328225359	-0.328225359	-0.328225359	-0.328225359	2.702479708	0.277915655	0.03136541	645293	Downregulation of TGF-beta receptor signaling	1686
-0.328601158	-0.328601158	-0.328601158	-0.328601158	-0.328601158	-0.328601158	0.003831294	106000	RNA Pol II CTD phosphorylation and interaction with CE	405
-0.328601158	-0.328601158	-0.328601158	-0.328601158	-0.328601158	-0.328601158	0.003831294	106558	RNA Pol II CTD phosphorylation and interaction with CE	754
-0.328824984	-0.328824984	-3.41493464	-0.328824984	-0.328824984	-0.946046915	0.039924697	576276	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1651
-0.329218006	-0.329218006	-0.329218006	-0.329218006	-0.329218006	-0.329218006	0.003867389	149806	Phototransduction	1036
-0.329887747	2.691062321	-3.350837816	2.691062321	-3.350837816	-0.329887747	26.82381297	105926	Gap junction trafficking and regulation	347
-0.330333723	-0.330333723	-0.330333723	-0.330333723	-0.330333723	-0.330333723	0.003933368	83046	Homologous recombination	85
-0.330356779	-0.330356779	-0.330356779	-0.330356779	-0.330356779	-0.330356779	0.003934741	105861	Double-Strand Break Repair	305
-0.330542294	-0.330542294	-0.330542294	-0.330542294	-0.330542294	-0.330542294	0.003945801	106265	Purine metabolism	565
-0.33066933	-0.33066933	-0.33066933	-0.33066933	-0.33066933	-0.33066933	0.003953389	138072	Nephrin/Neph1 signaling in the kidney podocyte	981
-0.330827276	-0.330827276	-0.330827276	-0.330827276	-0.330827276	-0.330827276	0.00396284	138076	Cellular roles of Anthrax toxin	984
-0.331388549	-0.331388549	-0.331388549	-0.331388549	-0.331388549	-0.331388549	0.003996571	106243	Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	547
-0.331996234	-0.331996234	-0.331996234	-0.331996234	-0.331996234	-0.331996234	0.004033349	105777	Activation of the pre-replicative complex	245
-0.332139757	-0.332139757	-0.332139757	-0.332139757	-0.332139757	-0.332139757	0.004042075	105789	DNA strand elongation	256
-0.332602611	-0.332602611	-0.332602611	-0.332602611	-0.332602611	-0.332602611	0.004070317	187228	Nephrin interactions	1253
-0.332923	2.670441904	-0.332923	2.670441904	5.673806808	2.069768924	4.484648512	198804	Tamoxifen metabolism	1306
-0.333356715	2.663108137	2.663108137	-0.333356715	-0.333356715	0.865229226	0.262727314	530736	GRB2 events in ERBB2 signaling	1543
-0.334211047	2.627340103	-0.334211047	-0.334211047	2.627340103	0.850409413	0.257688474	82966	beta-Alanine metabolism	27
-0.334282649	-0.334282649	2.681347922	-0.334282649	-0.334282649	0.268843465	0.033481778	920958	Trans-sulfuration and one carbon metabolism	1984
-0.334464733	-0.334464733	-0.334464733	-0.334464733	-0.334464733	-0.334464733	0.004185542	105884	Global Genomic NER (GG-NER)	316
-0.334522629	-0.334522629	-3.319999012	-0.334522629	-0.334522629	-0.931617905	0.041575737	104488	Cysteine and methionine metabolism	173
-0.33458879	-0.33458879	-0.33458879	-0.33458879	-0.33458879	-0.33458879	0.00419331	905997	Signaling by Leptin	1944
-0.334953668	-0.334953668	2.688093874	-0.334953668	-0.334953668	0.269655841	0.03383634	198756	One Carbon Metabolism	1260
-0.335227958	-0.335227958	-0.335227958	-0.335227958	-0.335227958	-0.335227958	0.004233516	645265	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1666
-0.335232247	-0.335232247	-0.335232247	-0.335232247	-0.335232247	-0.335232247	0.004233786	161040	CREB phosphorylation through the activation of CaMKII	1127
-0.335447585	-0.335447585	-0.335447585	-0.335447585	-0.335447585	-0.335447585	0.004247402	576259	Circadian Repression of Expression by REV-ERBA	1634
-0.336292849	-0.336292849	-0.336292849	-0.336292849	-0.336292849	-0.336292849	0.004301185	161037	Ras activation uopn Ca2+ infux through NMDA receptor	1124
-0.336328996	-0.336328996	-0.336328996	-0.336328996	-0.336328996	-0.336328996	0.004303498	138030	Canonical NF-kappaB pathway	943
-0.336665973	2.628247921	-3.301579867	-0.336665973	5.593161815	0.849299585	5.501029434	82974	Starch and sucrose metabolism	32
-0.337423192	-0.337423192	-0.337423192	-0.337423192	-0.337423192	-0.337423192	0.004373958	106430	mTOR signalling	660
-0.338240344	-0.338240344	-0.338240344	-0.338240344	-0.338240344	-0.338240344	0.004427179	82979	Amino sugar and nucleotide sugar metabolism	37
-0.339001207	-0.339001207	-0.339001207	-0.339001207	-0.339001207	-0.339001207	0.004477197	161059	Signal amplification	1143
-0.339040131	2.606573517	-0.339040131	2.606573517	-0.339040131	0.839205328	0.264784938	198900	Matrix Metalloproteinases	1399
-0.339060746	-0.339060746	-0.339060746	-0.339060746	-0.339060746	-0.339060746	0.00448113	576272	Signaling by NOTCH2	1647
-0.339439944	-0.339439944	-0.339439944	-0.339439944	-0.339439944	-0.339439944	0.004506244	366230	Voltage gated Potassium channels	1452
-0.339951165	-0.339951165	-0.339951165	-0.339951165	-0.339951165	-0.339951165	0.00454028	83120	Asthma	159
-0.33996733	-0.33996733	-0.33996733	-0.33996733	-0.33996733	-0.33996733	0.00454136	138059	S1P2 pathway	969
-0.340230088	-0.340230088	-0.340230088	-3.273248084	-0.340230088	-0.926833687	0.043860117	101142	Alanine, aspartate and glutamate metabolism	169
-0.340824649	-0.340824649	-0.340824649	-0.340824649	2.659392333	0.259218747	0.035884459	105703	Xenobiotics	205
-0.341755453	-0.341755453	-0.341755453	-0.341755453	-0.341755453	-0.341755453	0.004662054	198917	Eukaryotic Transcription Initiation	1415
-0.341960269	-0.341960269	-0.341960269	-0.341960269	-0.341960269	-0.341960269	0.00467604	198872	Serotonin Receptor 4/6/7 and NR3C Signaling	1371
-0.342318794	-0.342318794	-0.342318794	-0.342318794	-0.342318794	-0.342318794	0.004700605	138015	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	929
-0.342356397	-0.342356397	-0.342356397	-0.342356397	-0.342356397	-0.342356397	0.004703187	105945	mRNA Capping	359
-0.342534057	-0.342534057	-0.342534057	-0.342534057	-0.342534057	-0.342534057	0.004715403	137936	IL12 signaling mediated by STAT4	857
-0.342537314	-0.342537314	-0.342537314	-0.342537314	-0.342537314	-0.342537314	0.004715627	730321	Synthesis of IP3 and IP4 in the cytosol	1807
-0.344071859	-3.180608203	-3.180608203	-3.180608203	-0.344071859	-2.045993665	3.80915663	194385	Fat digestion and absorption	1259
-0.34455589	-0.34455589	-0.34455589	-0.34455589	-0.34455589	-0.34455589	0.00485622	106461	Signalling to RAS	683
-0.344704127	-0.344704127	-0.344704127	-0.344704127	-0.344704127	-0.344704127	0.004866676	198861	Monoamine GPCRs	1361
-0.3448257	-0.3448257	-0.3448257	-0.3448257	-0.3448257	-0.3448257	0.004875264	138061	CD40/CD40L signaling	971
-0.344831802	-0.344831802	-0.344831802	-0.344831802	-3.269613837	-0.929788209	0.046230193	119522	Sema4D induced cell migration and growth-cone collapse	776
-0.345049236	-0.345049236	-0.345049236	-0.345049236	-0.345049236	-0.345049236	0.004891087	83030	Aminoacyl-tRNA biosynthesis	69
-0.345880643	-6.144382624	-0.345880643	-0.345880643	-0.345880643	-1.505581039	0.087939357	530751	Glycosphingolipid metabolism	1557
-0.346136762	-0.346136762	-0.346136762	-0.346136762	-0.346136762	-0.346136762	0.004968653	645259	Cellular response to hypoxia	1661
-0.346136762	-0.346136762	-0.346136762	-0.346136762	-0.346136762	-0.346136762	0.004968653	645260	Regulation of Hypoxia-inducible Factor (HIF) by Oxygen	1662
-0.34627292	-0.34627292	-0.34627292	-0.34627292	-0.34627292	-0.34627292	0.004978433	106342	EGFR downregulation	587
-0.346357972	-0.346357972	-0.346357972	-0.346357972	-0.346357972	-0.346357972	0.00498455	161004	Recycling pathway of L1	1097
-0.346459251	-0.346459251	-0.346459251	-0.346459251	-0.346459251	-0.346459251	0.004991842	106019	The role of Nef in HIV-1 replication and disease pathogenesis	421
-0.346590796	-0.346590796	-0.346590796	2.510711727	-0.346590796	0.224869709	0.036229718	645267	Latent infection of Homo sapiens with Mycobacterium tuberculosis	1668
-0.346590796	-0.346590796	-0.346590796	2.510711727	-0.346590796	0.224869709	0.036229718	645268	Phagosomal maturation (early endosomal stage)	1669
-0.346693675	-0.346693675	-3.226209249	-3.226209249	-0.346693675	-1.498499905	0.433733354	83004	Propanoate metabolism	56
-0.346774307	-0.346774307	-0.346774307	-0.346774307	-0.346774307	-0.346774307	0.00501458	645266	Downregulation of SMAD2/3:SMAD4 transcriptional activity	1667
-0.346776228	-0.346776228	-0.346776228	-0.346776228	-0.346776228	-0.346776228	0.005014719	161054	Tat-mediated HIV elongation arrest and recovery	1139
-0.346776228	-0.346776228	-0.346776228	-0.346776228	-0.346776228	-0.346776228	0.005014719	161055	Pausing and recovery of Tat-mediated HIV elongation	1140
-0.346933445	-0.346933445	-0.346933445	-0.346933445	-0.346933445	-0.346933445	0.005026097	106097	Glucagon signaling in metabolic regulation	471
-0.347542627	-0.347542627	-0.347542627	-0.347542627	-0.347542627	-0.347542627	0.005070379	82990	Ether lipid metabolism	46
-0.347643959	-0.347643959	-0.347643959	-0.347643959	-0.347643959	-0.347643959	0.005077775	106428	PKB-mediated events	659
-0.347657274	-3.209034012	2.513719465	-0.347657274	-0.347657274	-0.347657274	0.338957376	82949	Glycine, serine and threonine metabolism	19
-0.347729742	2.509540117	2.509540117	-0.347729742	-0.347729742	0.795178202	0.264797451	530735	SHC1 events in ERBB2 signaling	1542
-0.347950598	-0.347950598	-0.347950598	-0.347950598	-0.347950598	-0.347950598	0.005100209	137969	Signaling events mediated by PRL	887
-0.348049601	2.518915808	-3.215015009	-3.215015009	-0.348049601	-0.921442682	3.154001828	83021	Porphyrin and chlorophyll metabolism	65
-0.348336032	-0.348336032	-0.348336032	-0.348336032	-0.348336032	-0.348336032	0.005128519	106082	NEP/NS2 Interacts with the Cellular Export Machinery	463
-0.348425204	-0.348425204	-0.348425204	-0.348425204	-0.348425204	-0.348425204	0.005135087	106080	Export of Viral Ribonucleoproteins from Nucleus	461
-0.34853076	-0.34853076	-0.34853076	-0.34853076	-0.34853076	-0.34853076	0.00514287	198883	IL-9 Signaling Pathway	1382
-0.348648676	-0.348648676	-0.348648676	-0.348648676	-0.348648676	-0.348648676	0.005151576	583255	Nicotine addiction	1654
-0.348712329	-0.348712329	-0.348712329	2.522529573	-0.348712329	0.225536051	0.037299712	187095	Interleukin receptor SHC signaling	1194
-0.349154919	-0.349154919	-0.349154919	-0.349154919	-0.349154919	-0.349154919	0.005189085	105949	Formation of the Early Elongation Complex	361
-0.349154919	-0.349154919	-0.349154919	-0.349154919	-0.349154919	-0.349154919	0.005189085	106002	Formation of the HIV-1 Early Elongation Complex	407
-0.349314204	-0.349314204	-0.349314204	-0.349314204	-0.349314204	-0.349314204	0.005200933	119527	Signaling by Robo receptor	781
-0.349510309	-0.349510309	-0.349510309	-0.349510309	-0.349510309	-0.349510309	0.005215548	106203	Regulation of Glucokinase by Glucokinase Regulatory Protein	526
-0.35032784	-0.35032784	-0.35032784	-0.35032784	-0.35032784	-0.35032784	0.005276832	137971	Paxillin-independent events mediated by a4b1 and a4b7	889
-0.351041142	-0.351041142	-0.351041142	-0.351041142	-0.351041142	-0.351041142	0.005330772	119556	CTLA4 inhibitory signaling	808
-0.351390721	-0.351390721	-0.351390721	-0.351390721	-0.351390721	-0.351390721	0.005357368	83084	Circadian rhythm	123
-0.352219746	-0.352219746	-0.352219746	-0.352219746	-0.352219746	-0.352219746	0.005420864	198834	MAPK Cascade	1335
-0.352245692	-0.352245692	2.539755062	-0.352245692	-0.352245692	0.226154459	0.039099805	138041	EPHA forward signaling	952
-0.352433754	-0.352433754	-0.352433754	-0.352433754	-0.352433754	-0.352433754	0.005437352	83038	Basal transcription factors	77
-0.352904508	-0.352904508	-0.352904508	-0.352904508	-0.352904508	-0.352904508	0.005473764	137964	Regulation of p38-alpha and p38-beta	884
-0.353289442	-0.353289442	-0.353289442	-0.353289442	-0.353289442	-0.353289442	0.005503682	161043	Activation of Kainate Receptors upon glutamate binding	1129
-0.353949341	-0.353949341	-0.353949341	-0.353949341	-0.353949341	-0.353949341	0.005555275	137980	Reelin signaling pathway	897
-0.3539855	-0.3539855	-0.3539855	2.504193749	-0.3539855	0.21765035	0.039319666	138009	Plasma membrane estrogen receptor signaling	923
-0.354372521	-0.354372521	-0.354372521	-0.354372521	-0.354372521	-0.354372521	0.005588563	576260	RORA Activates Circadian Expression	1635
-0.355146981	-3.187260068	-3.187260068	-0.355146981	-3.187260068	-2.054414833	4.083840385	138000	IL23-mediated signaling events	915
-0.355848122	-0.355848122	-0.355848122	-0.355848122	-0.355848122	-0.355848122	0.00570589	161051	HIV elongation arrest and recovery	1136
-0.355848122	-0.355848122	-0.355848122	-0.355848122	-0.355848122	-0.355848122	0.00570589	161053	Pausing and recovery of HIV elongation	1138
-0.35638078	-0.35638078	-0.35638078	-0.35638078	-0.35638078	-0.35638078	0.005748723	105658	Activation of BH3-only proteins	183
-0.35698708	-0.35698708	-0.35698708	-0.35698708	-0.35698708	-0.35698708	0.00579779	82927	Citrate cycle (TCA cycle)	2
-0.357295551	-0.357295551	-0.357295551	-0.357295551	-0.357295551	-0.357295551	0.005822883	198762	TOR signaling	1266
-0.357301075	-0.357301075	-0.357301075	2.42758649	-0.357301075	0.199676438	0.039565076	672449	miRs in Muscle Cell Differentiation	1735
-0.35743745	-0.35743745	-0.35743745	-0.35743745	-0.35743745	-0.35743745	0.005834455	137972	Signaling events mediated by HDAC Class III	890
-0.358038944	-0.358038944	-0.358038944	-0.358038944	-0.358038944	-0.358038944	0.005883711	137941	Calcium signaling in the CD4+ TCR pathway	862
-0.358151069	2.445379803	-3.161681941	-0.358151069	2.445379803	0.202555106	2.425176348	83033	Drug metabolism - other enzymes	72
-0.358262507	-0.358262507	-0.358262507	-0.358262507	-0.358262507	-0.358262507	0.005902103	83039	DNA replication	78
-0.358466935	-0.358466935	-0.358466935	-0.358466935	-0.358466935	-0.358466935	0.005918961	106562	RNA Polymerase III Transcription Initiation	758
-0.358842536	-0.358842536	-0.358842536	-0.358842536	-0.358842536	-0.358842536	0.005950036	105980	tRNA Aminoacylation	387
-0.35885303	-0.35885303	-0.35885303	-0.35885303	-0.35885303	-0.35885303	0.005950906	920978	Physiological and Pathological Hypertrophy of the Heart	1992
-0.3591961	-0.3591961	-0.3591961	-0.3591961	-0.3591961	-0.3591961	0.005979406	106383	Olfactory Signaling Pathway	620
-0.359249113	-0.359249113	-0.359249113	-0.359249113	-0.359249113	-0.359249113	0.00598382	83088	Taste transduction	127
-0.360003806	-0.360003806	-0.360003806	-0.360003806	-0.360003806	-0.360003806	0.006046937	83125	Primary immunodeficiency	164
-0.361988544	-0.361988544	-0.361988544	-0.361988544	-0.361988544	-0.361988544	0.006215472	106553	RNA Polymerase I Transcription Initiation	749
-0.36248081	-0.36248081	-0.36248081	2.394027253	5.150535317	1.291424028	0.587268247	82959	Tyrosine metabolism	24
-0.362988156	-0.362988156	-0.362988156	-0.362988156	-0.362988156	-0.362988156	0.006301766	198863	Estrogen signaling pathway	1363
-0.363227857	-0.363227857	-0.363227857	-0.363227857	2.391628854	0.187743485	0.04163038	645292	TGF-beta receptor signaling activates SMADs	1685
-0.363246573	-0.363246573	-0.363246573	-0.363246573	-0.363246573	-0.363246573	0.00632423	137970	EGF receptor (ErbB1) signaling pathway	888
-0.363590292	-3.159363398	-8.750909608	-5.955136503	-3.159363398	-4.27767264	189.128232	833811	Syndecan interactions	1906
-0.363808199	-0.363808199	-0.363808199	2.381914057	-0.363808199	0.185336252	0.04172689	138044	Trk receptor signaling mediated by the MAPK pathway	954
-0.364179221	-0.364179221	-0.364179221	-0.364179221	-0.364179221	-0.364179221	0.006405836	160960	SHC-mediated cascade	1067
-0.364199337	-0.364199337	-0.364199337	-0.364199337	-0.364199337	-0.364199337	0.006407605	106468	CaM pathway	690
-0.364199337	-0.364199337	-0.364199337	-0.364199337	-0.364199337	-0.364199337	0.006407605	106469	Calmodulin induced events	691
-0.364377549	-0.364377549	-3.097892543	-0.364377549	-0.364377549	-0.911080548	0.054610077	101144	Prion diseases	171
-0.364394034	-0.364394034	-0.364394034	-0.364394034	-0.364394034	-0.364394034	0.006424751	138078	p38 signaling mediated by MAPKAP kinases	985
-0.364561672	-0.364561672	-0.364561672	-0.364561672	-0.364561672	-0.364561672	0.006439543	106548	Packaging Of Telomere Ends	745
-0.364624865	-0.364624865	-0.364624865	-0.364624865	-0.364624865	-0.364624865	0.006445126	907942	purine nucleotide salvage	1979
-0.365169991	-0.365169991	-0.365169991	-0.365169991	-0.365169991	-0.365169991	0.006493449	137988	IL2 signaling events mediated by STAT5	903
-0.366506227	-0.366506227	-3.120121755	-3.120121755	-0.366506227	-1.467952438	0.479277626	138054	Nectin adhesion pathway	964
-0.366922014	-0.366922014	-3.115401519	-3.115401519	-3.115401519	-2.016009717	4.070892361	119533	Adherens junctions interactions	786
-0.367796193	-0.367796193	-0.367796193	-0.367796193	-0.367796193	-0.367796193	0.006730327	106036	GPVI-mediated activation cascade	431
-0.367997488	-0.367997488	-0.367997488	-0.367997488	-0.367997488	-0.367997488	0.006748764	106363	Amine ligand-binding receptors	605
-0.368100341	-0.368100341	-0.368100341	-0.368100341	2.338519814	0.17322369	0.042934453	170720	Carbohydrate digestion and absorption	1174
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105941	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	355
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105942	RNA Polymerase II Transcription Initiation And Promoter Clearance	356
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105943	RNA Polymerase II Transcription Initiation	357
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105944	RNA Polymerase II Promoter Escape	358
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105998	HIV Transcription Initiation	403
-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	-0.368982356	0.006839557	105999	RNA Polymerase II HIV Promoter Escape	404
-0.36923487	-0.36923487	-0.36923487	-0.36923487	-0.36923487	-0.36923487	0.006862993	198851	Monoamine Transport	1351
-0.369241588	-0.369241588	-0.369241588	2.374009435	-0.369241588	0.179408617	0.044129081	198772	Angiogenesis	1275
-0.369274587	-0.369274587	-3.102617204	-0.369274587	-3.102617204	-1.462611634	0.484735311	187180	GABA B receptor activation	1215
-0.369274587	-0.369274587	-3.102617204	-0.369274587	-3.102617204	-1.462611634	0.484735311	187181	Activation of GABAB receptors	1216
-0.369380601	-0.369380601	-0.369380601	-0.369380601	-0.369380601	-0.369380601	0.006876547	106417	Generation of second messenger molecules	649
-0.369399079	-3.092576959	-0.369399079	-3.092576959	-0.369399079	-1.458670231	0.482090372	106518	Neurotransmitter Release Cycle	725
-0.370054576	-0.370054576	-3.045792651	-0.370054576	-0.370054576	-0.905202191	0.057116745	82998	Pyruvate metabolism	54
-0.370500434	-0.370500434	-0.370500434	-0.370500434	-0.370500434	-0.370500434	0.006981417	198801	Ovarian Infertility Genes	1303
-0.370758315	-0.370758315	-0.370758315	-0.370758315	-0.370758315	-0.370758315	0.007005748	672455	FSH signaling pathway	1741
-0.370962312	-0.370962312	-0.370962312	2.37792477	2.37792477	0.728592521	0.288659323	198778	Fluoropyrimidine Activity	1281
-0.371125167	-0.371125167	-0.371125167	-0.371125167	-0.371125167	-0.371125167	0.007040476	105963	Transport of the SLBP independent Mature mRNA	371
-0.371178314	-0.371178314	-0.371178314	-0.371178314	-0.371178314	-0.371178314	0.007045519	137959	BARD1 signaling events	879
-0.371214178	-0.371214178	-0.371214178	-0.371214178	-0.371214178	-0.371214178	0.007048923	137920	TRAIL signaling pathway	841
-0.371447476	-0.371447476	-0.371447476	-0.371447476	-0.371447476	-0.371447476	0.007071101	198882	EPO Receptor Signaling	1381
-0.371690383	-0.371690383	-0.371690383	-0.371690383	-3.102699806	-0.917892267	0.059219543	119520	Sema4D in semaphorin signaling	774
-0.371788524	-0.371788524	-0.371788524	-0.371788524	-0.371788524	-0.371788524	0.007103623	106114	Triglyceride Biosynthesis	480
-0.37206262	-0.37206262	-0.37206262	-0.37206262	-0.37206262	-0.37206262	0.007129847	106007	Rev-mediated nuclear export of HIV RNA	411
-0.372281998	-0.372281998	-0.372281998	-0.372281998	-0.372281998	-0.372281998	0.007150891	161006	Signal transduction by L1	1099
-0.37236772	-0.37236772	-0.37236772	-0.37236772	-0.37236772	-0.37236772	0.007159128	138032	Canonical Wnt signaling pathway	945
-0.373478603	-0.373478603	-0.373478603	-0.373478603	-0.373478603	-0.373478603	0.007266556	138011	CXCR3-mediated signaling events	925
-0.373613394	-0.373613394	-0.373613394	-3.060513023	-0.373613394	-0.91099332	0.059632632	138039	Retinoic acid receptors-mediated signaling	950
-0.373648968	-3.077331807	-5.781014646	5.033716709	-5.781014646	-1.995858672	193.4349845	169349	Validated transcriptional targets of AP1 family members Fra1 and Fra2	1165
-0.373754503	-0.373754503	2.324833968	-0.373754503	-0.373754503	0.165963191	0.045366751	187191	Iron uptake and transport	1223
-0.374234223	-0.374234223	-3.003206634	-0.374234223	2.254738188	-0.374234223	0.354904769	198912	Prostaglandin Synthesis and Regulation	1410
-0.374716108	-0.374716108	-0.374716108	-0.374716108	-0.374716108	-0.374716108	0.007387744	105962	Transport of the SLBP Dependant Mature mRNA	370
-0.375337351	-0.375337351	-0.375337351	-0.375337351	-0.375337351	-0.375337351	0.007449188	106497	Ca-dependent events	709
-0.376188287	-0.376188287	-0.376188287	-0.376188287	-0.376188287	-0.376188287	0.007534013	366163	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	1440
-0.376264635	-0.376264635	-0.376264635	-0.376264635	-0.376264635	-0.376264635	0.007541661	82994	Sphingolipid metabolism	50
-0.376790479	-0.376790479	-0.376790479	-0.376790479	-0.376790479	-0.376790479	0.007594507	137992	IGF1 pathway	907
-0.377079934	-0.377079934	-0.377079934	-0.377079934	-0.377079934	-0.377079934	0.007623723	833795	Inactivation, recovery and regulation of the phototransduction cascade	1893
-0.37766462	-0.37766462	-0.37766462	-0.37766462	-0.37766462	-0.37766462	0.007683012	106073	Transport of Ribonucleoproteins into the Host Nucleus	456
-0.377743223	-0.377743223	-0.377743223	-0.377743223	-0.377743223	-0.377743223	0.007691011	106015	Nuclear import of Rev protein	418
-0.378180528	-0.378180528	-0.378180528	-0.378180528	-0.378180528	-0.378180528	0.007735632	83044	Nucleotide excision repair	83
-0.378710836	-0.378710836	-0.378710836	-0.378710836	-0.378710836	-0.378710836	0.007790022	142277	purine nucleotides de novo biosynthesis	1011
-0.378844442	-3.040203358	-0.378844442	-0.378844442	4.943873391	0.153427342	0.817245869	82964	Tryptophan metabolism	26
-0.379051383	2.269805241	-0.379051383	-0.379051383	2.269805241	0.680491267	0.280589519	138010	Glypican 1 network	924
-0.379244482	-0.379244482	-0.379244482	-0.379244482	-5.687074879	-1.440810561	0.117642983	161025	Smooth Muscle Contraction	1113
-0.379276607	-0.379276607	-0.379276607	-0.379276607	-0.379276607	-0.379276607	0.007848385	194384	African trypanosomiasis	1258
-0.379645785	-0.379645785	-0.379645785	-0.379645785	-0.379645785	-0.379645785	0.007886656	138063	S1P3 pathway	973
-0.380045543	-0.380045543	-0.380045543	-0.380045543	-0.380045543	-0.380045543	0.007928266	119553	CD28 co-stimulation	805
-0.380097864	-0.380097864	-0.380097864	-0.380097864	-0.380097864	-0.380097864	0.007933725	771580	Role of phospholipids in phagocytosis	1848
-0.38028997	-0.38028997	-0.38028997	-0.38028997	-0.38028997	-0.38028997	0.007953794	138013	Internalization of ErbB1	927
-0.380736987	-0.380736987	-0.380736987	-0.380736987	-0.380736987	-0.380736987	0.008000651	198776	Hypothetical Network for Drug Addiction	1279
-0.381131433	-0.381131433	-0.381131433	-0.381131433	-0.381131433	-0.381131433	0.008042181	105964	Transport of Mature mRNA Derived from an Intronless Transcript	372
-0.381300799	-0.381300799	-0.381300799	-0.381300799	-0.381300799	-0.381300799	0.008060066	106013	Vpr-mediated nuclear import of PICs	416
-0.381583371	-0.381583371	-3.005051033	-3.005051033	-0.381583371	-1.430970436	0.50173226	530747	O-linked glycosylation of mucins	1553
-0.38224316	-0.38224316	-0.38224316	-0.38224316	-0.38224316	-0.38224316	0.008160159	106501	DARPP-32 events	712
-0.382299808	-0.382299808	-0.382299808	-0.382299808	-0.382299808	-0.382299808	0.008166207	106065	Basigin interactions	449
-0.383405344	-0.383405344	-0.383405344	-0.383405344	-0.383405344	-0.383405344	0.008284968	645276	Signaling by FGFR1 mutants	1674
-0.383688513	-0.383688513	-0.383688513	-0.383688513	-0.383688513	-0.383688513	0.008315608	137984	Lissencephaly gene (LIS1) in neuronal migration and development	901
-0.384062306	-3.041013579	-0.384062306	-3.041013579	-0.384062306	-1.446842816	0.523892011	833828	FCERI mediated NF-kB activation	1917
-0.384240014	-0.384240014	-0.384240014	-0.384240014	-0.384240014	-0.384240014	0.008375542	106536	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	734
-0.384240014	-0.384240014	-0.384240014	-0.384240014	-0.384240014	-0.384240014	0.008375542	106537	Trafficking of AMPA receptors	735
-0.384291954	-0.384291954	-0.384291954	-0.384291954	-0.384291954	-0.384291954	0.008381205	187102	Negative regulators of RIG-I/MDA5 signaling	1201
-0.384421733	-0.384421733	-0.384421733	-0.384421733	-0.384421733	-0.384421733	0.008395366	105961	Transport of Mature mRNAs Derived from Intronless Transcripts	369
-0.384948198	2.25258656	-0.384948198	-0.384948198	2.25258656	0.670065705	0.289447531	137948	BMP receptor signaling	868
-0.385831738	-0.385831738	-0.385831738	-0.385831738	-0.385831738	-0.385831738	0.008550465	198865	Fatty Acid Beta Oxidation	1365
-0.38687254	-0.38687254	-0.38687254	-0.38687254	-0.38687254	-0.38687254	0.008666416	105754	Activation of ATR in response to replication stress	234
-0.387525835	-0.387525835	-0.387525835	-0.387525835	-0.387525835	-0.387525835	0.008739836	83057	SNARE interactions in vesicular transport	96
-0.38860873	-0.38860873	-0.38860873	-0.38860873	-0.38860873	-0.38860873	0.008862633	198856	Glycogen Metabolism	1356
-0.388631671	-0.388631671	-0.388631671	-0.388631671	-0.388631671	-0.388631671	0.008865249	645336	Synthesis of PIPs at the plasma membrane	1719
-0.389249114	-0.389249114	-0.389249114	-0.389249114	-0.389249114	-0.389249114	0.008935897	137990	Regulation of CDC42 activity	905
-0.389416682	-0.389416682	-0.389416682	-0.389416682	-0.389416682	-0.389416682	0.008955148	833793	The phototransduction cascade	1891
-0.391031919	-2.984941826	-0.391031919	-0.391031919	2.202877989	-0.391031919	0.39315422	835392	tryptophan utilization I	1926
-0.39129155	-0.39129155	-0.39129155	2.166169563	2.166169563	0.631692895	0.281116481	137956	HIF-2-alpha transcription factor network	876
-0.391402822	-0.391402822	-0.391402822	-0.391402822	-0.391402822	-0.391402822	0.009185859	477128	Growth hormone receptor signaling	1524
-0.392233637	-0.392233637	-0.392233637	-0.392233637	-0.392233637	-0.392233637	0.009283766	138052	Ephrin B reverse signaling	962
-0.393570455	2.149695813	-0.393570455	-0.393570455	-0.393570455	0.115082799	0.051578293	105766	G1 Phase	239
-0.393570455	2.149695813	-0.393570455	-0.393570455	-0.393570455	0.115082799	0.051578293	105767	Cyclin D associated events in G1	240
-0.394170408	-0.394170408	-0.394170408	-0.394170408	-0.394170408	-0.394170408	0.009515247	105890	Transcription-coupled NER (TC-NER)	321
-0.394382271	-0.394382271	-0.394382271	-0.394382271	2.133709211	0.111236025	0.051618427	137913	Alpha-synuclein signaling	834
-0.394605917	-0.394605917	-0.394605917	2.171936633	2.171936633	0.632011103	0.289857859	83063	Hedgehog signaling pathway	102
-0.394892565	-0.394892565	-0.394892565	-0.394892565	-0.394892565	-0.394892565	0.009602732	82975	N-Glycan biosynthesis	33
-0.395000853	-0.395000853	2.12735453	-0.395000853	-0.395000853	0.109470224	0.051788342	137991	ErbB4 signaling events	906
-0.395015899	-0.395015899	-0.395015899	4.70690078	4.70690078	1.645750773	1.365569519	730311	Molecules associated with elastic fibres	1797
-0.39507768	-0.39507768	-0.39507768	-0.39507768	-0.39507768	-0.39507768	0.00962526	187220	Transport to the Golgi and subsequent modification	1250
-0.395737301	-0.395737301	-0.395737301	-0.395737301	-0.395737301	-0.395737301	0.00970588	106014	Interactions of Rev with host cellular proteins	417
-0.395877502	-0.395877502	-0.395877502	-0.395877502	-0.395877502	-0.395877502	0.009723086	198800	G13 Signaling Pathway	1302
-0.396836605	-0.396836605	-0.396836605	-0.396836605	-0.396836605	-0.396836605	0.009841439	137943	p38 MAPK signaling pathway	864
-0.397407117	-0.397407117	-0.397407117	-0.397407117	-0.397407117	-0.397407117	0.009912386	106561	RNA Polymerase III Transcription	757
-0.397407117	-0.397407117	-0.397407117	-0.397407117	-0.397407117	-0.397407117	0.009912386	160949	RNA Polymerase III Abortive And Retractive Initiation	1056
-0.397458345	-0.397458345	-0.397458345	-0.397458345	-0.397458345	-0.397458345	0.009918776	106011	Interactions of Vpr with host cellular proteins	415
-0.397463038	4.652893231	-2.922641173	-2.922641173	-0.397463038	-0.397463038	6.278668871	105678	Apoptotic cleavage of cellular proteins	188
-0.397732116	-0.397732116	-0.397732116	-0.397732116	-0.397732116	-0.397732116	0.009952984	161036	CREB phosphorylation through the activation of Ras	1123
-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	0.01002802	106001	HIV Transcription Elongation	406
-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	0.01002802	106003	Tat-mediated elongation of the HIV-1 transcript	408
-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	-0.398330017	0.01002802	106004	Formation of HIV-1 elongation complex containing HIV-1 Tat	409
-0.398476286	-2.906982964	-2.906982964	-7.923996321	-5.415489643	-3.910385636	144.500533	187208	Retinoid metabolism and transport	1239
-0.398478158	-0.398478158	-0.398478158	-0.398478158	-0.398478158	-0.398478158	0.010046681	106460	Signalling to ERKs	682
-0.398967139	-0.398967139	-0.398967139	2.103178607	-2.901112886	-0.398967139	0.387482563	160997	Myogenesis	1090
-0.398967139	-0.398967139	-0.398967139	2.103178607	-2.901112886	-0.398967139	0.387482563	160998	CDO in myogenesis	1091
-0.399532431	-0.399532431	-0.399532431	-0.399532431	-0.399532431	-0.399532431	0.010180291	198771	DNA Replication	1274
-0.399890554	-0.399890554	-0.399890554	-0.399890554	-0.399890554	-0.399890554	0.010225999	106242	Chaperonin-mediated protein folding	546
-0.400986138	-0.400986138	-0.400986138	-0.400986138	-0.400986138	-0.400986138	0.01036685	366165	NOD1/2 Signaling Pathway	1442
-0.401576728	-0.401576728	-0.401576728	-0.401576728	-0.401576728	-0.401576728	0.010443419	83040	Proteasome	79
-0.402840742	-2.89258575	-2.89258575	-2.89258575	-2.89258575	-2.394636749	28.20189928	82986	Glycerolipid metabolism	42
-0.403025309	-2.903958038	-2.903958038	-0.403025309	-2.903958038	-1.903584947	3.977733196	672452	TWEAK Signaling Pathway	1738
-0.403368673	-0.403368673	-0.403368673	-0.403368673	-0.403368673	-0.403368673	0.010678514	477115	DAG and IP3 signaling	1513
-0.403761072	-0.403761072	-0.403761072	-0.403761072	-0.403761072	-0.403761072	0.010730556	106200	Glucose transport	525
-0.403873695	-0.403873695	7.066046673	-0.403873695	-0.403873695	1.090110379	0.188000399	119551	G alpha (z) signalling events	803
-0.403991749	-0.403991749	-0.403991749	-0.403991749	-0.403991749	-0.403991749	0.010761244	198870	Oxidative phosphorylation	1369
-0.404739082	-0.404739082	-0.404739082	-0.404739082	-0.404739082	-0.404739082	0.010861147	187194	Ion transport by P-type ATPases	1226
-0.404922839	-0.404922839	-0.404922839	2.054371657	-0.404922839	0.08693606	0.055229118	137924	VEGFR1 specific signals	845
-0.405291734	-0.405291734	-0.405291734	-0.405291734	-0.405291734	-0.405291734	0.010935502	169346	Regulation of RAC1 activity	1162
-0.405317919	-0.405317919	-0.405317919	-0.405317919	-0.405317919	-0.405317919	0.010939035	138047	EPHB forward signaling	957
-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	0.010996567	105948	RNA Polymerase II Transcription Elongation	360
-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	0.010996567	105950	Formation of RNA Pol II elongation complex	362
-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	-0.40574336	0.010996567	161052	Formation of HIV elongation complex in the absence of HIV Tat	1137
-0.405958527	-0.405958527	-0.405958527	-0.405958527	-0.405958527	-0.405958527	0.011025755	137967	Trk receptor signaling mediated by PI3K and PLC-gamma	885
-0.405990416	-0.405990416	-0.405990416	-0.405990416	-0.405990416	-0.405990416	0.011030086	477138	BMAL1:CLOCK/NPAS2 Activates Circadian Expression	1534
-0.407469636	2.028821164	-0.407469636	-0.407469636	2.028821164	0.567046684	0.278466713	138008	a6b1 and a6b4 Integrin signaling	922
-0.40768705	-0.40768705	-0.40768705	-0.40768705	-0.40768705	-0.40768705	0.011262494	672451	TSLP Signaling Pathway	1737
-0.408275665	-0.408275665	-0.408275665	2.043094285	-0.408275665	0.081998325	0.056767842	138012	Signaling mediated by p38-alpha and p38-beta	926
-0.408783456	-0.408783456	-0.408783456	-0.408783456	-0.408783456	-0.408783456	0.011414754	106467	PLC-gamma1 signalling	689
-0.408847163	-0.408847163	-0.408847163	-0.408847163	-0.408847163	-0.408847163	0.011423651	187189	Regulation of Water Balance by Renal Aquaporins	1222
-0.409949755	-0.409949755	-0.409949755	2.000101714	-0.409949755	0.072060539	0.056490394	672453	Endothelin	1739
-0.410200521	-0.410200521	-0.410200521	-0.410200521	-0.410200521	-0.410200521	0.011613979	106552	RNA Polymerase I Promoter Opening	748
-0.410722845	-0.410722845	-0.410722845	-0.410722845	-0.410722845	-0.410722845	0.01168811	672457	Synaptic Vesicle Pathway	1743
-0.410991663	-0.410991663	-0.410991663	-0.410991663	-0.410991663	-0.410991663	0.01172641	137944	IL1-mediated signaling events	865
-0.411780157	-0.411780157	-0.411780157	-0.411780157	-0.411780157	-0.411780157	0.011839329	105957	mRNA 3"-end processing	366
-0.413137655	-0.413137655	2.0358111	-0.413137655	-0.413137655	0.076652096	0.059308453	212237	Mineral absorption	1427
-0.413151295	-0.413151295	-0.413151295	-0.413151295	-0.413151295	-0.413151295	0.012037757	82956	Lysine degradation	21
-0.41328552	-0.41328552	-2.874050747	-2.874050747	-0.41328552	-1.397591611	0.583095154	138005	E-cadherin signaling in the nascent adherens junction	919
-0.413614238	-0.413614238	-0.413614238	-0.413614238	-0.413614238	-0.413614238	0.012105351	198836	Signaling of Hepatocyte Growth Factor Receptor	1337
-0.413974113	-0.413974113	-0.413974113	-0.413974113	-0.413974113	-0.413974113	0.012158106	105925	Regulation of Insulin Secretion by Glucagon-like Peptide-1	346
-0.414517013	-0.414517013	-0.414517013	-2.857162936	-0.414517013	-0.903046198	0.08435376	82952	Valine, leucine and isoleucine degradation	20
-0.41471267	-0.41471267	-0.41471267	-0.41471267	-0.41471267	-0.41471267	0.012266948	137912	Hedgehog signaling events mediated by Gli proteins	833
-0.414979275	-0.414979275	-2.808860295	-0.414979275	-0.414979275	-0.893755479	0.083298229	106327	Pyruvate metabolism and Citric Acid (TCA) cycle	574
-0.415128347	-0.415128347	-0.415128347	-0.415128347	-0.415128347	-0.415128347	0.012328549	105883	Nucleotide Excision Repair	315
-0.416248138	-0.416248138	-0.416248138	-0.416248138	-0.416248138	-0.416248138	0.012495727	920975	Amyotrophic lateral sclerosis (ALS)	1990
-0.416679722	-0.416679722	-0.416679722	-0.416679722	-0.416679722	-0.416679722	0.012560642	160141	Interleukin-1 signaling	1049
-0.416809005	-0.416809005	-0.416809005	-0.416809005	-0.416809005	-0.416809005	0.01258014	137995	HIV-1 Nef: Negative effector of Fas and TNF-alpha	910
-0.418135363	-0.418135363	-0.418135363	-0.418135363	-0.418135363	-0.418135363	0.012781579	477118	Negative regulation of FGFR signaling	1515
-0.418509635	-0.418509635	-0.418509635	-0.418509635	-0.418509635	-0.418509635	0.012838885	730320	Inositol phosphate metabolism	1806
-0.418601908	-0.418601908	-0.418601908	-0.418601908	-0.418601908	-0.418601908	0.012853045	137955	ErbB2/ErbB3 signaling events	875
-0.421311233	-0.421311233	-2.796903187	-0.421311233	-5.172495141	-1.846666405	1.081898804	137919	N-cadherin signaling events	840
-0.421376982	-2.808781979	-0.421376982	1.966028015	1.966028015	0.056104017	1.927698238	82957	Arginine and proline metabolism	22
-0.42138351	-0.42138351	-0.42138351	-0.42138351	-0.42138351	-0.42138351	0.013285799	106338	EGFR interacts with phospholipase C-gamma	583
-0.421415563	-0.421415563	-0.421415563	-0.421415563	-0.421415563	-0.421415563	0.013290853	477126	Cross-presentation of soluble exogenous antigens (endosomes)	1523
-0.422232043	-0.422232043	-0.422232043	-0.422232043	-0.422232043	-0.422232043	0.013420106	160993	Deadenylation-dependent mRNA decay	1086
-0.422793779	-0.422793779	-0.422793779	-0.422793779	-0.422793779	-0.422793779	0.013509614	138034	Arf6 signaling events	946
-0.422811359	-0.422811359	-0.422811359	-0.422811359	-0.422811359	-0.422811359	0.013512423	138022	Class I PI3K signaling events	936
-0.422971878	-0.422971878	-0.422971878	-0.422971878	-0.422971878	-0.422971878	0.013538092	138020	Class I PI3K signaling events mediated by Akt	934
-0.423444789	-0.423444789	-2.830748879	-0.423444789	-2.830748879	-1.386366425	0.608405411	187178	GABA receptor activation	1213
-0.423508367	-0.423508367	-0.423508367	-0.423508367	-0.423508367	-0.423508367	0.013624167	125137	Cytosolic DNA-sensing pathway	825
-0.423763674	-0.423763674	-0.423763674	-0.423763674	-0.423763674	-0.423763674	0.013665283	160958	FRS2-mediated cascade	1065
-0.424031688	-0.424031688	-7.594804307	-2.814289227	-0.424031688	-2.336237719	1.629597137	83115	Bladder cancer	154
-0.42456555	-0.42456555	-0.42456555	-0.42456555	-0.42456555	-0.42456555	0.013795065	128760	Intestinal immune network for IgA production	828
-0.425597689	-0.425597689	-0.425597689	1.957368094	1.957368094	0.527588624	0.295353956	83113	Basal cell carcinoma	152
-0.42572235	-0.42572235	-0.42572235	-0.42572235	-0.42572235	-0.42572235	0.013984027	106241	Protein folding	545
-0.426260748	-0.426260748	-0.426260748	-0.426260748	-0.426260748	-0.426260748	0.014072677	672450	Integrated Cancer pathway	1736
-0.426279745	-0.426279745	-0.426279745	-0.426279745	1.945894686	0.048155141	0.064253697	705377	Parkinsons Disease Pathway	1786
-0.426392669	-0.426392669	-0.426392669	-0.426392669	-0.426392669	-0.426392669	0.014094467	530738	PLCG1 events in ERBB2 signaling	1545
-0.426800639	-0.426800639	-0.426800639	-0.426800639	-0.426800639	-0.426800639	0.014162023	105953	mRNA Splicing - Minor Pathway	365
-0.427322482	-0.427322482	-0.427322482	-0.427322482	-0.427322482	-0.427322482	0.014248814	138023	Ceramide signaling pathway	937
-0.427498575	-0.427498575	-0.427498575	1.963433053	-0.427498575	0.050687751	0.065577489	138062	Signaling events mediated by HDAC Class II	972
-0.427575483	-0.427575483	-0.427575483	-0.427575483	-0.427575483	-0.427575483	0.014291045	83123	Allograft rejection	162
-0.427803962	-0.427803962	-0.427803962	-0.427803962	-0.427803962	-0.427803962	0.014329268	106198	Hexose transport	523
-0.427886824	-0.427886824	-0.427886824	-0.427886824	-0.427886824	-0.427886824	0.014343151	645264	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1665
-0.42826201	-0.42826201	-0.42826201	-0.42826201	-0.42826201	-0.42826201	0.014406144	160999	Netrin-1 signaling	1092
-0.428337738	-0.428337738	-0.428337738	-0.428337738	-0.428337738	-0.428337738	0.014418886	138051	EPO signaling pathway	961
-0.428406118	-0.428406118	-0.428406118	-0.428406118	-0.428406118	-0.428406118	0.014430398	576271	NOTCH1 Intracellular Domain Regulates Transcription	1646
-0.428715331	-0.428715331	-0.428715331	-0.428715331	-0.428715331	-0.428715331	0.014482551	105656	Intrinsic Pathway for Apoptosis	182
-0.428731803	-0.428731803	-2.781815244	-2.781815244	-0.428731803	-1.369965179	0.609836854	137918	Stabilization and expansion of the E-cadherin adherens junction	839
-0.429915893	-0.429915893	-0.429915893	-0.429915893	-0.429915893	-0.429915893	0.014686473	187187	Aquaporin-mediated transport	1220
-0.430338814	-0.430338814	-0.430338814	-0.430338814	-0.430338814	-0.430338814	0.014758853	198893	p38 MAPK Signaling Pathway	1392
-0.43118641	-0.43118641	-0.43118641	-0.43118641	-0.43118641	-0.43118641	0.014904771	920963	Allograft Rejection	1986
-0.433404413	-2.769816344	-0.433404413	-2.769816344	-0.433404413	-1.367969185	0.624571172	138055	TCR signaling in naive CD8+ T cells	965
-0.434090431	-0.434090431	-0.434090431	-0.434090431	-0.434090431	-0.434090431	0.015413493	161035	Post NMDA receptor activation events	1122
-0.434115262	-0.434115262	-0.434115262	-0.434115262	-0.434115262	-0.434115262	0.015417902	82935	Fatty acid degradation	10
-0.434636971	-0.434636971	-0.434636971	-0.434636971	-0.434636971	-0.434636971	0.015510769	105796	Ubiquitin-dependent degradation of Cyclin D	263
-0.434636971	-0.434636971	-0.434636971	-0.434636971	-0.434636971	-0.434636971	0.015510769	105797	Ubiquitin-dependent degradation of Cyclin D1	264
-0.436108648	-0.436108648	-0.436108648	-0.436108648	-0.436108648	-0.436108648	0.01577515	137915	Signaling events regulated by Ret tyrosine kinase	836
-0.436115375	-0.436115375	-0.436115375	-0.436115375	-0.436115375	-0.436115375	0.015776367	106228	Metabolism of non-coding RNA	534
-0.436115375	-0.436115375	-0.436115375	-0.436115375	-0.436115375	-0.436115375	0.015776367	106229	snRNP Assembly	535
-0.437148115	-0.437148115	-0.437148115	-0.437148115	-0.437148115	-0.437148115	0.015964049	833827	FCERI mediated Ca+2 mobilization	1916
-0.437756283	-0.437756283	-0.437756283	1.874133248	-0.437756283	0.024621624	0.068822432	205110	Interleukin-2 signaling	1421
-0.437856496	-0.437856496	-0.437856496	-0.437856496	-0.437856496	-0.437856496	0.016093814	169356	RhoA signaling pathway	1172
-0.438342391	-0.438342391	-0.438342391	-0.438342391	-0.438342391	-0.438342391	0.01618331	137957	LKB1 signaling events	877
-0.438531733	-0.438531733	-0.438531733	4.123566924	-0.438531733	0.473887998	0.152502566	730310	Elastic fibre formation	1796
-0.439727275	-0.439727275	-0.439727275	-2.724024805	-2.724024805	-1.353446287	0.630917143	645308	Chondroitin sulfate/dermatan sulfate metabolism	1700
-0.440083128	-0.440083128	-0.440083128	-0.440083128	-0.440083128	-0.440083128	0.016507207	106176	Regulation of ornithine decarboxylase (ODC)	514
-0.44028708	-0.44028708	-0.44028708	-0.44028708	-0.44028708	-0.44028708	0.016545493	105686	Regulation of activated PAK-2p34 by proteasome mediated degradation	194
-0.440394391	-0.440394391	-0.440394391	-0.440394391	-0.440394391	-0.440394391	0.016565666	105788	CDK-mediated phosphorylation and removal of Cdc6	255
-0.440967811	-0.440967811	-0.440967811	-2.710488194	4.098072957	0.012936266	0.952462467	198850	Tryptophan metabolism	1350
-0.44125407	-0.44125407	-0.44125407	-0.44125407	-0.44125407	-0.44125407	0.016727985	160939	Autodegradation of the E3 ubiquitin ligase COP1	1050
-0.44138405	-0.44138405	-0.44138405	-0.44138405	-0.44138405	-0.44138405	0.016752637	106559	RNA Polymerase II Transcription Termination	755
-0.44138405	-0.44138405	-0.44138405	-0.44138405	-0.44138405	-0.44138405	0.016752637	106560	Cleavage of Growing Transcript in the Termination Region	756
-0.442172365	-2.720824081	-0.442172365	-0.442172365	1.83647935	-0.442172365	0.431977675	546258	Cocaine addiction	1620
-0.443374312	-0.443374312	-0.443374312	-0.443374312	-0.443374312	-0.443374312	0.017133758	137938	IL2 signaling events mediated by PI3K	859
-0.443776432	-0.443776432	-0.443776432	-0.443776432	-0.443776432	-0.443776432	0.017211597	106418	Downstream TCR signaling	650
-0.44470721	-0.44470721	-0.44470721	-0.44470721	-0.44470721	-0.44470721	0.017392854	106444	NRAGE signals death through JNK	670
-0.444942503	-0.444942503	-0.444942503	-0.444942503	-0.444942503	-0.444942503	0.017438915	138070	Regulation of RhoA activity	979
-0.446085618	-0.446085618	-0.446085618	-0.446085618	-0.446085618	-0.446085618	0.017664084	198813	Diurnally regulated genes with circadian orthologs	1315
-0.446175187	-0.446175187	-0.446175187	-0.446175187	-0.446175187	-0.446175187	0.017681824	576265	Pre-NOTCH Expression and Processing	1640
-0.446992935	1.782398261	-2.676384131	-2.676384131	4.011789458	-0.001114696	22.89498871	83020	Retinol metabolism	64
-0.447301393	-0.447301393	-0.447301393	-0.447301393	-0.447301393	-0.447301393	0.01790611	138040	IFN-gamma pathway	951
-0.448298099	-0.448298099	-0.448298099	-0.448298099	-0.448298099	-0.448298099	0.018106499	685552	Activation of Gene Expression by SREBP (SREBF)	1770
-0.44868339	-0.44868339	-0.44868339	-0.44868339	-0.44868339	-0.44868339	0.018184441	868084	Fatty acid metabolism	1934
-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	0.018240551	105747	p53-Independent G1/S DNA damage checkpoint	229
-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	0.018240551	105748	p53-Independent DNA Damage Response	230
-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	-0.448959941	0.018240551	105749	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	231
-0.449753962	-0.449753962	-0.449753962	-0.449753962	-0.449753962	-0.449753962	0.018402422	143700	Vasopressin-regulated water reabsorption	1031
-0.451011732	-0.451011732	-0.451011732	-0.451011732	-0.451011732	-0.451011732	0.018661184	137914	Presenilin action in Notch and Wnt signaling	835
-0.451311302	-0.451311302	-0.451311302	-0.451311302	-0.451311302	-0.451311302	0.018723242	576249	Antigen Activates B Cell Receptor Leading to Generation of Second Messengers	1625
-0.451770793	-0.451770793	-0.451770793	-0.451770793	-0.451770793	-0.451770793	0.018818749	83124	Graft-versus-host disease	163
-0.451958581	-0.451958581	-0.451958581	-0.451958581	-2.651805655	-0.891927996	0.110646133	172846	Staphylococcus aureus infection	1176
-0.451958581	-0.451958581	-0.451958581	-0.451958581	-0.451958581	-0.451958581	0.018857894	199378	Ribosome biogenesis in eukaryotes	1417
-0.453026823	-0.453026823	-0.453026823	-0.453026823	-0.453026823	-0.453026823	0.019081811	105969	Formation of the ternary complex, and subsequently, the 43S complex	377
-0.453063069	-0.453063069	-0.453063069	-0.453063069	-0.453063069	-0.453063069	0.019089446	138081	FAS (CD95) signaling pathway	987
-0.453170214	-4.824235698	-7.00976844	-2.638702956	-4.824235698	-3.950022601	195.0799197	152665	Malaria	1038
-0.453382445	-0.453382445	-0.453382445	-0.453382445	-0.453382445	-0.453382445	0.019156824	160962	Respiratory electron transport	1069
-0.453536122	-0.453536122	-0.453536122	-0.453536122	-0.453536122	-0.453536122	0.019189312	138018	Downstream signaling in naive CD8+ T cells	932
-0.45416171	-0.45416171	-0.45416171	-0.45416171	-0.45416171	-0.45416171	0.019322022	771593	Constitutive Signaling by NOTCH1 PEST Domain Mutants	1860
-0.45416171	-0.45416171	-0.45416171	-0.45416171	-0.45416171	-0.45416171	0.019322022	771595	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	1862
-0.454556704	-0.454556704	-0.454556704	-0.454556704	-0.454556704	-0.454556704	0.019406192	833826	FCERI mediated MAPK activation	1915
-0.454716722	-0.454716722	-0.454716722	-0.454716722	-0.454716722	-0.454716722	0.019440375	106026	Vpu mediated degradation of CD4	427
-0.455040967	-0.455040967	-0.455040967	-0.455040967	-0.455040967	-0.455040967	0.019509785	161033	Activation of NMDA receptor upon glutamate binding and postsynaptic events	1120
-0.456510135	-0.456510135	-0.456510135	-0.456510135	-0.456510135	-0.456510135	0.019826777	105744	Stabilization of p53	228
-0.457018232	-0.457018232	-0.457018232	-0.457018232	3.958616862	0.426108787	0.17269413	105700	Cytochrome P450 - arranged by substrate type	203
-0.45835207	-0.45835207	-0.45835207	-0.45835207	-0.45835207	-0.45835207	0.020230005	160947	RNA Polymerase II Pre-transcription Events	1054
-0.458415806	-0.458415806	-0.458415806	-0.458415806	-0.458415806	-0.458415806	0.020244074	755439	Regulation of Microtubule Cytoskeleton	1831
-0.45874899	-0.45874899	-0.45874899	-0.45874899	-0.45874899	-0.45874899	0.02031775	138053	TNF receptor signaling pathway	963
-0.459430537	-0.459430537	-0.459430537	-2.627066944	-2.627066944	-1.326485099	0.669270762	645304	Heparan sulfate/heparin (HS-GAG) metabolism	1696
-0.461289144	-0.461289144	-0.461289144	-0.461289144	-0.461289144	-0.461289144	0.020886524	530771	Activation of Chaperone Genes by XBP1(S)	1572
-0.461584906	-0.461584906	-0.461584906	-0.461584906	-0.461584906	-0.461584906	0.020953568	106017	Vif-mediated degradation of APOBEC3G	420
-0.461875886	-0.461875886	-0.461875886	-0.461875886	-0.461875886	-0.461875886	0.021019697	117291	RNA degradation	769
-0.462354227	-0.462354227	-0.462354227	-0.462354227	-0.462354227	-0.462354227	0.021128767	373900	Synaptic vesicle cycle	1460
-0.462560257	-0.462560257	-0.462560257	-0.462560257	-0.462560257	-0.462560257	0.021175885	105824	CDT1 association with the CDC6:ORC:origin complex	283
-0.462939211	-0.462939211	-0.462939211	-0.462939211	-0.462939211	-0.462939211	0.02126277	106496	PLC beta mediated events	708
-0.463244916	-0.463244916	-0.463244916	-0.463244916	-0.463244916	-0.463244916	0.021333067	187212	Destabilization of mRNA by AUF1 (hnRNP D0)	1242
-0.46449396	-0.46449396	-0.46449396	1.713672323	-0.46449396	-0.028860703	0.079771556	138060	Thromboxane A2 receptor signaling	970
-0.465127722	1.705323617	1.705323617	-0.465127722	-0.465127722	0.403052814	0.292637708	105828	SCF-beta-TrCP mediated degradation of Emi1	287
-0.465145324	-0.465145324	-0.465145324	-0.465145324	3.89014797	0.405913335	0.182104534	198773	cytochrome P450	1276
-0.46529859	-4.785619756	-0.46529859	-0.46529859	-0.46529859	-1.329362823	0.224318521	119543	Sphingolipid metabolism	795
-0.465780739	-0.465780739	-2.606317226	-2.606317226	-2.606317226	-1.750102631	3.841005023	119532	Cell-cell junction organization	785
-0.466568301	-0.466568301	-0.466568301	1.69547202	-0.466568301	-0.034160237	0.080343648	187094	Interleukin-3, 5 and GM-CSF signaling	1193
-0.466885779	-0.466885779	-0.466885779	-0.466885779	-0.466885779	-0.466885779	0.022184683	105906	Activation of Chaperones by IRE1alpha	336
-0.467288846	-0.467288846	-0.467288846	-0.467288846	-0.467288846	-0.467288846	0.02228061	198885	IL-2 Signaling pathway	1384
-0.469023704	-0.469023704	-0.469023704	-0.469023704	-2.593706395	-0.893960242	0.125516257	698753	Interleukin-11 Signaling Pathway	1777
-0.470240778	-2.638248052	-2.638248052	-0.470240778	-2.638248052	-1.771045142	4.060574212	122191	NOD-like receptor signaling pathway	823
-0.471729515	1.672495553	1.672495553	-0.471729515	-0.471729515	0.385960512	0.29363586	530744	Nuclear signaling by ERBB4	1550
-0.472081025	-0.472081025	-0.472081025	-0.472081025	-0.472081025	-0.472081025	0.023446754	198857	IL-7 Signaling Pathway	1357
-0.472129994	-0.472129994	1.698083722	-0.472129994	-0.472129994	-0.038087251	0.084373383	198894	FAS pathway and Stress induction of HSP regulation	1393
-0.47236786	1.661181642	-0.47236786	-0.47236786	-0.47236786	-0.045657959	0.082706279	105771	SCF(Skp2)-mediated degradation of p27/p21	243
-0.472995496	-0.472995496	-0.472995496	-0.472995496	-0.472995496	-0.472995496	0.02367473	105996	Transcription of the HIV genome	402
-0.47396637	-0.47396637	-0.47396637	-0.47396637	-0.47396637	-0.47396637	0.023918704	106495	G-protein mediated events	707
-0.474168584	-2.573188435	-2.573188435	-0.474168584	-2.573188435	-1.733580495	3.830719268	469200	Legionellosis	1510
-0.474878354	3.749078544	-2.586856803	-2.586856803	-0.474878354	-0.474878354	5.657623788	105677	Apoptotic execution phase	187
-0.475052928	-0.475052928	-0.475052928	-0.475052928	-0.475052928	-0.475052928	0.024194129	106555	RNA Polymerase I Chain Elongation	751
-0.476747615	-0.476747615	-0.476747615	-0.476747615	-0.476747615	-0.476747615	0.024628766	169347	Notch-mediated HES/HEY network	1163
-0.476917962	-2.581586815	-0.476917962	-0.476917962	-0.476917962	-0.897851733	0.1335554	137958	Endothelins	878
-0.477087342	-0.477087342	-0.477087342	-0.477087342	-0.477087342	-0.477087342	0.024716642	105741	p53-Dependent G1/S DNA damage checkpoint	226
-0.477087342	-0.477087342	-0.477087342	-0.477087342	-0.477087342	-0.477087342	0.024716642	105743	p53-Dependent G1 DNA Damage Response	227
-0.477422165	-0.477422165	1.655354985	-0.477422165	-0.477422165	-0.050866735	0.086000594	137974	Caspase cascade in apoptosis	891
-0.477564525	-0.477564525	-0.477564525	-0.477564525	-0.477564525	-0.477564525	0.024840498	105836	Autodegradation of Cdh1 by Cdh1:APC/C	295
-0.477763977	-0.477763977	-0.477763977	-0.477763977	-0.477763977	-0.477763977	0.024892414	83121	Autoimmune thyroid disease	160
-0.478784793	-0.478784793	-0.478784793	-0.478784793	-0.478784793	-0.478784793	0.025159485	105685	Regulation of Apoptosis	193
-0.479120578	-0.479120578	-0.479120578	-0.479120578	-0.479120578	-0.479120578	0.025247834	645275	Signaling by FGFR mutants	1673
-0.480170971	-0.480170971	-0.480170971	-0.480170971	-0.480170971	-0.480170971	0.025525809	82987	Inositol phosphate metabolism	43
-0.480315942	-0.480315942	-0.480315942	-0.480315942	-0.480315942	-0.480315942	0.025564365	119546	Golgi Associated Vesicle Biogenesis	798
-0.48144673	1.603189467	1.603189467	-0.48144673	-0.48144673	0.352407749	0.286823297	105833	APC/C:Cdc20 mediated degradation of Securin	292
-0.481741723	-0.481741723	-0.481741723	-0.481741723	-0.481741723	-0.481741723	0.025946053	645332	PI Metabolism	1717
-0.482351153	-0.482351153	-0.482351153	-0.482351153	-0.482351153	-0.482351153	0.026110585	83099	Amyotrophic lateral sclerosis (ALS)	138
-0.482420481	-0.482420481	-2.540089415	-0.482420481	1.575248452	-0.482420481	0.449236753	138024	TGF-beta receptor signaling	938
-0.482651381	-0.482651381	-0.482651381	-0.482651381	-0.482651381	-0.482651381	0.026191946	547492	superpathway of inositol phosphate compounds	1621
-0.482682549	-0.482682549	-0.482682549	-0.482682549	-0.482682549	-0.482682549	0.026200404	106540	Telomere Maintenance	737
-0.483234455	-0.483234455	-0.483234455	-0.483234455	-0.483234455	-0.483234455	0.026350536	941396	Asymmetric localization of PCP proteins	2000
-0.4854594	-0.4854594	-0.4854594	-0.4854594	-0.4854594	-0.4854594	0.026962774	920993	Interferon type I	1995
-0.485475994	-0.485475994	-0.485475994	-0.485475994	-0.485475994	-0.485475994	0.026967383	366164	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1441
-0.48611874	-0.48611874	-0.48611874	-0.48611874	-0.48611874	-0.48611874	0.027146373	137977	Neurotrophic factor-mediated Trk receptor signaling	894
-0.487040505	-0.487040505	-0.487040505	-0.487040505	-0.487040505	-0.487040505	0.027404722	645313	Glycerophospholipid biosynthesis	1705
-0.487309279	-0.487309279	-0.487309279	-0.487309279	-0.487309279	-0.487309279	0.027480423	138019	p75(NTR)-mediated signaling	933
-0.487390095	-0.487390095	1.562189783	-0.487390095	-0.487390095	-0.077474119	0.088153709	905994	DNA Damage/Telomere Stress Induced Senescence	1941
-0.490685667	-0.490685667	-0.490685667	-0.490685667	-0.490685667	-0.490685667	0.028445716	105740	G1/S DNA Damage Checkpoints	225
-0.491828523	-0.491828523	-0.491828523	-0.491828523	-0.491828523	-0.491828523	0.028778527	105971	Translation initiation complex formation	379
-0.492523804	-2.532804682	-0.492523804	-0.492523804	-0.492523804	-0.900579979	0.149042662	93344	Cardiac muscle contraction	165
-0.494237148	-0.494237148	-0.494237148	-0.494237148	-0.494237148	-0.494237148	0.029490146	685554	Translocation of GLUT4 to the Plasma Membrane	1772
-0.495335603	-0.495335603	-0.495335603	-0.495335603	-0.495335603	-0.495335603	0.029819319	198789	Wnt Signaling Pathway	1292
-0.495337465	-0.495337465	-0.495337465	-0.495337465	-0.495337465	-0.495337465	0.02981988	105970	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	378
-0.495687005	-0.495687005	-0.495687005	-0.495687005	-0.495687005	-0.495687005	0.029925242	198765	GPCRs, Other	1269
-0.495977451	3.50626141	-0.495977451	3.50626141	3.50626141	1.905365865	10.60368309	213307	Endocrine and other factor-regulated calcium reabsorption	1429
-0.498764401	-0.498764401	-0.498764401	-0.498764401	-0.498764401	-0.498764401	0.030865779	105972	Ribosomal scanning and start codon recognition	380
-0.499233604	-0.499233604	-0.499233604	-0.499233604	-0.499233604	-0.499233604	0.031011234	138050	Fc-epsilon receptor I signaling in mast cells	960
-0.500450298	-0.500450298	-0.500450298	-0.500450298	-0.500450298	-0.500450298	0.031390972	105960	Transport of Mature mRNA derived from an Intron-Containing Transcript	368
-0.500694555	-0.500694555	-0.500694555	-0.500694555	-0.500694555	-0.500694555	0.031467652	198897	Peptide GPCRs	1396
-0.501970574	-0.501970574	-0.501970574	1.537316745	-0.501970574	-0.09411311	0.097605972	83066	VEGF signaling pathway	105
-0.503282727	-0.503282727	-0.503282727	-0.503282727	-0.503282727	-0.503282727	0.032289411	137922	IL12-mediated signaling events	843
-0.504516041	-0.504516041	-0.504516041	-0.504516041	-2.50974673	-0.905562179	0.162603472	218111	Pertussis	1434
-0.504570506	-0.504570506	-0.504570506	-0.504570506	-0.504570506	-0.504570506	0.032704635	83087	Olfactory transduction	126
-0.504623607	-0.504623607	-0.504623607	1.490330364	-0.504623607	-0.105632813	0.096639084	187173	Circadian Clock	1211
-0.505422553	-0.505422553	-0.505422553	-0.505422553	-0.505422553	-0.505422553	0.032981704	105821	Assembly of the pre-replicative complex	280
-0.505773173	-0.505773173	-0.505773173	-0.505773173	-0.505773173	-0.505773173	0.033096262	205242	Meiotic Recombination	1424
-0.505919906	-0.505919906	-2.496554987	-2.496554987	-0.505919906	-1.302173938	0.807100422	83103	Pathogenic Escherichia coli infection	142
-0.506225435	-0.506225435	-0.506225435	-0.506225435	1.447558567	-0.115468634	0.095063104	187104	Interferon alpha/beta signaling	1203
-0.506909914	-0.506909914	-0.506909914	-0.506909914	-0.506909914	-0.506909914	0.033469862	138071	PDGFR-beta signaling pathway	980
-0.507713679	-0.507713679	-0.507713679	-0.507713679	-0.507713679	-0.507713679	0.033736057	685551	Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	1769
-0.507994542	-0.507994542	-0.507994542	-0.507994542	-0.507994542	-0.507994542	0.033829473	169348	Signaling events mediated by focal adhesion kinase	1164
-0.508062675	-0.508062675	-0.508062675	-0.508062675	-0.508062675	-0.508062675	0.033852165	82989	Glycerophospholipid metabolism	45
-0.509233748	-0.509233748	-0.509233748	-0.509233748	-0.509233748	-0.509233748	0.03424411	198803	Translation Factors	1305
-0.510133942	-0.510133942	-0.510133942	-0.510133942	-0.510133942	-0.510133942	0.034547856	106263	Metabolism of nucleotides	563
-0.510230138	-0.510230138	-2.485569426	-2.485569426	-0.510230138	-1.300365853	0.820635158	672459	Pathogenic Escherichia coli infection	1745
-0.510433555	-0.510433555	-0.510433555	-0.510433555	-0.510433555	-0.510433555	0.034649429	117292	RIG-I-like receptor signaling pathway	770
-0.510962541	-0.510962541	-0.510962541	-0.510962541	-0.510962541	-0.510962541	0.034829346	105959	Transport of Mature Transcript to Cytoplasm	367
-0.511080321	-0.511080321	-0.511080321	-0.511080321	-0.511080321	-0.511080321	0.034869506	672447	RANKL/RANK Signaling Pathway	1733
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	576269	Signaling by NOTCH1	1644
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771587	Signaling by NOTCH1 in Cancer	1854
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771588	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1855
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771590	Signaling by NOTCH1 HD Domain Mutants in Cancer	1857
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771592	Signaling by NOTCH1 PEST Domain Mutants in Cancer	1859
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771594	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	1861
-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	-0.511275945	0.034936291	771596	FBXW7 Mutants and NOTCH1 in Cancer	1863
-0.511506078	-0.511506078	-0.511506078	-0.511506078	-0.511506078	-0.511506078	0.035014989	137976	IL2-mediated signaling events	893
-0.511951679	3.419334008	1.453691165	-0.511951679	-0.511951679	0.667434027	0.666961231	105835	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	294
-0.512995479	-2.487954012	-0.512995479	-2.487954012	-0.512995479	-1.302978892	0.835651717	137998	TCR signaling in naive CD4+ T cells	913
-0.513073588	-0.513073588	-0.513073588	-0.513073588	1.464850806	-0.117488709	0.101510748	138068	Signaling events mediated by Stem cell factor receptor (c-Kit)	977
-0.514088073	1.454466678	-0.514088073	-0.514088073	-0.514088073	-0.120377123	0.101590685	105770	Cyclin E associated events during G1/S transition	242
-0.514297775	-0.514297775	-0.514297775	-0.514297775	-0.514297775	-0.514297775	0.035981	941399	Ca2+ pathway	2003
-0.515173614	-0.515173614	-0.515173614	-0.515173614	-0.515173614	-0.515173614	0.03628842	138085	Coregulation of Androgen receptor activity	989
-0.515594687	-0.515594687	-0.515594687	-0.515594687	-0.515594687	-0.515594687	0.036436963	106165	trans-Golgi Network Vesicle Budding	509
-0.515594687	-0.515594687	-0.515594687	-0.515594687	-0.515594687	-0.515594687	0.036436963	119545	Clathrin derived vesicle budding	797
-0.515605062	-0.515605062	-2.47831942	-2.47831942	-0.515605062	-1.300690805	0.841910794	83109	Endometrial cancer	148
-0.51569315	-0.51569315	-0.51569315	-0.51569315	-0.51569315	-0.51569315	0.036471768	106443	Cell death signalling via NRAGE, NRIF and NADE	669
-0.515714886	-0.515714886	-0.515714886	-0.515714886	-0.515714886	-0.515714886	0.036479455	83119	Non-small cell lung cancer	158
-0.517412693	-0.517412693	-0.517412693	-0.517412693	-0.517412693	-0.517412693	0.037083899	106414	TCR signaling	646
-0.517838258	-2.461310797	-0.517838258	-2.461310797	5.312579358	-0.12914375	8.630314255	105699	Phase 1 - Functionalization of compounds	202
-0.518071273	-0.518071273	-2.435078759	-2.435078759	-0.518071273	-1.284874267	0.824507402	169355	RAC1 signaling pathway	1171
-0.518440975	-0.518440975	-0.518440975	-0.518440975	-0.518440975	-0.518440975	0.037453861	576251	Activation of NF-kappaB in B Cells	1627
-0.518668545	-0.518668545	-0.518668545	-2.441443504	-2.441443504	-1.287778529	0.831693084	119571	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	819
-0.519649427	-0.519649427	-0.519649427	-0.519649427	-0.519649427	-0.519649427	0.037892413	477124	ER-Phagosome pathway	1521
-0.520831922	-0.520831922	-0.520831922	-0.520831922	-0.520831922	-0.520831922	0.038325513	105921	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	342
-0.521162313	1.416604234	1.416604234	-0.521162313	-0.521162313	0.253944306	0.284063922	198844	ErbB signaling pathway	1344
-0.521772661	-0.521772661	-0.521772661	-0.521772661	-0.521772661	-0.521772661	0.038672887	160959	Phospholipase C-mediated cascade	1066
-0.523804793	1.414776974	-0.523804793	-0.523804793	-0.523804793	-0.13608844	0.106503985	105783	Cyclin A:Cdk2-associated events at S phase entry	250
-0.524050274	-0.524050274	-0.524050274	-0.524050274	-0.524050274	-0.524050274	0.039524352	105786	Switching of origins to a post-replicative state	253
-0.524050274	-0.524050274	-0.524050274	-0.524050274	-0.524050274	-0.524050274	0.039524352	105787	Orc1 removal from chromatin	254
-0.525370709	-0.525370709	-2.449100879	3.322089631	-2.449100879	-0.525370709	5.499920434	366221	Potassium Channels	1447
-0.528671797	-0.528671797	-0.528671797	-0.528671797	-0.528671797	-0.528671797	0.041298161	105901	Removal of licensing factors from origins	332
-0.529016248	-0.529016248	-0.529016248	-0.529016248	-0.529016248	-0.529016248	0.041432874	106378	Class B/2 (Secretin family receptors)	616
-0.529749809	-0.529749809	-0.529749809	-0.529749809	-0.529749809	-0.529749809	0.041720936	137953	Role of Calcineurin-dependent NFAT signaling in lymphocytes	873
-0.529968054	-2.39081094	-2.39081094	-2.39081094	-0.529968054	-1.646473786	3.838266156	219802	SREBP signalling	1436
-0.532385809	-0.532385809	-0.532385809	-0.532385809	-0.532385809	-0.532385809	0.042769321	137928	LPA receptor mediated events	849
-0.532755039	-0.532755039	-0.532755039	-0.532755039	1.383974729	-0.149409085	0.111490644	131226	Peroxisome	830
-0.533783087	-0.533783087	-2.420275709	-0.533783087	-0.533783087	-0.911081612	0.196482592	700638	Parkin-Ubiquitin Proteasomal System pathway	1784
-0.534045987	-0.534045987	-0.534045987	-0.534045987	-0.534045987	-0.534045987	0.043440346	82946	Pyrimidine metabolism	18
-0.53457946	-0.53457946	-0.53457946	-0.53457946	-0.53457946	-0.53457946	0.043657749	106511	Degradation of beta-catenin by the destruction complex	720
-0.534696989	-0.534696989	-0.534696989	-0.534696989	-0.534696989	-0.534696989	0.043705762	83117	Acute myeloid leukemia	156
-0.535438895	1.364628157	-0.535438895	-0.535438895	-0.535438895	-0.155425485	0.11216413	138067	p53 pathway	976
-0.536093398	-0.536093398	-0.536093398	-0.536093398	-2.423746207	-0.91362396	0.200193041	198871	Id Signaling Pathway	1370
-0.537146847	-0.537146847	-0.537146847	-0.537146847	1.323101975	-0.165097083	0.110145166	83106	Colorectal cancer	145
-0.537592397	-2.399061918	-0.537592397	-0.537592397	1.323877123	-0.537592397	0.493456063	547607	Amphetamine addiction	1622
-0.537709023	-0.537709023	-0.537709023	-0.537709023	-0.537709023	-0.537709023	0.044950717	198786	Proteasome Degradation	1289
-0.539221407	-0.539221407	-0.539221407	-0.539221407	-0.539221407	-0.539221407	0.045586435	119559	Transport of inorganic cations/anions and amino acids/oligopeptides	811
-0.539596553	-0.539596553	-0.539596553	-0.539596553	-0.539596553	-0.539596553	0.045745232	105899	Regulation of DNA replication	330
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	106504	Signaling by TGF-beta Receptor Complex	715
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906016	Signaling by TGF-beta Receptor Complex in Cancer	1963
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906017	Loss of Function of SMAD4 in Cancer	1964
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906018	SMAD4 MH2 Domain Mutants in Cancer	1965
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906019	Loss of Function of SMAD2/3 in Cancer	1966
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906020	SMAD2/3 Phosphorylation Motif Mutants in Cancer	1967
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906021	SMAD2/3 MH2 Domain Mutants in Cancer	1968
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906022	Loss of Function of TGFBR2 in Cancer	1969
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906023	TGFBR2 MSI Frameshift Mutants in Cancer	1970
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906024	TGFBR2 Kinase Domain Mutants in Cancer	1971
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906025	Loss of Function of TGFBR1 in Cancer	1972
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906026	TGFBR1 LBD Mutants in Cancer	1973
-0.5407883	-0.5407883	-0.5407883	-0.5407883	1.32593003	-0.167444634	0.113404361	906027	TGFBR1 KD Mutants in Cancer	1974
-0.542760109	-0.542760109	-0.542760109	-0.542760109	-0.542760109	-0.542760109	0.047102028	138027	Regulation of Androgen receptor activity	940
-0.542954519	-0.542954519	-0.542954519	-0.542954519	-0.542954519	-0.542954519	0.047186445	106551	RNA Polymerase I Promoter Clearance	747
-0.543086512	-0.543086512	1.285795496	-0.543086512	-0.543086512	-0.177310111	0.111853085	137934	E2F transcription factor network	855
-0.545720088	-0.545720088	1.307948689	-0.545720088	-2.399388865	-0.545720088	0.510036395	119519	Semaphorin interactions	773
-0.545746503	-0.545746503	-0.545746503	-0.545746503	-0.545746503	-0.545746503	0.048412199	83093	Adipocytokine signaling pathway	132
-0.54620119	-2.385572092	-0.54620119	-0.54620119	-0.54620119	-0.91407537	0.212325968	83081	B cell receptor signaling pathway	120
-0.546372916	-0.546372916	-0.546372916	-0.546372916	-0.546372916	-0.546372916	0.048690677	83082	Fc epsilon RI signaling pathway	121
-0.546851942	-2.394324719	-0.546851942	-0.546851942	-2.394324719	-1.285841053	0.937508846	138001	mTOR signaling pathway	916
-0.547312001	-0.547312001	-0.547312001	-0.547312001	-0.547312001	-0.547312001	0.049110557	119552	Costimulation by the CD28 family	804
-0.548719755	-0.548719755	-0.548719755	-0.548719755	-0.548719755	-0.548719755	0.049745406	198760	IL-4 signaling Pathway	1264
-0.548746634	-2.376683456	-0.548746634	-0.548746634	-2.376683456	-1.279921363	0.933379578	138045	HIF-1-alpha transcription factor network	955
-0.549040286	-0.549040286	-0.549040286	-0.549040286	-0.549040286	-0.549040286	0.049890868	106041	G alpha (12/13) signalling events	432
-0.550618972	-0.550618972	-0.550618972	-0.550618972	-0.550618972	-0.550618972	0.050612275	106427	PI3K Cascade	658
-0.551352521	-0.551352521	-0.551352521	1.302556428	-0.551352521	-0.180570732	0.120368821	83102	Epithelial cell signaling in Helicobacter pylori infection	141
-0.552523651	-0.552523651	-0.552523651	-0.552523651	-0.552523651	-0.552523651	0.051493732	106550	RNA Polymerase I Transcription	746
-0.552743979	-0.552743979	-0.552743979	-2.365019318	-0.552743979	-0.915199046	0.22076528	377263	GABAergic synapse	1464
-0.55324614	-0.55324614	-0.55324614	-0.55324614	-0.55324614	-0.55324614	0.051831283	83085	Long-term potentiation	124
-0.553305297	-0.553305297	-0.553305297	-0.553305297	1.250460952	-0.192552047	0.117200495	198826	Kit Receptor Signaling Pathway	1327
-0.554388601	-0.554388601	-0.554388601	-0.554388601	-0.554388601	-0.554388601	0.05236866	125138	Viral myocarditis	826
-0.554418723	-0.554418723	-0.554418723	-0.554418723	-0.554418723	-0.554418723	0.052382888	105820	M/G1 Transition	279
-0.554418723	-0.554418723	-0.554418723	-0.554418723	-0.554418723	-0.554418723	0.052382888	105898	DNA Replication Pre-Initiation	329
-0.555007062	-0.555007062	-0.555007062	-0.555007062	-0.555007062	-0.555007062	0.052661417	530760	Antiviral mechanism by IFN-stimulated genes	1563
-0.555007062	-0.555007062	-0.555007062	-0.555007062	-0.555007062	-0.555007062	0.052661417	530761	ISG15 antiviral mechanism	1564
-0.556892153	-0.556892153	-0.556892153	-0.556892153	-0.556892153	-0.556892153	0.053561841	83104	Shigellosis	143
-0.55807236	-0.55807236	-0.55807236	-0.55807236	-0.55807236	-0.55807236	0.054131813	144181	Leishmaniasis	1032
-0.560383398	-0.560383398	-2.351604104	-0.560383398	-0.560383398	-0.918627539	0.231902404	169353	Validated targets of C-MYC transcriptional repression	1169
-0.560567315	-0.560567315	-0.560567315	-0.560567315	-0.560567315	-0.560567315	0.055352706	138058	BCR signaling pathway	968
-0.561175173	-2.348641882	-0.561175173	-0.561175173	-0.561175173	-0.918668515	0.232922047	198860	Electron Transport Chain	1360
-0.562977516	-0.562977516	-0.562977516	-0.562977516	-0.562977516	-0.562977516	0.056552948	161013	Asparagine N-linked glycosylation	1106
-0.564029894	-2.360017456	-2.360017456	-0.564029894	-2.360017456	-1.641622431	4.181671288	711361	Oncostatin M Signaling Pathway	1788
-0.566901585	-0.566901585	-0.566901585	-0.566901585	-0.566901585	-0.566901585	0.058551545	375172	Salmonella infection	1462
-0.57025917	-0.57025917	-0.57025917	-0.57025917	-0.57025917	-0.57025917	0.06030612	83110	Glioma	149
-0.570539673	-0.570539673	-0.570539673	-0.570539673	-0.570539673	-0.570539673	0.060454585	198770	IL-5 Signaling Pathway	1273
-0.572141549	-0.572141549	-2.326638786	-2.326638786	-0.572141549	-1.273940444	1.01383759	83114	Melanoma	153
-0.573368994	-0.573368994	-0.573368994	-0.573368994	-0.573368994	-0.573368994	0.061968505	193328	mRNA surveillance pathway	1257
-0.575115303	-0.575115303	-0.575115303	-0.575115303	1.170038097	-0.226084623	0.128002867	83108	Pancreatic cancer	147
-0.576576426	-0.576576426	-0.576576426	-0.576576426	-0.576576426	-0.576576426	0.063721268	477122	Antigen processing-Cross presentation	1519
-0.576705736	-0.576705736	-0.576705736	-0.576705736	-0.576705736	-0.576705736	0.063792755	83052	Phosphatidylinositol signaling system	91
-0.577470586	-0.577470586	-0.577470586	1.172970717	-0.577470586	-0.227382325	0.130438754	187198	Platelet homeostasis	1230
-0.579635688	-0.579635688	-0.579635688	-0.579635688	-0.579635688	-0.579635688	0.065429799	83107	Renal cell carcinoma	146
-0.579881586	-0.579881586	-0.579881586	-0.579881586	-0.579881586	-0.579881586	0.065568703	672446	TSH signaling pathway	1732
-0.581092372	-0.581092372	-0.581092372	1.175535114	-0.581092372	-0.229766875	0.13403441	137940	Signaling events mediated by VEGFR1 and VEGFR2	861
-0.582581494	-4.037475456	-4.037475456	-4.037475456	-4.037475456	-3.346496664	154.8090217	905996	Senescence-Associated Secretory Phenotype (SASP)	1943
-0.583391213	-0.583391213	-0.583391213	-0.583391213	-0.583391213	-0.583391213	0.067577079	771579	Regulation of actin dynamics for phagocytic cup formation	1847
-0.583645004	-2.320425258	-2.320425258	-2.320425258	-0.583645004	-1.625713157	4.255987049	106413	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	645
-0.588146468	-0.588146468	1.136117584	-0.588146468	-0.588146468	-0.243293658	0.135945631	137987	Regulation of Telomerase	902
-0.588456068	-2.302572201	-2.302572201	-0.588456068	-2.302572201	-1.616925748	4.227346653	105904	Unfolded Protein Response	334
-0.590435793	-0.590435793	-0.590435793	-0.590435793	-0.590435793	-0.590435793	0.071756854	137910	CXCR4-mediated signaling events	831
-0.592866222	-0.592866222	-2.321843246	-2.321843246	-0.592866222	-1.284457032	1.123403866	137930	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	851
-0.594470048	-0.594470048	-0.594470048	-0.594470048	1.089342579	-0.257707523	0.136045566	83116	Chronic myeloid leukemia	155
-0.594868167	-4.03838867	-4.03838867	-0.594868167	-4.03838867	-2.660980468	23.30589592	200309	Rheumatoid arthritis	1419
-0.595804122	-0.595804122	-0.595804122	-0.595804122	-0.595804122	-0.595804122	0.075078833	672456	Leptin signaling pathway	1742
-0.596705708	-2.285893842	-2.285893842	-5.664270108	-3.975081975	-2.961569095	70.20407991	771581	Diseases associated with visual transduction	1849
-0.596705708	-2.285893842	-2.285893842	-5.664270108	-3.975081975	-2.961569095	70.20407991	771584	Visual phototransduction	1851
-0.597137535	-0.597137535	-0.597137535	-0.597137535	-0.597137535	-0.597137535	0.075922737	106441	p75 NTR receptor-mediated signalling	668
-0.597713014	-0.597713014	-0.597713014	-0.597713014	-0.597713014	-0.597713014	0.076289287	106426	IRS-mediated signalling	657
-0.597886636	-0.597886636	-0.597886636	-0.597886636	-0.597886636	-0.597886636	0.076400154	941395	PCP/CE pathway	1999
-0.601916138	-0.601916138	-0.601916138	-2.258946112	-0.601916138	-0.933322133	0.296517152	153376	Salivary secretion	1039
-0.602001047	-0.602001047	-0.602001047	-0.602001047	-0.602001047	-0.602001047	0.079065356	106493	Opioid Signalling	705
-0.602472914	-0.602472914	-0.602472914	-0.602472914	-0.602472914	-0.602472914	0.079375712	552665	Morphine addiction	1623
-0.604905723	-2.279385232	-0.604905723	-0.604905723	-2.279385232	-1.274697526	1.150001851	198822	Apoptosis Modulation and Signaling	1323
-0.605080439	-0.605080439	-0.605080439	-0.605080439	-0.605080439	-0.605080439	0.08110835	114228	Fc gamma R-mediated phagocytosis	767
-0.605329693	-0.605329693	-0.605329693	-0.605329693	-0.605329693	-0.605329693	0.081275545	105784	Synthesis of DNA	251
-0.60622683	-0.60622683	-0.60622683	-0.60622683	-0.60622683	-0.60622683	0.08187961	634527	NF-kappa B signaling pathway	1659
-0.606483827	-0.606483827	-0.606483827	-0.606483827	-0.606483827	-0.606483827	0.082053313	537443	Retrograde endocannabinoid signaling	1574
-0.606566712	-0.606566712	-0.606566712	-0.606566712	-0.606566712	-0.606566712	0.082109397	187106	Interferon gamma signaling	1205
-0.610047449	-0.610047449	-2.27684376	-0.610047449	-3.94364007	-1.610125236	2.038549904	117293	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	771
-0.610047449	-0.610047449	-2.27684376	-0.610047449	-3.94364007	-1.610125236	2.038549904	672454	Arrhythmogenic right ventricular cardiomyopathy	1740
-0.610919986	-0.610919986	-2.26832635	-0.610919986	-0.610919986	-0.942401259	0.315967832	83074	Antigen processing and presentation	113
-0.613810167	-0.613810167	-0.613810167	-0.613810167	-0.613810167	-0.613810167	0.087130536	672462	Prolactin Signaling Pathway	1748
-0.614416559	-0.614416559	-0.614416559	-0.614416559	-0.614416559	-0.614416559	0.087561775	83060	Apoptosis	99
-0.616155745	-0.616155745	-2.261870875	-2.261870875	-0.616155745	-1.274441797	1.19676016	137994	CDC42 signaling events	909
-0.619592782	-0.619592782	-0.619592782	-0.619592782	-0.619592782	-0.619592782	0.091312819	730348	IRS-related events triggered by IGF1R	1823
-0.620565656	-0.620565656	-0.620565656	-0.620565656	-0.620565656	-0.620565656	0.092031962	114229	Hypertrophic cardiomyopathy (HCM)	768
-0.620570549	-0.620570549	-2.254295833	-2.254295833	-0.620570549	-1.274060663	1.214493793	169352	Regulation of Wnt-mediated beta catenin signaling and target gene transcription	1168
-0.621693184	-2.249588403	-0.621693184	-0.621693184	-0.621693184	-0.947272228	0.336052777	82942	Oxidative phosphorylation	16
-0.62342866	-0.62342866	-0.62342866	-0.62342866	-0.62342866	-0.62342866	0.094174607	187211	Regulation of mRNA Stability by Proteins that Bind AU-rich Elements	1241
-0.625748758	-0.625748758	-0.625748758	-0.625748758	-0.625748758	-0.625748758	0.095940059	730345	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	1820
-0.625748758	-0.625748758	-0.625748758	-0.625748758	-0.625748758	-0.625748758	0.095940059	730346	IGF1R signaling cascade	1821
-0.625806165	-0.625806165	-0.625806165	-0.625806165	-0.625806165	-0.625806165	0.095984076	105897	DNA Replication	328
-0.631554343	0.960064465	0.960064465	-0.631554343	-0.631554343	0.00509318	0.232184363	83049	ErbB signaling pathway	88
-0.633192117	0.944463588	-0.633192117	-0.633192117	-0.633192117	-0.317660976	0.151819381	198784	MicroRNAs in cardiomyocyte hypertrophy	1287
-0.638415564	-0.638415564	-0.638415564	-0.638415564	-0.638415564	-0.638415564	0.106051625	105978	Eukaryotic Translation Termination	385
-0.640055321	-0.640055321	-0.640055321	-0.640055321	-0.640055321	-0.640055321	0.107420597	106557	RNA Polymerase II Transcription	753
-0.642889488	-0.642889488	-0.642889488	-0.642889488	-0.642889488	-0.642889488	0.109820046	106077	Viral mRNA Translation	460
-0.643241344	-0.643241344	-0.643241344	-0.643241344	0.937204218	-0.327152231	0.160446422	83092	Melanogenesis	131
-0.644752156	0.916769171	0.916769171	-0.644752156	0.916769171	0.29216064	0.320306393	685535	Constitutive PI3K/AKT Signaling in Cancer	1753
-0.644971232	-0.644971232	-0.644971232	-0.644971232	-0.644971232	-0.644971232	0.111609643	105977	Peptide chain elongation	384
-0.646605539	-0.646605539	-2.195175863	2.45053511	-2.195175863	-0.646605539	4.937173713	920957	Corticotropin-releasing hormone	1983
-0.647059642	-0.647059642	-5.343839039	0.918533491	-0.647059642	-1.273296895	1.329784612	83078	Hematopoietic cell lineage	117
-0.649138006	-0.649138006	-2.196362429	-0.649138006	-0.649138006	-0.958582891	0.389988819	477137	The citric acid (TCA) cycle and respiratory electron transport	1533
-0.649717171	2.465685233	-0.649717171	4.023386435	-0.649717171	0.907984031	2.720836319	198879	Delta-Notch Signaling Pathway	1378
-0.650367321	-2.197939768	-0.650367321	-0.650367321	0.897205126	-0.650367321	0.542479919	525336	Serotonergic synapse	1539
-0.651873544	-0.651873544	-0.651873544	-0.651873544	-0.651873544	-0.651873544	0.117710927	948277	Inflammatory mediator regulation of TRP channels	2010
-0.652559014	-0.652559014	-0.652559014	-0.652559014	-0.652559014	-0.652559014	0.118331118	198853	Cytoplasmic Ribosomal Proteins	1353
-0.653359776	-0.653359776	-2.19612194	-0.653359776	-2.19612194	-1.270464642	1.34514804	83072	Gap junction	111
-0.654708608	-0.654708608	-0.654708608	-0.654708608	-0.654708608	-0.654708608	0.120292972	905993	Oxidative Stress Induced Senescence	1940
-0.654878001	-0.654878001	-0.654878001	-0.654878001	-0.654878001	-0.654878001	0.12044867	198849	G Protein Signaling Pathways	1349
-0.655081295	-0.655081295	-0.655081295	-0.655081295	-0.655081295	-0.655081295	0.120635741	198827	DNA damage response (only ATM dependent)	1328
-0.658656404	-0.658656404	-0.658656404	-0.658656404	-0.658656404	-0.658656404	0.123963718	366242	Nonsense Mediated Decay Independent of the Exon Junction Complex	1458
-0.658895146	-0.658895146	-0.658895146	-0.658895146	-0.658895146	-0.658895146	0.124188546	672458	Signaling Pathways in Glioblastoma	1744
-0.661118005	-0.661118005	-0.661118005	-0.661118005	-0.661118005	-0.661118005	0.12629755	105976	Eukaryotic Translation Elongation	383
-0.662722756	-0.662722756	-0.662722756	-0.662722756	-0.662722756	-0.662722756	0.127837838	198806	Androgen receptor signaling pathway	1308
-0.662773188	-0.662773188	-0.662773188	-0.662773188	-0.662773188	-0.662773188	0.127886487	121494	Dilated cardiomyopathy	822
-0.663077257	0.853914866	0.853914866	-0.663077257	0.853914866	0.247118017	0.273761258	160961	PI-3K cascade	1068
-0.663077257	0.853914866	0.853914866	-0.663077257	0.853914866	0.247118017	0.273761258	366239	PIP3 activates AKT signaling	1455
-0.663077257	0.853914866	0.853914866	-0.663077257	0.853914866	0.247118017	0.273761258	530737	PI3K events in ERBB2 signaling	1544
-0.663077257	0.853914866	0.853914866	-0.663077257	0.853914866	0.247118017	0.273761258	530743	PI3K events in ERBB4 signaling	1549
-0.663077257	0.853914866	0.853914866	-0.663077257	0.853914866	0.247118017	0.273761258	685534	PI3K/AKT Signaling in Cancer	1752
-0.665436069	-0.665436069	-2.204194467	-2.204194467	0.873322329	-0.973187749	1.878828137	83070	Adherens junction	109
-0.666940629	-2.188767506	-0.666940629	-0.666940629	-0.666940629	-0.971306004	0.433060259	83098	Parkinson"s disease	137
-0.668054834	0.837929914	0.837929914	-0.668054834	0.837929914	0.235536015	0.262571332	106474	PI3K/AKT activation	695
-0.669185177	-0.669185177	-0.669185177	-0.669185177	-0.669185177	-0.669185177	0.134193525	106485	Signaling by NOTCH	704
-0.670388024	-0.670388024	-0.670388024	-0.670388024	-0.670388024	-0.670388024	0.13540392	119549	G alpha (s) signalling events	801
-0.670968762	-2.18403396	-0.670968762	-2.18403396	-0.670968762	-1.276194841	1.440872915	83080	T cell receptor signaling pathway	119
-0.672056884	-0.672056884	-0.672056884	-0.672056884	-0.672056884	-0.672056884	0.137097701	217716	Cholinergic synapse	1433
-0.672597232	-0.672597232	-0.672597232	-0.672597232	-0.672597232	-0.672597232	0.137649734	198847	Wnt Signaling Pathway and Pluripotency	1347
-0.673360081	-0.673360081	-0.673360081	-0.673360081	-0.673360081	-0.673360081	0.138432108	106502	Signaling by Rho GTPases	713
-0.673360081	-0.673360081	-0.673360081	-0.673360081	-0.673360081	-0.673360081	0.138432108	106503	Rho GTPase cycle	714
-0.674378967	-0.674378967	-0.674378967	-0.674378967	-0.674378967	-0.674378967	0.139482616	105968	Formation of a pool of free 40S subunits	376
-0.674600737	0.819697053	0.819697053	-0.674600737	0.819697053	0.221977937	0.25064194	106341	GAB1 signalosome	586
-0.674613491	-0.674613491	-0.674613491	-0.674613491	-0.674613491	-0.674613491	0.139725319	771577	Fcgamma receptor (FCGR) dependent phagocytosis	1845
-0.679543932	-0.679543932	-0.679543932	-0.679543932	-0.679543932	-0.679543932	0.144906443	160948	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1055
-0.681986025	-2.169090309	-2.169090309	-0.681986025	-0.681986025	-1.276827739	1.492387813	147809	Chagas disease (American trypanosomiasis)	1035
-0.682027132	-0.682027132	-0.682027132	-0.682027132	-0.682027132	-0.682027132	0.14757346	645312	Phospholipid metabolism	1704
-0.682260283	-0.682260283	-0.682260283	-0.682260283	-0.682260283	-0.682260283	0.147825872	105995	Late Phase of HIV Life Cycle	401
-0.684507275	-0.684507275	-0.684507275	-0.684507275	-0.684507275	-0.684507275	0.150276247	83091	GnRH signaling pathway	130
-0.685024984	-0.685024984	-0.685024984	-0.685024984	-0.685024984	-0.685024984	0.150845394	213818	Glutamatergic synapse	1431
-0.685246255	-3.624640376	-3.624640376	-0.685246255	-2.154943315	-2.154943315	13.294103	812256	TNF signaling pathway	1888
-0.686358058	-0.686358058	-0.686358058	-0.686358058	-0.686358058	-0.686358058	0.152318861	198864	IL-6 Signaling Pathway	1364
-0.690596078	0.779539267	3.719809957	-0.690596078	-0.690596078	0.485512198	0.955060914	83065	Axon guidance	104
-0.691234954	-0.691234954	-0.691234954	-0.691234954	-0.691234954	-0.691234954	0.157807797	198881	IL-3 Signaling Pathway	1380
-0.70183988	0.755317558	-0.70183988	-0.70183988	-0.70183988	-0.410408392	0.183265935	105782	S Phase	249
-0.702567735	-0.702567735	-0.702567735	-0.702567735	-3.592603669	-1.280574922	0.875310453	96530	Vascular smooth muscle contraction	166
-0.704184578	-0.704184578	-0.704184578	-0.704184578	-2.152379084	-0.993823479	0.529254796	83083	Leukocyte transendothelial migration	122
-0.705910981	-0.705910981	-2.125683671	0.713861708	-0.705910981	-0.705910981	0.533780294	799177	Estrogen signaling pathway	1887
-0.707043653	-2.126667493	-0.707043653	-0.707043653	-0.707043653	-0.990968421	0.531477038	173973	Hepatitis C	1178
-0.707761044	-0.707761044	-0.707761044	-0.707761044	-0.707761044	-0.707761044	0.177596039	106074	Influenza Viral RNA Transcription and Replication	457
-0.708700358	-0.708700358	-0.708700358	-0.708700358	-0.708700358	-0.708700358	0.178777665	530746	SRP-dependent cotranslational protein targeting to membrane	1552
-0.709242667	-0.709242667	-0.709242667	-0.709242667	-0.709242667	-0.709242667	0.17946273	83036	Ribosome	75
-0.711573949	-0.711573949	-0.711573949	-0.711573949	-0.711573949	-0.711573949	0.182431656	366240	Nonsense-Mediated Decay	1456
-0.711573949	-0.711573949	-0.711573949	-0.711573949	-0.711573949	-0.711573949	0.182431656	366241	Nonsense Mediated Decay Enhanced by the Exon Junction Complex	1457
-0.712575071	-0.712575071	-0.712575071	-0.712575071	-0.712575071	-0.712575071	0.183718599	160955	L13a-mediated translational silencing of Ceruloplasmin expression	1062
-0.716747898	-0.716747898	-0.716747898	-0.716747898	-0.716747898	-0.716747898	0.189161235	125136	Spliceosome	824
-0.718122932	-0.718122932	-2.115385179	-0.718122932	-0.718122932	-0.997575381	0.562580453	213306	Measles	1428
-0.718956313	0.692699514	0.692699514	-0.718956313	0.692699514	0.128037184	0.171806524	833829	Role of LAT2/NTAL/LAB on calcium mobilization	1918
-0.720301752	-0.720301752	-0.720301752	0.683795231	-0.720301752	-0.439482356	0.184070399	138057	ErbB1 downstream signaling	967
-0.722800942	-0.722800942	-0.722800942	-0.722800942	-0.722800942	-0.722800942	0.197284766	105984	HIV Life Cycle	391
-0.723978073	-0.723978073	-0.723978073	-0.723978073	-0.723978073	-0.723978073	0.198896466	83079	Natural killer cell mediated cytotoxicity	118
-0.724881911	-0.724881911	0.669523997	-0.724881911	-0.724881911	-0.44600073	0.184856701	105951	mRNA Splicing	363
-0.724881911	-0.724881911	0.669523997	-0.724881911	-0.724881911	-0.44600073	0.184856701	105952	mRNA Splicing - Major Pathway	364
-0.727860505	-0.727860505	-2.127323117	-2.127323117	-0.727860505	-1.28764555	1.745064089	198799	Wnt Signaling Pathway NetPath	1301
-0.730738317	-0.730738317	-0.730738317	-0.730738317	-0.730738317	-0.730738317	0.208357627	105973	GTP hydrolysis and joining of the 60S ribosomal subunit	381
-0.731118449	-0.731118449	-0.731118449	-0.731118449	-0.731118449	-0.731118449	0.208900132	99052	Lysosome	168
-0.732486691	-0.732486691	-0.732486691	0.653092976	-0.732486691	-0.455370757	0.188006976	160140	Signaling by Interleukins	1048
-0.737179033	-0.737179033	-2.098418131	-0.737179033	-2.098418131	-1.281674673	1.764017886	83071	Tight junction	110
-0.741488934	-0.741488934	-0.741488934	-0.741488934	-0.741488934	-0.741488934	0.224142066	82944	Purine metabolism	17
-0.746502248	-0.746502248	-0.746502248	-0.746502248	-0.746502248	-0.746502248	0.231822507	101143	Neurotrophin signaling pathway	170
-0.747795645	-0.747795645	-0.747795645	-0.747795645	-0.747795645	-0.747795645	0.233837768	105966	Eukaryotic Translation Initiation	374
-0.747795645	-0.747795645	-0.747795645	-0.747795645	-0.747795645	-0.747795645	0.233837768	105967	Cap-dependent Translation Initiation	375
-0.749779726	-2.105252428	-0.749779726	-0.749779726	0.605692977	-0.749779726	0.537474412	469199	Dopaminergic synapse	1509
-0.755925419	1.910478176	0.577276378	-0.755925419	-0.755925419	0.043995659	0.476390088	83056	Ubiquitin mediated proteolysis	95
-0.757305116	-0.757305116	-0.757305116	-0.757305116	-0.757305116	-0.757305116	0.249088945	83061	Wnt signaling pathway	100
-0.759102806	-0.759102806	-0.759102806	-0.759102806	-0.759102806	-0.759102806	0.25205945	106010	Host Interactions of HIV factors	414
-0.765069118	-0.765069118	-2.093198825	-0.765069118	-2.093198825	-1.296321	1.962108323	106534	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell	732
-0.77037518	-0.77037518	-0.77037518	-0.77037518	-0.77037518	-0.77037518	0.271338494	941394	beta-catenin independent WNT signaling	1998
-0.772777706	-0.772777706	-2.09184864	-3.410919573	-3.410919573	-2.09184864	14.53390727	83069	Cell adhesion molecules (CAMs)	108
-0.781599316	-0.781599316	-0.781599316	0.501709634	-2.064908265	-0.781599316	0.494658771	83077	Jak-STAT signaling pathway	116
-0.782590812	-0.782590812	-3.383424351	0.517825958	-0.782590812	-1.042674166	0.839739384	137939	Direct p53 effectors	860
-0.783834058	-0.783834058	0.488314052	-0.783834058	-0.783834058	-0.529404436	0.18432988	198843	mRNA processing	1343
-0.784586128	-0.784586128	-0.784586128	-0.784586128	-0.784586128	-0.784586128	0.297305626	177876	RNA transport	1179
-0.784704258	-0.784704258	-0.784704258	0.512971048	0.512971048	-0.265634135	0.127146303	946598	Thyroid hormone signaling pathway	2009
-0.788160615	-0.788160615	-0.788160615	-0.788160615	-0.788160615	-0.788160615	0.304140072	694606	Hepatitis B	1775
-0.797819305	0.476041952	0.476041952	-0.797819305	0.476041952	-0.033502551	0.068666477	477120	Signaling by SCF-KIT	1517
-0.802022523	-0.802022523	-3.3247009	-0.802022523	2.981995043	-0.549754685	5.114688538	749777	Hippo signaling pathway	1827
-0.803074972	-0.803074972	-0.803074972	-0.803074972	-0.803074972	-0.803074972	0.334026142	908257	Adrenergic signaling in cardiomyocytes	1981
-0.805426619	-0.805426619	-2.076517313	-2.076517313	-0.805426619	-1.313862897	2.252937006	161012	Post-translational protein modification	1105
-0.807527352	-0.807527352	0.442321513	-0.807527352	0.442321513	-0.307587806	0.10302624	106169	Metabolism of amino acids and derivatives	510
-0.815286496	0.437747387	0.437747387	-0.815286496	0.437747387	-0.063466166	0.055755946	160957	Downstream signaling of activated FGFR	1064
-0.817063563	-0.817063563	0.428080544	-0.817063563	-0.817063563	-0.568034742	0.190787038	160950	Processing of Capped Intron-Containing Pre-mRNA	1057
-0.8201446	-0.8201446	-3.29008768	-0.8201446	-0.8201446	-1.314133216	1.488569755	153910	Phagosome	1040
-0.82190634	-0.82190634	-0.82190634	-0.82190634	-0.82190634	-0.82190634	0.375069415	106068	Influenza Life Cycle	451
-0.823892671	-3.293039807	-2.058466239	-3.293039807	-3.293039807	-2.552295666	60.56271408	905991	Cellular Senescence	1938
-0.828103446	-0.828103446	-2.067964871	-0.828103446	-0.828103446	-1.076075731	0.972481895	167325	Protein processing in endoplasmic reticulum	1158
-0.838183148	-0.838183148	-0.838183148	-0.838183148	-0.838183148	-0.838183148	0.413708671	106067	Influenza Infection	450
-0.838227093	0.373083735	0.373083735	-0.838227093	0.373083735	-0.111440596	0.036487351	106343	Signaling by FGFR	588
-0.842552719	-0.842552719	-0.842552719	-0.842552719	-0.842552719	-0.842552719	0.424605312	105965	Translation	373
-0.84262096	0.367954372	0.367954372	-0.84262096	0.367954372	-0.116275761	0.035370925	530741	Signaling by ERBB4	1547
-0.842982283	1.567777088	-2.048361969	-2.048361969	-0.842982283	-0.842982283	4.674494095	105648	Apoptosis	174
-0.845135094	0.337533663	-0.845135094	-0.845135094	-2.027803852	-0.845135094	0.413163022	198886	GPCRs, Class A Rhodopsin-like	1385
-0.848568025	-0.848568025	-2.036955428	-2.036955428	0.339819378	-1.086245506	1.015276932	219801	Integrated Breast Cancer Pathway	1435
-0.848880083	0.339861106	-2.037621272	0.339861106	-2.037621272	-0.848880083	0.407095412	106160	Membrane Trafficking	504
-0.851215564	0.345152059	0.345152059	-0.851215564	0.345152059	-0.13339499	0.029792745	530734	Signaling by ERBB2	1541
-0.851410144	0.345146871	0.345146871	-0.851410144	0.345146871	-0.133475935	0.029805023	685550	DAP12 signaling	1768
-0.852011674	0.343710274	0.343710274	-0.852011674	0.343710274	-0.134578505	0.029476006	106385	Downstream signal transduction	622
-0.853958231	-0.853958231	0.34063956	-2.048556023	0.34063956	-0.615038673	0.173344981	576250	Downstream Signaling Events Of B Cell Receptor (BCR)	1626
-0.859756497	-0.859756497	-0.859756497	-0.859756497	-0.859756497	-0.859756497	0.469761403	213780	Tuberculosis	1430
-0.864758909	-0.864758909	-0.864758909	-0.864758909	0.295757643	-0.632655598	0.165392631	187103	Interferon Signaling	1202
-0.866417362	-0.866417362	-4.303672168	-2.012168964	1.425085843	-1.324718002	9.264008517	852705	MicroRNAs in cancer	1931
-0.866794773	-0.866794773	-0.866794773	-0.866794773	-0.866794773	-0.866794773	0.489306989	106510	Signaling by Wnt	719
-0.874220621	-2.034279831	-0.874220621	-0.874220621	-0.874220621	-1.106232463	1.188214583	198774	TGF-beta Receptor Signaling Pathway	1277
-0.87786866	-0.87786866	-2.013753579	-0.87786866	-2.013753579	-1.332222627	2.743476754	377873	Herpes simplex infection	1465
-0.886134742	0.261336598	0.261336598	-0.886134742	0.261336598	-0.197651938	0.01401523	645274	Signaling by FGFR in disease	1672
-0.887590663	-2.013546091	-2.013546091	-2.013546091	-2.013546091	-1.788355005	14.59012544	106516	Transmission across Chemical Synapses	723
-0.888354836	0.258501394	0.258501394	-0.888354836	0.258501394	-0.200241098	0.013632064	685549	DAP12 interactions	1767
-0.893959383	-0.893959383	-0.893959383	-2.035815792	-2.035815792	-1.350701947	2.960944856	119558	SLC-mediated transmembrane transport	810
-0.898240966	0.235901668	0.235901668	-0.898240966	0.235901668	-0.217755386	0.010592019	106337	Signaling by EGFR	582
-0.905038419	0.2211215	0.2211215	-0.905038419	0.2211215	-0.229342467	0.008855783	530768	Signaling by EGFR in Cancer	1569
-0.914510095	1.316410427	0.200950166	-0.914510095	-0.914510095	-0.245233938	0.202322971	658418	Viral carcinogenesis	1730
-0.923924078	-0.923924078	-0.923924078	-0.923924078	-0.923924078	-0.923924078	0.673257851	198884	TNF-alpha/NF-kB Signaling Pathway	1383
-0.928427312	-0.928427312	0.191103994	-2.047958619	0.191103994	-0.704521051	0.064469829	833825	Fc epsilon receptor (FCERI) signaling	1914
-0.929028866	0.176168453	-2.034226184	-0.929028866	-2.034226184	-1.150068329	0.629194671	198782	EGFR1 Signaling Pathway	1285
-0.938198793	-3.133329334	-2.035764063	-3.133329334	-3.133329334	-2.474790171	58.75440696	645258	Cellular responses to stress	1660
-0.940031262	-0.940031262	-1.998029305	-1.998029305	0.117966782	-1.15163087	0.416148212	102279	Endocytosis	172
-0.947502753	-0.947502753	-0.947502753	-0.947502753	-0.947502753	-0.947502753	0.76366415	105983	HIV Infection	390
-0.949011329	0.129839724	-2.027862381	-0.949011329	-0.949011329	-0.949011329	0.225040277	585562	Epstein-Barr virus infection	1655
-0.957111437	-0.957111437	0.11528233	-2.029505203	0.11528233	-0.742632683	0.024708175	576248	Signaling by the B Cell Receptor (BCR)	1624
-1.031907092	-2.018716973	-2.018716973	-0.045097212	-2.018716973	-1.426631045	0.382839368	106513	Neuronal System	722
-1.150016743	-1.150016743	-1.150016743	-0.26025524	-0.26025524	-0.794112141	0.103017606	366171	Cytokine Signaling in Immune system	1446
-1.308749859	-2.092667114	-1.308749859	-2.092667114	-2.092667114	-1.779100212	15.69689467	106572	Transmembrane transport of small molecules	764
-1.460022394	-3.578862942	-2.166302577	-1.460022394	2.07137852	-1.318766357	34.23282071	160976	Metabolism of lipids and lipoproteins	1079
-1.48790316	-2.030517638	-1.48790316	-2.030517638	-1.48790316	-1.704948951	13.5811808	105937	Gene Expression	352
-2.020291929	0.08226244	0.08226244	0.08226244	0.08226244	-0.338248434	9.25168E-05	106459	NGF signalling via TRKA from the plasma membrane	681
-2.029608329	-2.029608329	-5.081192043	-3.0468029	-1.012413757	-2.639925072	64.56430499	868086	Rap1 signaling pathway	1936
-2.036879795	-2.036879795	0.350042095	0.350042095	-0.84341885	-0.84341885	0.428760386	645295	Gastrin-CREB signalling pathway via PKC and MAPK	1688
-2.039896735	-2.039896735	-2.039896735	-1.076112872	-0.112329009	-1.461626417	1.026063652	83048	MAPK signaling pathway	87
-2.042010218	-2.986532625	0.791557003	0.791557003	-3.931055033	-1.475296774	15.02099459	105688	Axon guidance	195
-2.045045282	-3.09502489	-2.045045282	-3.09502489	-0.995065674	-2.255041204	39.86446083	868085	Ras signaling pathway	1935
-2.046366033	-0.249140403	-0.249140403	-0.249140403	-0.249140403	-0.608585529	0.007884242	106439	Signalling by NGF	667
-2.049013285	-2.049013285	-0.890429539	-2.049013285	-3.207597032	-2.049013285	24.57048246	198845	Insulin Signaling	1345
-2.050717935	-4.490959417	-4.490959417	-0.830597194	-2.050717935	-2.782790379	70.44993229	99051	Chemokine signaling pathway	167
-2.052365322	-0.844914037	-2.052365322	0.362537248	-3.259816607	-1.569384808	4.205984456	712093	BDNF signaling pathway	1789
-2.055302574	-2.055302574	-0.853019699	-0.853019699	-0.853019699	-1.333932849	2.621976015	198909	B Cell Receptor Signaling Pathway	1407
-2.059393579	-2.059393579	-2.059393579	-0.878345475	0.302702629	-1.350764717	2.32220002	198779	MAPK signaling pathway	1282
-2.073692927	-2.073692927	-2.073692927	-2.073692927	-2.073692927	-2.073692927	38.34619107	83090	Insulin signaling pathway	129
-2.074166671	-2.074166671	0.525202551	0.525202551	-0.77448206	-0.77448206	0.919077893	106043	G alpha (q) signalling events	433
-2.088166082	0.573274247	-0.757445918	-0.757445918	-0.757445918	-0.757445918	0.520214385	477132	Cell-Cell communication	1528
-2.115038372	-3.495116262	-2.115038372	-2.115038372	-2.115038372	-2.39105395	69.94144978	862188	Non-alcoholic fatty liver disease (NAFLD)	1933
-2.118426028	-0.738388877	-2.118426028	-0.738388877	-0.738388877	-1.290403738	1.806683365	169642	Toxoplasmosis	1173
-2.127492667	-2.127492667	-2.127492667	-0.71043957	-0.71043957	-1.560671428	4.860248791	755440	Prostate Cancer	1832
-2.131993689	-2.131993689	-2.131993689	-0.691943916	-2.131993689	-1.843983735	14.29600049	695200	HIF-1 signaling pathway	1776
-2.134763936	-2.134763936	-2.134763936	-2.134763936	-2.134763936	-2.134763936	44.33526275	83111	Prostate cancer	150
-2.144137036	-4.417957641	-0.628256633	0.129683569	-4.417957641	-2.295725077	3.409711771	477129	Developmental Biology	1525
-2.145026597	-3.593488071	-2.145026597	0.751896351	-5.041949545	-2.434718892	62.68130691	739007	Spinal Cord Injury	1825
-2.153846942	-2.153846942	-2.153846942	-2.153846942	-2.153846942	-2.153846942	46.35260961	106419	Signaling by Insulin receptor	651
-2.172866767	-2.172866767	-2.172866767	-2.172866767	-2.172866767	-2.172866767	48.4356897	106096	Integration of energy metabolism	470
-2.176214426	-2.176214426	-0.667416682	-0.667416682	-0.667416682	-1.27093578	1.4079737	198816	Integrin-mediated cell adhesion	1317
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	645297	Glycosaminoglycan metabolism	1690
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685536	Mucopolysaccharidoses	1754
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685537	MPS I - Hurler syndrome	1755
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685538	MPS II - Hunter syndrome	1756
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685539	MPS IIIA - Sanfilippo syndrome A	1757
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685540	MPS IIIB - Sanfilippo syndrome B	1758
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685541	MPS IIIC - Sanfilippo syndrome C	1759
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685542	MPS IIID - Sanfilippo syndrome D	1760
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685543	MPS IV - Morquio syndrome A	1761
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685544	MPS IV - Morquio syndrome B	1762
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685545	MPS VI - Maroteaux-Lamy syndrome	1763
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685546	MPS VII - Sly syndrome	1764
-2.208372914	-2.208372914	-0.666213058	-2.208372914	-3.75053277	-2.208372914	26.91059749	685547	MPS IX - Natowicz syndrome	1765
-2.235289563	-4.286139366	-4.286139366	-4.286139366	-2.918906164	-3.602522765	513.7511283	106230	Metabolism of proteins	536
-2.236864487	-0.612475767	-2.236864487	-0.612475767	-2.236864487	-1.587108999	4.198525977	198855	Toll-like receptor signaling pathway	1355
-2.238111694	-0.610157305	-2.238111694	-0.610157305	-2.238111694	-1.586929938	4.173773711	83076	Toll-like receptor signaling pathway	115
-2.238416732	-0.609055302	-2.238416732	-0.609055302	-2.238416732	-1.58667216	4.160411488	920955	Regulation of toll-like receptor signaling pathway	1982
-2.250952587	-2.250952587	-2.250952587	-2.250952587	-2.250952587	-2.250952587	57.78721126	106420	Insulin receptor signalling cascade	652
-2.256585803	-2.256585803	-2.256585803	1.061190868	-2.256585803	-1.593030469	27.51698899	777534	Insulin secretion	1868
-2.289501138	-2.289501138	-2.289501138	-2.289501138	-2.289501138	-2.289501138	62.90777411	106424	IRS-related events	655
-2.293791043	1.10781952	-0.592985761	-0.592985761	-0.592985761	-0.592985761	0.529853322	160966	Cell junction organization	1070
-2.303721319	-0.597829713	-2.303721319	2.813953498	-0.597829713	-0.597829713	5.337425077	198812	Endochondral Ossification	1314
-2.316491589	1.153128105	-5.786111283	-0.581681742	1.153128105	-1.275605681	10.36711835	83064	TGF-beta signaling pathway	103
-2.31671308	-2.31671308	-2.31671308	-2.31671308	-2.31671308	-2.31671308	66.73616615	814182	Prolactin signaling pathway	1889
-2.325527387	1.171243362	1.171243362	1.171243362	1.171243362	0.471889213	4.376329659	198807	Alpha6-Beta4 Integrin Signaling Pathway	1309
-2.32730032	-2.32730032	-2.32730032	-2.32730032	-2.32730032	-2.32730032	68.27506876	105909	Regulation of Insulin Secretion	339
-2.342939095	-2.342939095	-0.565561539	-0.565561539	-2.342939095	-1.631988072	4.113795816	187097	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1196
-2.353826704	-2.353826704	-4.144217442	-2.353826704	-4.144217442	-3.069982999	223.9796311	154409	Gastric acid secretion	1041
-2.354923992	-2.354923992	-2.354923992	-0.558026512	-2.354923992	-1.995544496	17.16178315	698754	AGE/RAGE pathway	1778
-2.393671892	-0.544705499	-0.544705499	-0.544705499	-0.544705499	-0.914498778	0.210722864	835410	Thyroid hormone synthesis	1929
-2.42253786	-2.42253786	-2.42253786	-0.525261077	-0.525261077	-1.663627147	3.922492839	193146	Bile secretion	1255
-2.422619337	-6.22161469	-4.322117014	-2.422619337	-4.322117014	-3.942217478	682.1289961	833812	ECM proteoglycans	1907
-2.430532529	-0.524680942	-4.336384116	-4.336384116	-6.242235704	-3.574043481	149.6898595	137989	FGF signaling pathway	904
-2.438785865	-0.517650046	-2.438785865	-0.517650046	-0.517650046	-1.286104374	0.825004106	138006	ATF-2 transcription factor network	920
-2.466907271	-2.466907271	-2.466907271	-2.466907271	-2.466907271	-2.466907271	91.36169009	83059	mTOR signaling pathway	98
-2.492270735	-2.492270735	-2.492270735	-2.492270735	-4.4835385	-2.890524288	172.9823429	138017	Signaling events mediated by PTP1B	931
-2.500578606	-2.500578606	1.497628383	-2.500578606	-4.4996821	-2.100757907	105.3676824	645289	Collagen biosynthesis and modifying enzymes	1682
-2.528420826	-2.528420826	-4.546395068	-2.528420826	-2.528420826	-2.932015675	185.8080851	83101	Vibrio cholerae infection	140
-2.535061634	-2.535061634	-0.488924474	-0.488924474	-2.535061634	-1.71660677	3.89447682	576255	Cytosolic sensors of pathogen-associated DNA	1630
-2.540755557	-0.497854892	-0.497854892	1.545045773	-0.497854892	-0.497854892	0.48440941	160135	MAP kinase activation in TLR cascade	1043
-2.548433556	-2.548433556	-6.66229377	-4.605363663	-2.548433556	-3.78259162	507.817489	833810	Non-integrin membrane-ECM interactions	1905
-2.569930557	1.619376733	-2.569930557	-0.475276912	5.808684022	0.362584546	29.52671564	83032	Drug metabolism - cytochrome P450	71
-2.593591993	-2.593591993	-2.593591993	-4.718006944	-2.593591993	-3.018474983	213.4839367	83095	Type I diabetes mellitus	134
-2.629423216	-2.629423216	-2.629423216	-2.629423216	-2.629423216	-2.629423216	125.6905035	169350	Signaling events mediated by TCPTP	1166
-2.630219388	-0.464716846	-0.464716846	-0.464716846	1.700785697	-0.464716846	0.448959139	82991	Arachidonic acid metabolism	47
-2.640671072	-2.640671072	-4.827924507	-7.015177942	-2.640671072	-3.953023133	623.6516644	137954	Arf6 trafficking events	874
-2.707998738	-0.440277984	-0.440277984	-0.440277984	1.827442769	-0.440277984	0.422350634	685553	Arachidonic acid metabolism	1771
-2.722853884	-2.722853884	-0.441929164	-2.722853884	-2.722853884	-2.26666894	24.29125811	198918	Type II interferon signaling (IFNG)	1416
-2.746528351	-2.746528351	-2.746528351	-2.746528351	-2.746528351	-2.746528351	156.2861282	83094	Type II diabetes mellitus	133
-2.753444151	-2.753444151	-2.753444151	-2.753444151	-2.753444151	-2.753444151	158.2637163	138026	Insulin Pathway	939
-2.890789576	-7.871474579	-7.871474579	-0.400447074	-5.381132077	-4.883063577	385.9645799	106359	Chemokine receptors bind chemokines	602
-2.910604513	-3.599553909	-0.843756325	-0.843756325	-2.910604513	-2.221655117	21.70946707	106356	Signaling by GPCR	599
-2.91365802	-2.91365802	0.110691181	-0.645396119	-2.157570719	-1.703918339	1.308523609	119548	GPCR downstream signaling	800
-2.914513408	-0.407944147	-0.407944147	2.098625113	-0.407944147	-0.407944147	0.415243691	160138	MAPK targets/ Nuclear events mediated by MAP kinases	1046
-2.915816104	-2.915816104	-2.915816104	-2.915816104	-2.915816104	-2.915816104	210.7660473	130626	Aldosterone-regulated sodium reabsorption	829
-2.939559614	-0.399763853	-2.939559614	-0.399763853	-2.939559614	-1.92364131	4.059325346	137960	Osteopontin-mediated events	880
-2.94136921	-2.94136921	-2.94136921	0.691744933	-2.94136921	-2.214746381	51.77786684	161020	GPCR ligand binding	1109
-2.98832099	-2.98832099	-2.98832099	-0.382643709	-0.382643709	-1.946050077	3.907247214	83035	ABC transporters	74
-3.023089787	-3.023089787	-3.023089787	-3.023089787	-3.023089787	-3.023089787	252.4964232	137981	Insulin-mediated glucose transport	898
-3.044280169	-2.018855698	-3.044280169	-2.018855698	-3.044280169	-2.63411038	114.9911485	83053	Neuroactive ligand-receptor interaction	92
-3.086655811	-3.086655811	-3.086655811	1.189527213	-3.086655811	-2.231419206	107.9759913	106357	Class A/1 (Rhodopsin-like receptors)	600
-3.092473885	-4.15558155	-5.218689215	-0.966258556	-2.029366221	-3.092473885	131.50827	83051	Cytokine-cytokine receptor interaction	90
-3.116284719	-0.367147302	-0.367147302	2.381990115	-0.367147302	-0.367147302	0.36736528	106481	Nuclear Events (kinase and transcription factor activation)	700
-3.125746506	-0.36923475	-0.36923475	-0.36923475	-0.36923475	-0.920537101	0.05809838	198792	NOD pathway	1295
-3.133595234	2.404504416	-0.364545409	2.404504416	-0.364545409	0.189264556	2.407672007	730309	Collagen degradation	1795
-3.144801878	2.425902481	-0.359449699	-0.359449699	-0.359449699	-0.359449699	0.354308034	755436	AhR pathway	1828
-3.151788517	-0.357030355	-0.357030355	-3.151788517	-3.151788517	-2.033885252	3.990997819	82973	Glutathione metabolism	31
-3.155949684	-3.155949684	-3.155949684	-3.155949684	-3.155949684	-3.155949684	313.0764156	83058	Regulation of autophagy	97
-3.169117638	-2.018029743	-5.471293428	-2.018029743	-3.169117638	-3.169117638	223.7803009	217173	Influenza A	1432
-3.185222535	-3.185222535	-3.185222535	-3.185222535	-3.185222535	-3.185222535	327.8678995	106573	ABC-family proteins mediated transport	765
-3.209742844	-3.209742844	-0.347478849	-3.209742844	-3.209742844	-2.637290045	36.88156419	771600	Scavenging of Heme from Plasma	1865
-3.221975464	-3.221975464	-3.221975464	-0.347265021	-3.221975464	-2.647033376	37.42397862	645301	Keratan sulfate/keratin metabolism	1693
-3.232066008	-0.348095268	-0.348095268	-0.348095268	-0.348095268	-0.924889416	0.047453986	106057	Formation of Fibrin Clot (Clotting Cascade)	442
-3.273046854	-3.273046854	-3.273046854	-3.273046854	-3.273046854	-3.273046854	375.6307274	106328	Regulation of beta-cell development	575
-3.276164815	-2.05893843	1.592740725	0.37551434	-2.05893843	-1.085157322	8.306614813	119550	G alpha (i) signalling events	802
-3.295893068	-0.339802599	-0.339802599	2.616287869	-0.339802599	-0.339802599	0.338328615	106482	ERK/MAPK targets	701
-3.425873949	-3.425873949	-0.328618774	-0.328618774	-3.425873949	-2.186971879	4.342090603	160134	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1042
-3.445692958	-9.704899057	-0.316089908	-6.575296007	-3.445692958	-4.697534177	239.4804755	833814	Scavenging by Class A Receptors	1909
-3.448198282	-0.322140277	-0.322140277	-0.322140277	-0.322140277	-0.947351878	0.037134052	906029	Laminin interactions	1976
-3.457178919	-3.457178919	-3.457178919	-0.317713864	-3.457178919	-2.829285908	45.38617576	645302	Keratan sulfate biosynthesis	1694
-3.471662046	-2.111426158	-0.751190269	0.609045619	-2.111426158	-1.567331802	7.080909011	106388	Toll-Like Receptors Cascades	625
-3.525297134	-4.926476464	-3.525297134	2.079420184	-3.525297134	-2.684589536	448.8134374	106358	Peptide ligand-binding receptors	601
-3.537951296	-2.123873758	-0.70979622	-2.123873758	2.118358856	-1.275427235	23.99619943	105698	Biological oxidations	201
-3.57226404	-3.57226404	-3.57226404	-3.57226404	-3.57226404	-3.57226404	581.7250415	83096	Maturity onset diabetes of the young	135
-3.578140267	-3.578140267	-0.309387454	-0.309387454	-3.578140267	-2.270639141	4.385079591	187101	TRAF6 mediated NF-kB activation	1200
-3.598971532	-2.152032469	-0.705093406	0.741845658	-2.152032469	-1.573256843	8.718389391	106398	Toll Like Receptor 4 (TLR4) Cascade	632
-3.628885365	-3.628885365	-0.302531852	-0.302531852	-3.628885365	-2.29834396	4.373830609	576256	ZBP1(DAI) mediated induction of type I IFNs	1631
-3.629812324	-6.954425186	-3.629812324	-3.629812324	-6.954425186	-4.959657469	2312.996583	920974	Vitamin B12 Metabolism	1989
-3.669391502	-2.176373028	-0.683354555	0.809663918	-2.176373028	-1.579165639	9.616379643	106400	Activated TLR4 signalling	633
-3.688151078	-3.688151078	-3.688151078	-3.688151078	-3.688151078	-3.688151078	682.4070643	106438	Insulin receptor recycling	666
-3.69527126	-0.299038311	-3.69527126	-3.69527126	-0.299038311	-2.33677808	4.512244616	137968	ALK1 signaling events	886
-3.745041188	-3.745041188	-0.291321275	-0.291321275	-3.745041188	-2.363553223	4.457734497	576258	RIP-mediated NFkB activation via ZBP1	1633
-3.769719922	-2.212306197	-0.654892471	0.902521254	-2.212306197	-1.589340707	10.9050332	106391	Toll Like Receptor 3 (TLR3) Cascade	628
-3.769719922	-2.212306197	-0.654892471	0.902521254	-2.212306197	-1.589340707	10.9050332	106401	MyD88-independent cascade	634
-3.769719922	-2.212306197	-0.654892471	0.902521254	-2.212306197	-1.589340707	10.9050332	187089	TRIF-mediated TLR3/TLR4 signaling	1188
-3.776458435	-3.776458435	-2.204898537	-3.776458435	-3.776458435	-3.462146455	448.4638546	814926	Carbon metabolism	1890
-3.826023856	-3.826023856	-3.826023856	-7.366835347	-3.826023856	-4.534186154	1578.598398	105903	Insulin Processing	333
-3.838427493	-0.28037457	-0.28037457	-3.838427493	-3.838427493	-2.415206324	4.44567045	105727	Glutathione conjugation	216
-3.849490564	-3.849490564	-3.849490564	-3.849490564	-3.849490564	-3.849490564	845.310565	106332	Regulation of gene expression in beta cells	578
-3.870144945	-2.249684808	-0.629224671	0.991235466	-2.249684808	-1.601500754	12.21667884	106390	MyD88:Mal cascade initiated on plasma membrane	627
-3.870144945	-2.249684808	-0.629224671	0.991235466	-2.249684808	-1.601500754	12.21667884	106402	Toll Like Receptor 2 (TLR2) Cascade	635
-3.870144945	-2.249684808	-0.629224671	0.991235466	-2.249684808	-1.601500754	12.21667884	106403	Toll Like Receptor TLR1:TLR2 Cascade	636
-3.870144945	-2.249684808	-0.629224671	0.991235466	-2.249684808	-1.601500754	12.21667884	106404	Toll Like Receptor TLR6:TLR2 Cascade	637
-3.877603569	-2.250682545	-0.623761521	1.003159503	-2.250682545	-1.599914135	12.29080883	106397	Toll Like Receptor 9 (TLR9) Cascade	631
-3.944258095	-2.277447143	-0.610636192	1.056174759	-2.277447143	-1.610722763	13.19411496	106396	Toll Like Receptor 7/8 (TLR7/8) Cascade	630
-3.944258095	-2.277447143	-0.610636192	1.056174759	-2.277447143	-1.610722763	13.19411496	187081	MyD88 dependent cascade initiated on endosome	1180
-3.954853318	-2.281974286	-0.609095255	1.063783776	-2.281974286	-1.612822674	13.34413578	187082	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	1181
-3.970266245	-0.2680411	-3.970266245	-0.2680411	-3.970266245	-2.489376187	4.496366246	198769	Osteoclast Signaling	1272
-3.970421953	-2.28782588	-0.605229807	1.077366265	-2.28782588	-1.614787451	13.55084202	106389	Toll Like Receptor 10 (TLR10) Cascade	626
-3.970421953	-2.28782588	-0.605229807	1.077366265	-2.28782588	-1.614787451	13.55084202	106395	Toll Like Receptor 5 (TLR5) Cascade	629
-3.970421953	-2.28782588	-0.605229807	1.077366265	-2.28782588	-1.614787451	13.55084202	205107	MyD88 cascade initiated on plasma membrane	1420
-3.970519082	-2.281511475	1.096503738	-2.281511475	-5.659526688	-2.619312996	128.257518	645288	Collagen formation	1681
-4.056380527	-0.264307491	-4.056380527	-0.264307491	-0.264307491	-1.781136705	0.303812608	198840	Blood Clotting Cascade	1341
-4.077929239	-4.077929239	-0.262144417	-0.262144417	-4.077929239	-2.55161531	4.660154156	83014	Nicotinate and nicotinamide metabolism	61
-4.104767969	-0.259011686	-0.259011686	-4.104767969	-0.259011686	-1.797314199	0.292775884	83025	Nitrogen metabolism	67
-4.113031664	-4.113031664	-3.072508583	-4.113031664	-4.113031664	-3.904927048	879.3085915	106196	Metabolism of carbohydrates	521
-4.119362277	-4.119362277	-4.119362277	-4.119362277	-4.119362277	-4.119362277	1186.1782	106421	SHC-related events	653
-4.138925394	-4.138925394	-0.569116744	-2.354021069	-4.138925394	-3.067982799	94.98925968	105689	NCAM signaling for neurite out-growth	196
-4.139265024	-0.26009814	-0.26009814	-4.139265024	-4.139265024	-2.58759827	4.797822678	198824	Glutathione metabolism	1325
-4.204620758	-3.220364253	-2.728236	-3.220364253	-3.712492506	-3.417215554	441.6562142	106386	Immune System	623
-4.211429754	-0.255921391	-0.255921391	-0.255921391	-0.255921391	-1.047023064	0.018065747	106483	ERKs are inactivated	702
-4.228322691	3.732371446	-4.228322691	-4.228322691	-4.228322691	-2.636183863	1193.046451	730349	Signaling by Activin	1824
-4.243887292	-4.243887292	-4.243887292	-4.243887292	-4.243887292	-4.243887292	1376.63627	119538	Synthesis, Secretion, and Deacylation of Ghrelin	791
-4.252898477	-4.252898477	-4.252898477	-4.252898477	-4.252898477	-4.252898477	1391.313752	106199	Glucose metabolism	524
-4.285577608	-2.036402837	-3.160990223	-2.036402837	-3.160990223	-2.936072746	177.5755041	106384	Signaling by PDGF	621
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	106249	Metabolism of vitamins and cofactors	553
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	106250	Metabolism of water-soluble vitamins and cofactors	554
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	905998	Defects in vitamin and cofactor metabolism	1945
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	905999	Defects in cobalamin (B12) metabolism	1946
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906000	Defective AMN causes hereditary megaloblastic anemia 1	1947
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906001	Defective CUBN causes hereditary megaloblastic anemia 1	1948
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906002	Defective TCN2 causes hereditary megaloblastic anemia	1949
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906003	Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF	1950
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906004	Defective GIF causes intrinsic factor deficiency	1951
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906005	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1952
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906006	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1953
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906007	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1954
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906008	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1955
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906009	Defective MMAB causes methylmalonic aciduria type cblB	1956
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906010	Defective MMAA causes methylmalonic aciduria type cblA	1957
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906011	Defective MUT causes methylmalonic aciduria mut type	1958
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906012	Defective CD320 causes methylmalonic aciduria	1959
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906013	Defects in biotin (Btn) metabolism	1960
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906014	Defective HLCS causes multiple carboxylase deficiency	1961
-4.28936479	-6.16918107	1.350084053	-4.28936479	-6.16918107	-3.913401533	945.3699793	906015	Defective BTD causes biotidinase deficiency	1962
-4.302643038	-0.248517873	-4.302643038	-4.302643038	-0.248517873	-2.680992972	4.919502729	82977	Mucin type O-Glycan biosynthesis	35
-4.339261022	3.306003519	-2.427944887	-0.516628751	1.394687384	-0.516628751	25.09651139	673221	Chemical carcinogenesis	1751
-4.346411028	-4.346411028	-4.346411028	-4.346411028	-4.346411028	-4.346411028	1551.150616	160975	Signal attenuation	1078
-4.367664243	-4.367664243	-0.515853724	-4.367664243	-8.219474761	-4.367664243	353.279447	730306	Assembly of collagen fibrils and other multimeric structures	1792
-4.383191681	-4.383191681	-2.451163788	-4.383191681	-4.383191681	-3.996786103	904.7616516	790012	Biosynthesis of amino acids	1886
-4.397617984	-4.397617984	-0.240293363	-0.240293363	-4.397617984	-2.734688136	4.910616872	187092	Advanced glycosylation endproduct receptor signaling	1191
-4.40373933	-2.457206154	-4.40373933	-6.350272506	-2.457206154	-4.014432695	743.5646915	771603	Peptide hormone metabolism	1867
-4.46060553	3.471475078	-2.477585378	-0.494565226	3.471475078	-0.097961196	65.8679471	83031	Metabolism of xenobiotics by cytochrome P450	70
-4.487483423	-0.234952342	-0.234952342	-4.487483423	-4.487483423	-2.786470991	4.988478785	142435	glutathione-mediated detoxification I	1027
-4.531400371	-4.531400371	-0.232770792	-0.232770792	-4.531400371	-2.81194854	5.041436198	833822	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1912
-4.56240364	4.100251014	4.100251014	4.100251014	4.100251014	2.367720083	1289.541977	160970	Type I hemidesmosome assembly	1073
-4.562441889	-4.562441889	-2.52940404	-4.562441889	-4.562441889	-4.155834319	1095.992524	366238	Amyloids	1454
-4.579595195	-0.492130722	-0.492130722	-0.492130722	-2.535862959	-1.718370064	1.384185528	105721	Phase II conjugation	212
-4.583900302	-2.535138211	-2.535138211	-2.535138211	-2.535138211	-2.944890629	189.339719	83073	Complement and coagulation cascades	112
-4.606976681	-2.545920119	-6.668033243	-2.545920119	-2.545920119	-3.782554056	506.930112	82926	Glycolysis / Gluconeogenesis	1
-4.625116506	-0.229871323	-0.229871323	-0.229871323	4.16537386	-0.229871323	0.234008187	730333	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1810
-4.63700935	1.585076326	-8.785066467	-0.488952233	-0.488952233	-2.562980791	15.43711253	198810	TGF Beta Signaling Pathway	1312
-4.688491623	-5.209090963	-2.606094264	-5.209090963	-5.209090963	-4.584371755	1727.066613	530764	Disease	1567
-4.74453705	-4.74453705	-2.606924899	-4.74453705	-4.74453705	-4.31701462	1321.003261	137932	IL6-mediated signaling events	853
-4.792702798	-4.792702798	-4.792702798	-0.219076691	-4.792702798	-3.877977576	115.5894417	645303	Keratan sulfate degradation	1695
-4.802594907	-0.220621996	-4.802594907	-4.802594907	-0.220621996	-2.969805742	5.391697093	413362	O-glycan biosynthesis, mucin type core	1481
-4.828969581	-0.216332671	-0.216332671	-0.216332671	-0.216332671	-1.138860053	0.010576523	907943	superpathway of steroid hormone biosynthesis	1980
-4.88558694	-2.104628982	-2.104628982	-2.104628982	2.066807954	-1.826533187	94.13334909	198837	metapathway biotransformation	1338
-4.927684369	-2.026913585	-6.861531559	0.873857199	-3.960760775	-3.380606618	237.2019536	782000	Proteoglycans in cancer	1869
-4.942682997	-0.443608723	-2.69314586	-0.443608723	-2.69314586	-2.243238433	7.054766823	712094	Cardiac Progenitor Differentiation	1790
-4.947406304	-0.209419037	-0.209419037	-4.947406304	-0.209419037	-2.104613944	0.224803792	645352	Reversible Hydration of Carbon Dioxide	1729
-5.063295681	-5.063295681	-7.375355629	-5.063295681	-5.063295681	-5.525707671	4847.481103	198814	Glycolysis and Gluconeogenesis	1316
-5.064129309	-5.787307743	-6.510486178	-2.171415569	-2.171415569	-4.340950874	899.6646975	106028	Hemostasis	428
-5.068185167	-5.068185167	-0.208947231	-0.208947231	-5.068185167	-3.124489993	5.683693655	105726	Methylation	215
-5.072547896	-5.072547896	-5.072547896	-5.072547896	-2.753032648	-4.608644846	1822.703331	137979	FOXA1 transcription factor network	896
-5.116456153	-2.772522235	-2.772522235	-2.772522235	-2.772522235	-3.241309019	302.3217605	198880	Complement and Coagulation Cascades	1379
-5.233913086	-5.233913086	-0.416246402	-2.825079744	-5.233913086	-3.788613081	168.6012238	105697	NCAM1 interactions	200
-5.235022267	-5.235022267	-2.825068409	-5.235022267	-7.644976124	-5.235022267	3098.56565	106405	Complement cascade	638
-5.283784123	-0.197108674	-5.283784123	-0.197108674	-0.197108674	-2.231778853	0.213799821	106061	Dissolution of Fibrin Clot	445
-5.332113246	-0.197181384	-5.332113246	-0.197181384	-5.332113246	-3.278140501	5.894268467	198761	Osteopontin Signaling	1265
-5.352038531	-5.352038531	-5.352038531	-5.352038531	-5.352038531	-5.352038531	4391.330832	835393	conversion of glucose to acetyl CoA and entry into the TCA cycle	1927
-5.41289722	-5.41289722	-0.1923762	-0.1923762	-5.41289722	-3.324688812	5.869377249	161021	Formyl peptide receptors bind formyl peptides and many other ligands	1110
-5.429228713	-7.029732431	-5.429228713	-7.029732431	-8.630236149	-6.709631687	12571.19445	169306	Pancreatic secretion	1159
-5.583017036	-0.183319724	-0.183319724	-0.183319724	-0.183319724	-1.263259186	0.0063053	730307	Anchoring fibril formation	1793
-5.637209226	-3.601821724	-2.244896722	-2.923359223	-4.280284225	-3.737514224	570.3448527	106387	Innate Immune System	624
-5.770202207	-5.770202207	-2.312869289	-5.770202207	-9.227535125	-5.770202207	4100.245815	172847	Protein digestion and absorption	1177
-5.81346608	-0.82058071	-5.81346608	-0.82058071	-2.068802053	-3.067379127	47.07949887	198874	Regulation of Actin Cytoskeleton	1373
-5.828023583	-5.828023583	-5.828023583	-5.828023583	-5.828023583	-5.828023583	6723.671737	105911	Glycolysis	340
-5.918724447	-0.175456826	-5.918724447	-5.918724447	-5.918724447	-4.770070923	215.3191981	160988	Peptide hormone biosynthesis	1084
-6.05039964	-6.05039964	-6.05039964	-6.05039964	-6.05039964	-6.05039964	8108.122613	106204	Gluconeogenesis	527
-6.158897316	-1.257950519	-5.34207285	-1.257950519	0.375698413	-2.728234558	19.56046828	83105	Pathways in cancer	144
-6.240996342	-2.029371453	-6.240996342	-2.029371453	-4.135183898	-4.135183898	663.3241022	83089	Regulation of actin cytoskeleton	128
-6.266309454	-12.01987989	-0.512739019	-6.266309454	-8.184166266	-6.649880817	1980.590155	771599	Binding and Uptake of Ligands by Scavenger Receptors	1864
-6.296081802	-0.337127821	-0.337127821	-0.337127821	-0.337127821	-1.528918617	0.081329619	106144	Bile acid and bile salt metabolism	490
-6.376565319	-0.160680619	-6.376565319	-0.160680619	-6.376565319	-3.890211439	6.694026592	530758	Alpha-defensins	1561
-6.382959021	-6.382959021	-3.354846198	-6.382959021	-9.411071845	-6.382959021	8210.656293	106406	Initial triggering of complement	639
-6.434464921	-6.434464921	-6.434464921	-6.434464921	-6.434464921	-6.434464921	11029.66159	413340	Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate	1466
-6.443491357	-0.161448501	-6.443491357	-6.443491357	-6.443491357	-5.187082786	278.303725	160989	Glycoprotein hormones	1085
-6.495828079	-6.495828079	-6.495828079	-6.495828079	-6.495828079	-6.495828079	11565.71832	82930	Fructose and mannose metabolism	5
-6.507182313	-7.856972769	-4.707461705	-5.607322009	-2.457810945	-5.427349948	3316.95049	477135	Metabolism	1531
-6.509460651	-6.509460651	-6.509460651	-0.157527931	-0.157527931	-3.968687563	6.844632871	198866	Steroid Biosynthesis	1366
-6.538107646	-0.697252127	-6.538107646	-0.697252127	-2.157466007	-3.325637111	44.83609608	106062	Cell surface interactions at the vascular wall	446
-6.776507153	-6.776507153	-6.776507153	-6.776507153	-6.776507153	-6.776507153	14289.91039	82928	Pentose phosphate pathway	3
-6.80035369	-6.80035369	-3.556374445	-3.556374445	-6.80035369	-5.502761992	3977.493379	198833	Folate Metabolism	1334
-6.841606283	-6.841606283	-3.572021441	-6.841606283	-10.11119113	-6.841606283	11566.19768	106407	Creation of C4 and C2 activators	640
-6.913847591	-0.146181586	-0.146181586	-0.146181586	-0.146181586	-1.499714787	0.003157116	545302	androgen biosynthesis	1590
-7.081361603	-7.081361603	-7.081361603	-7.081361603	-7.081361603	-7.081361603	17806.7171	137911	FOXA2 and FOXA3 transcription factor networks	832
-7.141103479	-4.910101252	-4.910101252	-2.679099025	-2.679099025	-4.463900807	1235.730468	790011	Ovarian steroidogenesis	1885
-7.176862325	-0.29225172	-0.29225172	-0.29225172	-0.29225172	-1.669173841	0.052355573	106145	Synthesis of bile acids and bile salts	491
-7.27458377	-0.612266919	-8.940162982	-2.277846131	-2.277846131	-4.276541187	206.6061041	149807	Bacterial invasion of epithelial cells	1037
-7.327049186	-7.327049186	-8.388148392	-3.08265236	-3.08265236	-5.841510296	4279.306763	106034	Platelet activation, signaling and aggregation	430
-7.335263393	-0.437869552	-5.036132113	-0.437869552	1.861261728	-2.277174576	13.18286392	82940	Steroid hormone biosynthesis	15
-7.457342221	-7.457342221	-7.457342221	-7.457342221	-7.457342221	-7.457342221	23063.24262	413342	Gluconeogenesis, oxaloacetate => fructose-6P	1468
-7.485851781	-0.135611925	-0.135611925	-0.135611925	-0.135611925	-1.605659896	0.00253182	530759	Beta defensins	1562
-7.492317602	-0.28036467	-0.28036467	-0.28036467	-0.28036467	-1.722755257	0.04629236	106146	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	492
-7.663976221	-7.663976221	-7.663976221	-7.663976221	-7.663976221	-7.663976221	26440.56572	106425	IRS activation	656
-7.703132927	-11.26820156	-5.92059861	-7.703132927	-9.485667245	-8.416146654	37551.12009	198825	Selenium Pathway	1326
-7.819373431	-4.531228341	-8.641409703	-3.709192068	-5.353264613	-6.010893631	6079.537367	692234	PI3K-Akt signaling pathway	1774
-7.915127085	-4.736926444	-6.553041096	-4.282897781	-6.099012433	-5.917400968	6417.925225	477114	Signal Transduction	1512
-7.928273578	-7.928273578	-4.093001917	-7.928273578	-11.76354524	-7.928273578	23994.74055	106409	Classical antibody-mediated complement activation	642
-7.961129217	-7.961129217	-7.961129217	-7.961129217	-7.961129217	-7.961129217	31979.62487	782396	glycolysis	1880
-8.008535647	-4.001137043	-9.010385298	-4.001137043	-7.006685996	-6.405576205	8094.238258	83067	Focal adhesion	106
-8.280896389	-8.280896389	-8.280896389	-8.280896389	-8.280896389	-8.280896389	38939.1757	782382	gluconeogenesis	1873
-8.369742769	-3.065958546	-9.430499614	-4.12671539	-5.187472235	-6.036077711	5180.520468	198795	Focal Adhesion	1298
-8.462773673	-0.24189923	-0.24189923	-0.24189923	-0.24189923	-1.886074119	0.028976817	106147	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	493
-8.797527368	-8.797527368	-5.983669262	-5.983669262	-11.61138547	-8.234755747	32176.62265	576264	Activation of Matrix Metalloproteinases	1639
-8.926846359	-13.27504235	-0.230454387	-8.926846359	-13.27504235	-8.926846359	3236.330983	833804	Cobalamin (Cbl, vitamin B12) transport and metabolism	1899
-9.08364843	-0.468349204	-9.08364843	1.685475602	-2.622174011	-3.914468895	170.7947039	137917	Angiopoietin receptor Tie2-mediated signaling	838
-9.163174977	-4.022159299	-5.735831192	-4.022159299	-7.449503085	-6.078565571	6334.147605	576263	Degradation of the extracellular matrix	1638
-9.324643218	-0.448574331	-11.54366044	-0.448574331	-2.667591553	-4.886608775	57.77819064	137945	amb2 Integrin signaling	866
-9.645437575	-0.207862589	-0.207862589	-0.207862589	-0.207862589	-2.095377586	0.018006415	198911	Benzo(a)pyrene metabolism	1409
-9.712747063	-8.204064564	-11.22142956	-2.169334566	-3.678017065	-6.997118564	7134.435444	106048	Response to elevated platelet cytosolic Ca2+	436
-9.713559535	-2.757083382	-9.713559535	-2.757083382	-2.757083382	-5.539673843	1977.454568	106053	Platelet Aggregation (Plug Formation)	438
-9.763863285	-0.211583008	-4.987723147	-0.211583008	-4.987723147	-4.032495119	10.8739653	530757	Defensins	1560
-9.831269145	-0.426506008	-9.831269145	-2.777696792	-5.128887576	-5.599125733	587.2896426	138031	Syndecan-2-mediated signaling events	944
-9.900632907	-8.357588956	-11.44367686	-2.185413149	-3.7284571	-7.123153794	7715.645297	106050	Platelet degranulation	437
-10.19456106	-2.855856774	-17.53326535	-2.855856774	-2.855856774	-7.259079346	4163.327796	138064	Syndecan-4-mediated signaling events	974
-10.24809687	-10.24809687	-15.67891886	-7.532685871	-8.890391368	-10.51963797	110274.0417	198780	Senescence and Autophagy	1283
-10.37920089	-2.896718391	-15.36752256	-2.896718391	-2.896718391	-6.887375724	3876.917925	198766	Inflammatory Response Pathway	1270
-10.81830545	-0.49234194	-10.81830545	-0.49234194	-2.557534642	-5.035765885	72.55605635	137999	Integrins in angiogenesis	914
-10.85001801	-0.188967127	-0.188967127	-0.188967127	-0.188967127	-2.321177303	0.013834883	106148	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	494
-11.00553369	-3.036764953	-11.00553369	-3.036764953	-3.036764953	-6.224272448	3391.999279	106054	Integrin alphaIIb beta3 signaling	439
-11.16312272	-5.163338931	-11.16312272	-5.163338931	-8.163230826	-8.163230826	27120.31584	83068	ECM-receptor interaction	107
-11.40435636	-7.648722967	-11.40435636	-4.831997923	-11.40435636	-9.338757994	54818.60869	576262	Extracellular matrix organization	1637
-11.54442965	-0.636552542	-6.869625173	-2.1948207	-3.753088858	-4.999703384	415.8413519	83118	Small cell lung cancer	157
-11.57216544	-11.57216544	-11.57216544	-11.57216544	-5.873977275	-10.43252781	105339.3898	545347	sucrose degradation V (mammalian)	1609
-11.5832404	-0.348419872	-11.5832404	-3.157125004	-3.157125004	-5.965830136	465.9578274	137996	VEGFR3 signaling in lymphatic endothelium	911
-12.01541776	-2.131763112	-9.191516429	-4.955664439	-4.955664439	-6.650005235	5781.875936	167324	Amoebiasis	1157
-13.97524679	-0.294478537	-13.97524679	-0.294478537	-3.7146706	-6.450824251	62.91389498	106056	p130Cas linkage to MAPK signaling for integrins	441
-13.98869421	-0.295767223	-13.98869421	-0.295767223	-3.718998969	-6.457584367	63.66203227	106055	GRB2:SOS provides linkage to MAPK signaling for Intergrins	440
-14.69269283	-7.63089282	-18.22359284	-5.865442817	-9.396342823	-11.16179283	112608.3034	106110	Integrin cell surface interactions	478
